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IINTRODUCTION 
Lower Urinary Tract Symptoms (LUTS) are divided into storage phase 
symptoms, voiding phase symptoms and post micturition symptoms. 
Overactive bladder (OAB) syndrome is one of the storage phase disorders 
that presents with urgency with or without urgency incontinence, usually 
with frequency and nocturia in absence of infection or any other obvious 
pathology[1]. OAB syndrome is highly prevalent in Western society, 13% of 
women and 11% of men above 18 years have these symptoms. 
 
Clinical assessment of patients with OAB symptoms can be summarized as 
follows[2]: 
1. History and clinical examination: to exclude underlying medical disease 
such as upper motor neuron lesion, diabetes mellitus or diabetes 
insipidus. Urological diseases can be the cause of OAB symptoms and 
therefore it is necessary to exclude urinary tract infection, reduced 
bladder capacity, interstitial cystitis, vesical tumors or stones and 
urethral syndrome. Some gynecological conditions can also resemble 
cause OAB symptoms such as, stress urinary incontinence, pelvic organ 
prolapse, fibroids and postmenopausal genital atrophy. 
2. Voiding diary and urgency severity scales to measure the severity of 
urgency severity e.g. Urgency Severity Scales, Patient Perception of 
Intensity of Urgency Score and Urgency Perception Score. 
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3. Quality of Life questionnaires. 
4. Urine analysis, culture and sensitivity in all cases of incontinence to 
exclude UTI. 
5. Refractory and/or complex symptoms may receive one or all of the 
following tests: 
a) Uroflowmetry to exclude a significant post void residual urine 
b) Cystourethroscopy in patients with hematuria, painful bladder 
syndrome and recurrent incontinence; it is of great value to exclude 
vesical tumor or stones. 
c) Filling cystometry to prove the presence of detrusor overactivity 
(DO), which is a urodynamic finding in about 60% of women with 
OAB[3]. 
 
Voiding LUTS can be caused by bladder outlet obstruction (BOO). 
Assessment of patients with voiding LUTS includes[4]:  
1. A focused history taking supported by voiding diaries and International 
Prostate Symptoms Score (IPSS) questionnaire. 
2. Urinary flowmetry can prove the presence of diminished flow rate and 
high residual urine suggestive of BOO, but can still indicate a case of 
bladder hypo-contractility, which makes its specificity questionable. 
3. Cystoscopy can confirm the presence of an organic cause of BOO, such 
as enlarged prostatic gland or stricture urethra, but still lack a 
functional or dynamic assessment of voiding act. 
4. Pressure flow studies can confirm the presence of high voiding pressure 
versus low flow rate, and can also exclude the presence of detrusor 
hypo-contractility. They can be saved for patients who might 
necessitate surgical interference to treat LUTS.  
 
Filling cystometry and pressure flow studies are invasive procedures as they 
imply insertion of a gas- or water-filled urethral catheter in the bladder 
through which water is infused at room temperature with certain filling 
rates as requested by the primary patient’s physician. This catheter is 
provided with a pressure sensor to monitor changes in intravesical pressure 
(Pves) during filling; another catheter is to be inserted in the rectum to 
monitor abdominal pressure (Pabd) changes. Detrusor pressure (Pdet) 
changes can be obtained by subtracting the Pabd from the Pves values
[1,5]. 
The invasive nature of filling cystometry can lead to various morbidities, 
such as patient’s discomfort, pain and sometimes urinary tract infections 
(UTI)[6]. Therefore, it is worthwhile to develop non-invasive techniques that 
can replace the conventional urodynamics in the diagnosis of functional 
lower urinary tract disorders. 
 
The knowledge about non-invasive urodynamics is growing and gaining 
reasonable evidence, at least on theoretical and scientific basis. Some trials 
were done to develop less- or non-invasive diagnostic tools to replace 
conventional urodynamics, for example ultrasonographic measurement of 
bladder wall thickness (BWT)[7,8], detrusor wall thickness (DWT)9,10], 
ultrasonographic estimated bladder weight (UEBW)[11] and measurement of 
isovolumetric bladder pressure[12]. Nerve Growth Factor (NGF) and other 
neurotrophins as biomarkers for DO were also investigated[13]. 
 
This thesis describes three new non-invasive diagnostic techniques for 
functional lower urinary tract disorders. 
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Near-infrared spectroscopy (NIRS) is an imaging technology. NIRS of 
biologic tissues enables non-invasive evaluation of oxygen dependent 
hemodynamic changes in these tissues by measurement of the relevant 
changes in the concentration of tissue hemoglobin. Oxy-hemoglobin (O2Hb) 
and deoxy-hemoglobin (HHb) respectively represent the oxygen supply and 
consumption of the tissue. The sum of O2Hb and HHb is Hbsum, it represents 
the total blood perfusion of the tissue under monitoring[14-16]. 
 
In chapters 1 and 4, systematic reviews are presented of the clinical studies 
that have been done to develop non-invasive diagnostic tools in the storage 
and voiding phases of the micturition cycle. 
 
In chapters 2 and 3, a novel diagnostic technique for DO in patients with 
OAB syndrome that has been developed at the Department of Urology of 
the Radboud University Nijmegen Medical Centre, The Netherlands. In 
these two chapters, the feasibility, reproducibility and accuracy of NIRS in 
the diagnosis of DO were determined in patients with OAB symptoms.  
 
Chapter 5 describes our experience with a new home-based uroflowmeter 
in the diagnosis of voiding LUTS. Chapter 6 describes the results of NIRS 
monitoring of the bladder activity during voiding in men with LUTS. The 
preliminary observations from our trial to apply 2D ultrasonography in real-
time monitoring of voiding activity in men with LUTS are presented in 
chapter 7. A summary of all these studies with future directions is given in 
chapter 8. 
 
 
 
References 
1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary 
tract function: report from the Standardisation Sub-committee of the International 
Continence Society. Neurourol Urodyn. 2002: 21:167-78 
2. Robinson D, Cardozo L. Overactive bladder: Diagnosis and management. Maturitas. 
2012: 71:188-93 
3. Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor 
overactivity? Journal of Urology. 2006: 175:191-4 
4. Novara G, Galfano A, Gardi M, Ficarra V, Boccon-Gibod L, Artibani W. Critical review of 
guidelines for BPH diagnosis and treatment strategy. European Urology, Supplements. 
2006: 5:418-29 
5. Schafer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling 
cystometry, and pressure-flow studies. Neurourol Urodyn. 2002: 21:261-74 
6. Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. 
Morbidity of the evaluation of the lower urinary tract with transurethral multichannel 
pressure-flow studies. J Urol. 1998: 159:191-4 
7. Manieri C, Carter SS, Romano G, Trucchi A, Valenti M, Tubaro A. The diagnosis of 
bladder outlet obstruction in men by ultrasound measurement of bladder wall 
thickness. J Urol. 1998: 159:761-5 
8. Khullar V, Salvatore S, Cardozo L, Bourne TH, Abbott D, Kelleher C. A novel technique 
for measuring bladder wall thickness in women using transvaginal ultrasound. 
Ultrasound Obstet Gynecol. 1994: 4:220-3 
9. Kuo HC. Measurement of detrusor wall thickness in women with overactive bladder by 
transvaginal and transabdominal sonography. Int Urogynecol J Pelvic Floor Dysfunct. 
2009: 20:1293-9 
10. Oelke M, Hofner K, Wiese B, Grunewald V, Jonas U. Increase in detrusor wall thickness 
indicates bladder outlet obstruction (BOO) in men. World J Urol. 2002: 19:443-52 
11. Panayi DC, Khullar V, Digesu GA, Hendricken C, Fernando R, Tekkis P. Is ultrasound 
estimation of bladder weight a useful tool in the assessment of patients with lower 
urinary tract symptoms? Int Urogynecol J Pelvic Floor Dysfunct. 2009: 20:1445-9 
12. Drinnan MJ, Robson W, Reddy M, Pickard RS, Ramsden PD, Griffiths CJ. Transmission of 
penile cuff pressure to the penile urethra. J Urol. 2001: 166:2545-9 
13. Kuo HC, Liu HT, Chancellor MB. Can urinary nerve growth factor be a biomarker for 
overactive bladder? Rev Urol. 2010: 12:e69-e77 
14. Villringer A, Chance B. Non-invasive optical spectroscopy and imaging of human brain 
function. Trends Neurosci. 1997: 20:435-42 
15. Ferrari M, Mottola L, Quaresima V. Principles, techniques, and limitations of near 
infrared spectroscopy. Can J Appl Physiol. 2004: 29:463-87 
16. Boushel R, Piantadosi CA.Near-infrared spectroscopy for monitoring muscle 
oxygenation. Acta Physiol Scand. 2000:168:615-22. 
 
13
Near-infrared spectroscopy (NIRS) is an imaging technology. NIRS of 
biologic tissues enables non-invasive evaluation of oxygen dependent 
hemodynamic changes in these tissues by measurement of the relevant 
changes in the concentration of tissue hemoglobin. Oxy-hemoglobin (O2Hb) 
and deoxy-hemoglobin (HHb) respectively represent the oxygen supply and 
consumption of the tissue. The sum of O2Hb and HHb is Hbsum, it represents 
the total blood perfusion of the tissue under monitoring[14-16]. 
 
In chapters 1 and 4, systematic reviews are presented of the clinical studies 
that have been done to develop non-invasive diagnostic tools in the storage 
and voiding phases of the micturition cycle. 
 
In chapters 2 and 3, a novel diagnostic technique for DO in patients with 
OAB syndrome that has been developed at the Department of Urology of 
the Radboud University Nijmegen Medical Centre, The Netherlands. In 
these two chapters, the feasibility, reproducibility and accuracy of NIRS in 
the diagnosis of DO were determined in patients with OAB symptoms.  
 
Chapter 5 describes our experience with a new home-based uroflowmeter 
in the diagnosis of voiding LUTS. Chapter 6 describes the results of NIRS 
monitoring of the bladder activity during voiding in men with LUTS. The 
preliminary observations from our trial to apply 2D ultrasonography in real-
time monitoring of voiding activity in men with LUTS are presented in 
chapter 7. A summary of all these studies with future directions is given in 
chapter 8. 
 
 
 
References 
1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary 
tract function: report from the Standardisation Sub-committee of the International 
Continence Society. Neurourol Urodyn. 2002: 21:167-78 
2. Robinson D, Cardozo L. Overactive bladder: Diagnosis and management. Maturitas. 
2012: 71:188-93 
3. Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor 
overactivity? Journal of Urology. 2006: 175:191-4 
4. Novara G, Galfano A, Gardi M, Ficarra V, Boccon-Gibod L, Artibani W. Critical review of 
guidelines for BPH diagnosis and treatment strategy. European Urology, Supplements. 
2006: 5:418-29 
5. Schafer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling 
cystometry, and pressure-flow studies. Neurourol Urodyn. 2002: 21:261-74 
6. Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. 
Morbidity of the evaluation of the lower urinary tract with transurethral multichannel 
pressure-flow studies. J Urol. 1998: 159:191-4 
7. Manieri C, Carter SS, Romano G, Trucchi A, Valenti M, Tubaro A. The diagnosis of 
bladder outlet obstruction in men by ultrasound measurement of bladder wall 
thickness. J Urol. 1998: 159:761-5 
8. Khullar V, Salvatore S, Cardozo L, Bourne TH, Abbott D, Kelleher C. A novel technique 
for measuring bladder wall thickness in women using transvaginal ultrasound. 
Ultrasound Obstet Gynecol. 1994: 4:220-3 
9. Kuo HC. Measurement of detrusor wall thickness in women with overactive bladder by 
transvaginal and transabdominal sonography. Int Urogynecol J Pelvic Floor Dysfunct. 
2009: 20:1293-9 
10. Oelke M, Hofner K, Wiese B, Grunewald V, Jonas U. Increase in detrusor wall thickness 
indicates bladder outlet obstruction (BOO) in men. World J Urol. 2002: 19:443-52 
11. Panayi DC, Khullar V, Digesu GA, Hendricken C, Fernando R, Tekkis P. Is ultrasound 
estimation of bladder weight a useful tool in the assessment of patients with lower 
urinary tract symptoms? Int Urogynecol J Pelvic Floor Dysfunct. 2009: 20:1445-9 
12. Drinnan MJ, Robson W, Reddy M, Pickard RS, Ramsden PD, Griffiths CJ. Transmission of 
penile cuff pressure to the penile urethra. J Urol. 2001: 166:2545-9 
13. Kuo HC, Liu HT, Chancellor MB. Can urinary nerve growth factor be a biomarker for 
overactive bladder? Rev Urol. 2010: 12:e69-e77 
14. Villringer A, Chance B. Non-invasive optical spectroscopy and imaging of human brain 
function. Trends Neurosci. 1997: 20:435-42 
15. Ferrari M, Mottola L, Quaresima V. Principles, techniques, and limitations of near 
infrared spectroscopy. Can J Appl Physiol. 2004: 29:463-87 
16. Boushel R, Piantadosi CA.Near-infrared spectroscopy for monitoring muscle 
oxygenation. Acta Physiol Scand. 2000:168:615-22. 
 
  
 
 
 
 
 
 
 
 
CHAPTER 1 
Non-Invasive Techniques in the Diagnosis of 
Bladder Storage Disorders 
 
 
Fawzy F. Farag 1,2  MD 
John P. Heesakkers 1  MD, PhD 
1Department of Urology, Radboud University Nijmegen Medical Centre, 
Nijmegen, The Netherlands. 
2Department of Urology, Sohag University, Sohag, Egypt. 
 
Published in Neurourology and Urodynamics. 2011 Nov;30(8):1422-8 
 
 
 
 
 
 
 
 
 
 
15
  
 
 
 
 
 
 
 
 
CHAPTER 1 
Non-Invasive Techniques in the Diagnosis of 
Bladder Storage Disorders 
 
 
Fawzy F. Farag 1,2  MD 
John P. Heesakkers 1  MD, PhD 
1Department of Urology, Radboud University Nijmegen Medical Centre, 
Nijmegen, The Netherlands. 
2Department of Urology, Sohag University, Sohag, Egypt. 
 
Published in Neurourology and Urodynamics. 2011 Nov;30(8):1422-8 
 
 
 
 
 
 
 
 
 
 
16
Chapter 1 
Abstract 
 
Aims 
To review the clinical studies, which have been performed to develop non-
invasive diagnostic tools in the storage phase of the micturition cycle. 
Methods 
Pub Med and Web of Science searches were carried out. The search 
covered the published data of non-invasive diagnostic techniques for 
detrusor overactivity (DO) and/or low compliance bladder in patients with 
urinary storage symptoms. The pathophysiological and clinical relevance of 
these methods were addressed. Diagnostic accuracy of these techniques 
was scrutinized. 
Results 
18 studies were included in the review. Ultrasonography and biomarkers 
were the most investigated techniques in the diagnosis of storage 
disorders. Assessment of diagnostic accuracy was possible in four studies. 
The heterogeneity in data reporting was too high to conduct a meta-
analysis. Ultrasonographic parameters and cut-off values have been 
developed to define DO, such as bladder wall thickness (BWT), detrusor 
wall thickness and bladder weight. The likelihood ratio of vaginal 
ultrasonography in the measurement of BWT was good. Guidelines are 
currently developed to standardize the methodologies applied in these 
techniques. Laboratory biomarkers of DO are recently gaining more 
attention, but their specificity for DO should be carefully defined. Near-
infrared spectroscopy (NIRS) is a potential non-invasive diagnostic method 
that is able to detect the DO episodes in real-time. However, a solution 
needs to be found for motion artifacts in this technique. 
Conclusions 
Non-invasive diagnostic techniques for storage disorders show limited 
progress with some limitations. These techniques still cannot replace the 
standard filling cystometry in routine clinical practice yet. 
 
 
Non-Invasive Techniques in the Diagnosis of Bladder Storage Disorders 
 
Introduction 
Overactive bladder (OAB) syndrome is highly prevalent in the Western 
community where 13% of women and 11% of men above 18 years have 
OAB symptoms[1]. It negatively affects the patient’s quality of life[2]. OAB 
syndrome is defined as ‘urgency’, with or without urgency incontinence, 
usually with frequency and nocturia in absence of infection or other 
obvious pathology[3]. Detrusor overactivity (DO) is a major cause of these 
symptoms. Although a diagnosis of OAB syndrome would be derived from 
these symptoms, some other bladder disorders may share these non-
specific symptoms. This fact makes it reasonable to clarify the actual 
etiology and pathophysiology of OAB syndrome applying the available 
diagnostic techniques[4]. 
 
Filling cystometry is the current standard urodynamic test applied in the 
diagnosis of DO in patients with OAB syndrome. Clarke[5] believed that it is 
inappropriate to rely on the symptoms of the lower urinary tract alone in 
the diagnosis and planning treatment strategies. He found that the 
symptoms of urinary stress incontinence, although associated with 
urodynamic stress incontinence in 95% of cases, were also associated with 
DO in 64% of cases. This ratio would have been missed if the diagnosis was 
based on symptoms only. Salvatore et al.[6] reported a significant difference 
in tolterodine efficacy when used in different forms of DO. The authors 
assumed a substantial correlation between the pathophysiology of DO 
either spontaneous ’myogenic‘ or provocative ’neurogenic‘. This shows the 
importance of addressing the definite etiology and pathology of OAB 
syndrome, especially in planning treatment strategies. 
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Urodynamics equipment measures pressure changes in the bladder 
suggestive of DO or poor compliance. In order to monitor these pressure 
changes, insertion of transurethral and rectal catheters is mandatory[7]. This 
can explain the invasive nature and potential morbidity of filling 
cystometry[8]. Moreover, authors agree that the correspondence between 
OAB symptoms and DO is not that perfect[9]; one study showed that only 
55% of women with OAB were diagnosed urodynamically to have DO, while 
only 30% of women with a urodynamic diagnosis of DO had these 
symptoms[10]. Radley et al.[11] found that conventional cystometry classified 
only 32 out of 106 women with OAB symptoms as having DO, while 
ambulatory urodynamics classified 70 women as having DO. 
 
The above-mentioned drawbacks make it worthwhile to develop new non-
invasive diagnostic tools that can replace the conventional cystometry in 
the diagnosis of bladder storage disorders. This is important in certain 
patient groups that need to undergo regular urodynamic evaluation. 
 
Methods 
Pub Med and Web of Science searches (1980–2010) were carried out to 
obtain the literature. Keywords used in search were: urinary bladder, 
overactive; low compliance bladder; diagnosis; non-invasive; 
ultrasonography; laboratory techniques and procedures; biological markers; 
spectroscopy, near-infrared; nerve growth factor; bladder weight; bladder 
wall thickness; detrusor wall thickness. The search was limited to studies 
conducted in humans and written in English. The target disease was DO or 
low compliance bladder in adult subjects with bladder storage symptoms. 
An article to be included had to describe a non-invasive diagnostic test 
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being evaluated as compared to a reference urodynamics test of bladder 
storage disorders. Articles evaluating treatment and/or surgery outcomes 
were not included. For every technique, the index study was presented 
followed by the more recent studies. 
 
We focused on the rational implied to address the pathophysiological and 
clinical relevance of the non-urodynamic parameters derived from these 
studies. Studies providing diagnostic cut-offs were assessed for their quality 
applying the QUADAS tool (Table 2)[12]. These studies were further analyzed 
to calculate their likelihood ratio (LR+). This ratio indicates the pre-test to 
post-test probability to detect the disease[13]. 
 
Results 
Provisional online database searches found 953 hits. Eighteen original 
articles met the inclusion criteria. Figure 1 shows the flow diagram of the 
studies included for full revision. Ten articles[14-23] described three different 
potential ultrasonographic diagnostic parameters for DO in adults with OAB 
symptoms, applying three different approaches. Only one article[24] 
described a potential ultrasonographic diagnostic parameter for low 
compliance bladder in adults. Six articles[25-30] described potential biological 
markers for DO. Finally, one article[31] described experimental non-invasive 
near-infrared spectroscopy of the bladder for the diagnosis of DO in 
patients with OAB symptoms. 
 
Only five articles[17-19;22,23] provided diagnostic cut-offs for ultrasonographic 
parameters. It was possible in four[17-19;23] out of these five articles to 
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calculate the LR+ in our study (Table 1). Two studies[14-15] found no 
significant difference between cases with DO and controls. Ten studies 
presented significant correlation between the non-urodynamic and the 
urodynamic parameters in cases with DO and/or low compliance. Some of 
them presented significant qualitative or quantitative discrimination 
between cases and controls. Thirteen studies were conducted on women, 
one study on men and four studies included both genders. 
 
                                    
 
 
 
 
 
 
 
 
 
 
 Figure 1: Flow diagram for studies search and inclusion 
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Ultrasonographic Methods 
Bladder wall thickness measurement 
Elbadawi et al.[32] studied the ultra-structural morphologic changes in 
bladder wall specimens obtained from patients with bladder outlet 
obstruction (BOO). The changes were mainly increase in the smooth 
muscles bulk with or without interstitial collagen deposition. Experimental 
studies have revealed similar features in animals with bladder outlet 
obstruction[33]. These findings strengthened the assumption that 
measurement of the increased bladder wall thickness (BWT) can be used as 
a diagnostic test for BOO. In urinary bladders with DO, frequent detrusor 
contractions during the storage phase while the urethral sphincter is closed, 
are supposed to increase work load on the muscle with consequent 
hypertrophy[16,19,22,34]. 
 
The bladder wall consists of bladder adventitia, which gives a hyperechoic 
(bright) appearance on ultrasonography, the detrusor muscle layer, which 
gives a hypoechoic (dark) appearance on ultrasonography, and the 
innermost layer is the bladder mucosa, which gives a hyperechoic (bright) 
appearance on ultrasonography[35,36]. If the inner and outer hyperechoic 
lines were included in the measurement, then BWT is the measured 
parameter. If measurement skips these two lines, then the detrusor wall 
thickness (DWT) is the measured parameter. 
 
When an ultrasonographic trans-vaginal (TVUS) approach was applied to 
measure the BWT of female patients with irritative urinary symptoms, 
Khullar et al.[17] found a significant difference in median BWT between 
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female patients with OAB due to DO, and those without DO (6.3 mm vs. 3.9 
mm; р < 0.001). A cut-off BWT 5 mm had 84% sensitivity and 89% specificity 
for DO, while Robinson et al.[22] reported a cut-off of 6.0 mm to be highly 
suggestive of DO. 
 
Applying the same TVUS approach to study BWT in different forms of DO, 
Serati et al.[23] reported significantly thicker BWT in patients with 
urodynamic ‘pure DO’ than in patients with other urodynamic diagnoses of 
urodynamic stress incontinence (USI), mixed incontinence (USI + DO) or 
normal urodynamics. BWT was 5.22 ± 1.17 vs. 4.37 ± 1.13 mm respectively; 
p < 0.0001. A cut-off BWT of 6.5 mm could identify patients having ‘pure 
DO’ with 13.33% sensitivity and 97.67% specificity for DO. The sensitivity of 
this cut-off BWT declined to 10.9% when it identified women having ‘all DO’ 
diagnosis (‘pure DO’ + ‘mixed DO’). This means that applying this cut-off 
BWT as a screening test, only 10-13% of women with OAB will not undergo 
further invasive urodynamics. 
 
However, other conclusions were drawn with other techniques. Blatt et 
al.[14] applied trans-abdominal ultrasound (TAUS) to measure the BWT at 
200 ml filling volume of the bladder in 180 patients with non-neurogenic 
voiding dysfunctions. Conventional urodynamics classification of  these 
patients identified 69 as having normal urodynamics, 39 as having BOO, 38 
had increased bladder sensations, while 34 patients were diagnosed as 
having DO. No significant difference in BWT was found between patients 
with normal urodynamics and those with DO (2.0 mm vs. 1.9 mm 
respectively; p = 0.309). 
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Detrusor wall thickness measurement 
Detrusor muscle has been considered the actual component of the bladder 
wall that hypertrophies due to the frequent contractions against the high 
resistance of the bladder outlet complex. A trans-labial ultrasonographic 
(TLUS) approach was applied to measure the DWT of 686 women with OAB 
symptoms[19]. Authors reported significant difference in the average DWT 
between patients with DO (4.7 ± 1.9 mm) and those without DO (4.1 ± 1.6 
mm; р < 0.001). They suggested various cut-offs for the diagnosis of DO: ≥5 
mm, ≥6 mm and ≥7 mm. These cut-offs had a sensitivity of 37%, 22% and 
13%, respectively. Having this relatively low sensitivity for DO, authors 
found none of these cut-offs to be clinically useful as a diagnostic tool for 
DO. 
 
An interesting study was done by Kuo et al.[18] including 25 women with 
OAB wet symptoms, 28 women with OAB dry symptoms and 28 women 
free of urinary symptoms as controls. The mean DWT was assessed with 
both TVUS and TAUS approaches during natural and catheter filling. 
Authors found no significant difference in mean DWT measured by TVUS 
among different subgroups of the study (ANOVA p = 0.243). The mean DWT 
was derived from these women applying TAUS approach at bladder 
capacity and at 250 ml filling. There was no significant difference among the 
three groups at 250 ml bladder filling, neither with natural filling (ANOVA p 
= 0.057), nor with catheter filling (ANOVA p = 0.189). This can be explained 
by the smaller bladder capacity in patients with wet OAB. However, at 
bladder capacity, DWT, was significantly higher in patients with urodynamic 
DO than the urodynamically normal women during both natural filling 
(1.036 ± 0.397 vs. 0.770 ± 0.209; p = 0.006) and catheter filling (0.927 ± 
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0.407 vs. 0.667 ± 0.184; p = 0.006). A cut-off DWT of 0.75 mm at bladder 
capacity during natural filling had 73% sensitivity and 67% specificity for DO 
diagnosis. The same cut-off had 73% sensitivity and 50% specificity during 
catheter filling. 
 
Table 1 shows the results of calculating the LR+ in four studies. Two studies 
applying TVUS approach presented a cut-off BWT >5 mm [17] and >6.5 mm 
[23], respectively. Both studies could identify DO in women with OAB 
symptoms with good LR+ >5. While the other two studies applying TLUS 
(Lekskulchai and Dietz 535-39 and TAUS)[18] presented a cut-off of 5 mm 
and 0.75 mm respectively. Both methods had minimal LR+ <2. 
Ultrasonographic measurements of BWT and DWT to investigate OAB were 
performed using devices with various resolutions and zooming powers. 
Applied approaches were also different in every study. Moreover, filling 
conditions were different in every study set-up, which may explain part of 
the discrepancy in results. Oelke et al.[37] have proved that DWT decreases 
significantly between 50 to 250 ml filling. This may hinder the clinical 
applicability of this method, especially for patients with smaller functional 
capacity. 
 
These debates were discussed during The Second World Congress on 
Controversies in Urology that was preceded by a web based survey[38]. In 
that survey 49% of the participants had a positive impression about the role 
of BWT measurement in the assessment of OAB. However, by the end of 
the debate session, only 20% of participants were still having the same 
enthusiasm to reliably apply ultrasonography in the diagnosis of DO. Some 
suggestions have been made by experts in this field during The 
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International Consultation on Incontinence-Research Society (ICI-RS 
meeting)[39]. They agreed on the necessity of using digital ultrasound 
machines with high frequency probes, and to consider the gender 
difference effect on applying cut-off values of BWT and/or DWT as they are 
significantly higher in men with BOO than in women or children with the 
same disorder. Perpendicular imaging was also recommended to avoid over 
or under estimation. Experts reported no differences when various parts of 
the bladder wall were addressed during the scan. 
 
We feel that this last recommendation might be argued by the cystoscopic 
finding in men with BPH/BOO which – sometimes – reveals patchy 
distribution of bladder trabeculations. This argument might be generalized 
to BWT and DWT measurement in patients with OAB/DO. 
Ultrasonographic measurement of BWT and DWT in the diagnosis of DO is 
currently a progressing technique with various cut-off values being 
suggested, especially when the TVUS approach is applied. However, results 
of various performed studies are inconsistent making the technique 
universally not yet accepted. On the other hand, although the rational of 
detecting a potential hypertrophy in bladders with frequent involuntary 
contractions against a closed sphincter sounds fair, the ultra-structural 
studies by Elbadawi et al.[40] found that the characteristic profile of 
hypertrophied detrusor muscle cells is absent or only sparse in bladder 
biopsies from 15 patients with DO. 
 
Although the rational of increased BWT/DWT in men with LUTS/BOO can be 
accepted, it can be a matter of debate in case of women with OAB/DO. In 
general, the amplitude of involuntary detrusor muscle contraction is low in 
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0.407 vs. 0.667 ± 0.184; p = 0.006). A cut-off DWT of 0.75 mm at bladder 
capacity during natural filling had 73% sensitivity and 67% specificity for DO 
diagnosis. The same cut-off had 73% sensitivity and 50% specificity during 
catheter filling. 
 
Table 1 shows the results of calculating the LR+ in four studies. Two studies 
applying TVUS approach presented a cut-off BWT >5 mm [17] and >6.5 mm 
[23], respectively. Both studies could identify DO in women with OAB 
symptoms with good LR+ >5. While the other two studies applying TLUS 
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These debates were discussed during The Second World Congress on 
Controversies in Urology that was preceded by a web based survey[38]. In 
that survey 49% of the participants had a positive impression about the role 
of BWT measurement in the assessment of OAB. However, by the end of 
the debate session, only 20% of participants were still having the same 
enthusiasm to reliably apply ultrasonography in the diagnosis of DO. Some 
suggestions have been made by experts in this field during The 
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International Consultation on Incontinence-Research Society (ICI-RS 
meeting)[39]. They agreed on the necessity of using digital ultrasound 
machines with high frequency probes, and to consider the gender 
difference effect on applying cut-off values of BWT and/or DWT as they are 
significantly higher in men with BOO than in women or children with the 
same disorder. Perpendicular imaging was also recommended to avoid over 
or under estimation. Experts reported no differences when various parts of 
the bladder wall were addressed during the scan. 
 
We feel that this last recommendation might be argued by the cystoscopic 
finding in men with BPH/BOO which – sometimes – reveals patchy 
distribution of bladder trabeculations. This argument might be generalized 
to BWT and DWT measurement in patients with OAB/DO. 
Ultrasonographic measurement of BWT and DWT in the diagnosis of DO is 
currently a progressing technique with various cut-off values being 
suggested, especially when the TVUS approach is applied. However, results 
of various performed studies are inconsistent making the technique 
universally not yet accepted. On the other hand, although the rational of 
detecting a potential hypertrophy in bladders with frequent involuntary 
contractions against a closed sphincter sounds fair, the ultra-structural 
studies by Elbadawi et al.[40] found that the characteristic profile of 
hypertrophied detrusor muscle cells is absent or only sparse in bladder 
biopsies from 15 patients with DO. 
 
Although the rational of increased BWT/DWT in men with LUTS/BOO can be 
accepted, it can be a matter of debate in case of women with OAB/DO. In 
general, the amplitude of involuntary detrusor muscle contraction is low in 
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women as compared to men. Some women with mixed incontinence and 
high grades of prolapse might have a relative urethral anatomical kink[16] 
leading to infravesical obstruction. Therefore, in case of increased 
BWT/DWT - if any - in these women it needs to be clarified whether this is 
due to DO or infravesical obstruction. 
Some women present with weak pelvic floor muscles making it 
questionable if they can efficiently contract their pelvic floor muscle during 
the DO episode. 
 
The concept that DWT is a more specific measure of bladder muscular 
hypertrophy in case of BOO can be explained by the mechanical theory of 
contraction against infravesical obstruction. However, the complex 
etiology, pathophysiology and the substantial contribution of bladder 
urothelium and sub-urothelial layer in this process cannot be easily ignored. 
Sub-urothelium is rich in sensory afferents. ATP is one of the purogenic 
neurotransmitters that stimulate these sensory nerves triggering the 
overactive detrusor contraction. There is accumulative evidence that ATP is 
over expressed from urothelium in patients with DO as compared to 
controls[41]. 
 
Ultrasonographic estimation of bladder weight as a predictor for DO in 
patients with OAB symptoms 
Ultrasonographic estimation of bladder weight (UEBW) has previously been 
proven to correlate with BOO. Kojima et al.[36] studied 10 bladder autopsies 
taken from 10 men in the age of 25-92. After filling of these bladders with 
50 to 100 ml of saline, an ultrasonographic scan of the bladders was 
performed to measure BWT and inner and outer bladder dimensions. 
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Assuming the bladder to be a sphere, a specific equation was applied. The 
inner calculated bladder volume was subtracted from the outer total 
bladder volume. The outcome was multiplied by the bladder specific 
gravity. Bladder actual weights were measured directly after emptying. 
Then cross sections were obtained and compared to ultrasonographic 
measurements. The authors found no difference between the 
ultrasonographic and the actual BWT. Spherical UEBW correlated with the 
actual bladder weight (r = 0.970; р < 0.0001). 
 
One year later, Kojima et al. applied this new tool in the non-invasive 
diagnosis of BOO in men with LUTS. UEBW significantly correlated with 
pressure flow parameters. It was significantly higher in the obstructed than 
in the unobstructed group (46.2 ± 13.3 vs. 29.3 ± 9.4 gm; p < 0.0001). A cut-
off UEBW of 35 gm had 86.2% ’diagnostic accuracy’ for BOO[43]. 
 
An important fact about the rational of this technique is that the increased 
BWT in response to BOO can also be expected in case of DO. So a study was 
performed on 118 women to study the correlation between UEBW and OAB 
symptoms or urodynamic diagnosis of DO[21]. According to their medical 
history, patients were classified into three groups to differentiate between 
women with OAB symptoms, stress urinary incontinence (SUI) or mixed 
urinary incontinence (MUI) symptoms. Patients were reclassified by 
conventional urodynamics into 3 categories: category I having DO, category 
II having SUI and category III having mixed incontinence. The mean UEBW 
of these women was significantly higher in the OAB group than in the other 
two symptomatic groups (48 g in the OAB group, 35 g in the SUI group and 
40 g in the MUI group; p < 0.001). Also it was significantly higher in the DO 
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diagnosis of BOO in men with LUTS. UEBW significantly correlated with 
pressure flow parameters. It was significantly higher in the obstructed than 
in the unobstructed group (46.2 ± 13.3 vs. 29.3 ± 9.4 gm; p < 0.0001). A cut-
off UEBW of 35 gm had 86.2% ’diagnostic accuracy’ for BOO[43]. 
 
An important fact about the rational of this technique is that the increased 
BWT in response to BOO can also be expected in case of DO. So a study was 
performed on 118 women to study the correlation between UEBW and OAB 
symptoms or urodynamic diagnosis of DO[21]. According to their medical 
history, patients were classified into three groups to differentiate between 
women with OAB symptoms, stress urinary incontinence (SUI) or mixed 
urinary incontinence (MUI) symptoms. Patients were reclassified by 
conventional urodynamics into 3 categories: category I having DO, category 
II having SUI and category III having mixed incontinence. The mean UEBW 
of these women was significantly higher in the OAB group than in the other 
two symptomatic groups (48 g in the OAB group, 35 g in the SUI group and 
40 g in the MUI group; p < 0.001). Also it was significantly higher in the DO 
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group than in the other two urodynamic groups (48 g in the DO category, 
30 g in SUI category and 45 g in the mixed urodynamic incontinence 
category; p < 0.001) with good inter- and intraobserver agreements. 
 
The rationale of application of UEBW in the assessment of patients with 
OAB symptoms and those suspected to have DO is theoretically fair. 
However, it still needs to be investigated on an ultra-structural basis similar 
to UEBW investigation in BOO studies. UEBW can be affected by severe 
bladder deformities like diverticulae, which can be expected in neurogenic 
bladder disorders. More basic investigations are needed to elucidate the 
pathophysiology of these changes in bladder weight. It should be clear if it 
is due to DO in these patients, to chronic inflammation of bladder mucosa 
caused by frequent infections, or both. 
 
UEBW as a predictor of poor detrusor muscle compliance 
Follow-up of patients with neurogenic bladder disorders requires repeated 
filling cystometry to assess the functional performance of the detrusor 
muscle to guard against upper tract deterioration. This carries the risk of 
inducing urinary tract infections in these relatively vulnerable patients. 
 
The feasibility of application of UEBW method to evaluate bladder capacity 
and compliance in these patients was investigated in a study including 25 
patients with detrusor areflexia[24]. UEBW correlated significantly with 
results obtained from conventional urodynamics, cystoscopy and from 
radiography, as well in terms of bladder deformity and low compliance (r = 
0.56; р < 0.01). A diagnostic cut-off value of 40 g was suggested for high 
grade bladder deformity with 63% sensitivity and 88% specificity. When the 
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same diagnostic cut-off value was applied for low compliant bladder, it had 
100% sensitivity and 95% specificity. On the other hand, it was difficult to 
prove any correlation between UEBW and vesico-ureteral reflux, which was 
identified in three patients only. 
These results presented UEBW as a potential diagnostic method that might 
save some invasive follow-up investigations in patients with detrusor 
areflexia. However, more studies are needed in a larger patients’ 
population to validate this method. It would be more interesting if such 
studies include patients with both low compliance and/or DO. 
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same diagnostic cut-off value was applied for low compliant bladder, it had 
100% sensitivity and 95% specificity. On the other hand, it was difficult to 
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Question Khullar [17] Lekskulschai [19] Kuo [18] Serati [23] 
1 
Was the spectrum of patients 
representative for the patients who 
will receive the test in practice? 
Y Y Y Y 
2 
Were selection criteria clearly 
described? 
N Y Y Y 
3 
Is the reference standard likely to 
correctly classify the target 
condition? 
Y Y Y Y 
4 
 
Is the time period between 
reference standard and index test 
short enough to be reasonably sure 
that the target condition did not 
change between the two tests? 
Y 
 
Y 
 
Y 
 
Y 
 
5 
Did the whole sample or a random 
selection of the sample, receive 
verification using a reference 
standard of diagnosis? 
Y Y Y Y 
6 
Did patients receive the same 
reference standard regardless of 
the index test result? 
Y Y Y Y 
7 
Was the reference standard 
independent of the index test (i.e. 
the index test did not form part of 
the reference standard)? 
Y Y Y Y 
8 
Was the execution of the index test 
described in sufficient detail to 
permit replication of the test? 
Y Y Y Y 
9 
Was the execution of the reference 
standard described in sufficient 
detail to permit its replication? 
Y Y Y Y 
10 
Were the index test results 
interpreted without knowledge of 
the results of the reference 
standard? 
Y N/C Y Y 
11 
Were the reference standard 
results interpreted without 
knowledge of the results of the 
index test? 
Y N/C Y Y 
12 
 
Were the same clinical data 
available when test results were 
interpreted as would be available 
when the test is used in practice? 
N N N 
N 
 
13 
Were un interpretable/ 
intermediate  
test results reported? 
N/A N/A N/A N/A 
14 
Were withdrawals from the study 
explained? 
N/W N/A N/W N/W 
Table 2: Quality assessment of studies, which present potential diagnostic cut-off for detrusor overactivity 
(DO). Y= yes; N = no; N/A = not applicable; N/C = not clear; N/W = no withdrawal 
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Question Khullar [17] Lekskulschai [19] Kuo [18] Serati [23] 
1 
Was the spectrum of patients 
representative for the patients who 
will receive the test in practice? 
Y Y Y Y 
2 
Were selection criteria clearly 
described? 
N Y Y Y 
3 
Is the reference standard likely to 
correctly classify the target 
condition? 
Y Y Y Y 
4 
 
Is the time period between 
reference standard and index test 
short enough to be reasonably sure 
that the target condition did not 
change between the two tests? 
Y 
 
Y 
 
Y 
 
Y 
 
5 
Did the whole sample or a random 
selection of the sample, receive 
verification using a reference 
standard of diagnosis? 
Y Y Y Y 
6 
Did patients receive the same 
reference standard regardless of 
the index test result? 
Y Y Y Y 
7 
Was the reference standard 
independent of the index test (i.e. 
the index test did not form part of 
the reference standard)? 
Y Y Y Y 
8 
Was the execution of the index test 
described in sufficient detail to 
permit replication of the test? 
Y Y Y Y 
9 
Was the execution of the reference 
standard described in sufficient 
detail to permit its replication? 
Y Y Y Y 
10 
Were the index test results 
interpreted without knowledge of 
the results of the reference 
standard? 
Y N/C Y Y 
11 
Were the reference standard 
results interpreted without 
knowledge of the results of the 
index test? 
Y N/C Y Y 
12 
 
Were the same clinical data 
available when test results were 
interpreted as would be available 
when the test is used in practice? 
N N N 
N 
 
13 
Were un interpretable/ 
intermediate  
test results reported? 
N/A N/A N/A N/A 
14 
Were withdrawals from the study 
explained? 
N/W N/A N/W N/W 
Table 2: Quality assessment of studies, which present potential diagnostic cut-off for detrusor overactivity 
(DO). Y= yes; N = no; N/A = not applicable; N/C = not clear; N/W = no withdrawal 
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Conventional cystometry enables differentiation between these two 
conditions by observing pressure lines behavior. On the other hand, it is still 
unclear to what extent ultrasonography can be beneficial in such 
differentiation. Evaluation of bladder storage function should address some 
essential parameters, especially when neurological deficit is expected. 
These parameters are bladder sensation, detrusor activity, bladder 
compliance and bladder capacity[3]. Moreover, it is of great importance to 
assess the performance of the urethral sphincter complex and pelvic floor 
muscles. Again, the current sonographic techniques still cannot present 
reliable ‘surrogates’ for these parameters. 
 
Laboratory Biomarkers 
Nerve growth factor (NGF) is a signaling protein that induces neuronal 
differentiation, normally produced by bladder urothelium and smooth 
muscles[44]. It is produced in higher levels in bladder pain 
syndrome/interstitial cystitis (BPS/IC)[45]. Kim et al. reported significantly 
higher urinary NGF in men[25] and women[26] with OAB symptoms than 
controls. A study included 40 women with IC/BPS, 57 women with OAB 
symptoms and 27 controls[29]. Authors normalized urinary NGF level [pg/ml] 
by the concentration of urinary creatinine (cr) [mg/dl]. A ratio was 
developed: NGF/cr. This ratio was found to be significantly higher in 
patients with urodynamic DO than controls (1.93 vs. 0.09 respectively; p = 
0.01). And also higher in patients with IC/BPS than controls (1.35 vs. 0.09 
respectively; p = 0.01). 
 
Urinary NGF level was assessed together with DWT in 81 women with OAB 
symptoms[27]. Patients were classified symptomatically into 28 controls, 28 
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patients with OAB dry and 25 women with OAB wet. Video-urodynamics 
classified these patients into 3 subgroups: a group with normal bladders (n 
= 27), a group with increased bladder sensations on cystometry (n = 30) and 
a group with DO (n = 22). The urinary NGF levels in OAB wet subgroup were 
significantly higher than its levels in OAB dry and control subgroups, also it 
was significantly higher in DO subgroups (55.81 ± 103.03 pg/ml) than in 
women with urodynamically normal bladders (1.76 ± 4.18 pg/ml; p = 0.09) 
or those with increased bladder sensations in cystometry (6.21 ± 14.43 
pg/ml; p = 0.013). Authors found no significant difference in DWT between 
all subgroups when measured at fixed bladder volume of 250 ml; they 
concluded that NGF was superior to DWT as a biomarker for assessment of 
OAB wet or DO. 
 
NGF can increase in many lower urinary tract disorders such as BOO, 
prostatitis and interstitial cystitis[46-48]. However, Kuo et al. in their 
comprehensive review of NGF application in urology, think that NGF still 
can be used as a surrogate biomarker to evaluate the therapeutic outcome 
in patients with idiopathic or neurogenic DO. They also proposed that some 
new systemic and local therapeutic lines based on NGF rule in the 
pathogenesis of DO[49]. 
 
Near-Infrared Spectroscopy 
Near-infrared spectroscopy (NIRS) as an optical technology has been proven 
by Macnab et al.[50] to be capable of non-invasive detection of oxygen 
dependant hemodynamic changes in the bladder detrusor during voiding. 
This technology measures the changes in the concentration of bladder wall 
chromophores, such as oxy-hemoglobin (O2Hb) and deoxy-hemoglobin 
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(HHb) relative to baseline. Stothers et al.[51] reported NIRS as an 
independent predictor of BOO with 94% ‘precision’ in men with LUTS and 
clinical BPH according to their voiding pattern. 
 
Doppler ultrasound studies revealed significant variations in hemodynamics 
of the bladder wall during the micturition cycle[52,53] and bladder 
contractions in animal models[54].  
Based on these previous findings, a pilot study was performed. The 
hypothesis was that involuntary detrusor contractions during a storage 
phase have specific hemodynamic effects. The objective was to evaluate 
the feasibility of the non-invasive NIRS of the bladder region to detect these 
effects. 
 
14 patients with DO were enrolled in this study. All patients had one or 
more filling cystometry with simultaneous trans-cutaneous NIRS of the 
bladder region. A total number of 40 DO episodes was obtained. NIRS 
curves representing O2Hb, HHb and total hemoglobin (Hbsum [O2Hb + HHb]) 
demonstrated significant concomitant deviation from baseline in 37 out of 
40 (93%) DO episodes. All onsets of NIRS deviations occurred within the 
time limit of the DO episodes with a mean delay of 3 seconds (range: 0-
9)[55]. 
 
After approving the feasibility of this technique, a larger clinical study was 
performed to evaluate the clinical applicability of NIRS in the diagnosis of 
DO[31]. Forty-one patients with OAB symptoms underwent 53 filling 
cystometries with simultaneous NIRS of the bladder. Diagnosis of DO was 
done according to the ICS guidelines. After exclusion of 28% of the graphs 
Non-Invasive Techniques in the Diagnosis of Bladder Storage Disorders 
due to motion artifacts, the separated graphs representing both tests were 
presented to three experienced urodynamicists with three weeks between 
the first and second presentation. 
 
The graphs showed curves with and without DO episodes where all bladder 
sensations were marked. The stability was confirmed by stable abdominal 
pressure curves and extra surface EMG of the abdominal muscles. The 
urodynamicists marked pressure changes suggestive of DO in the 
cystometry curves. For NIRS curves they marked definite deviations from 
baseline. 
NIRS curve representing the Hbsum had an average sensitivity of 92% and 
72% specificity for DO (AUC: 0.80-0.82; p < 0.001). O2Hb curves had 82% 
sensitivity and 86% specificity for DO (AUC: 0.80-0.85; p < 0.001). The 
sensitivity and specificity of the HHb curve for DO were 77% and 80%, 
respectively (AUC 0.73-0.84; p < 0.001). 
 
The inter- and intra-observer agreements to identify or rule out the effect 
of DO on NIRS curves were substantial (kappa >0.6). NIRS curves correlated 
well with DO episodes detected by conventional urodynamics and were 
able to detect the hemodynamic changes caused by detrusor contractions. 
This implies that NIRS can be used to study the regulatory mechanisms of 
blood perfusion to the bladder during filling as well as the hemodynamic 
phenomenon of DO. 
This real time feature of NIRS is unique in comparison to other non-invasive 
diagnostic techniques that are examined for DO[15,17]. It can be a potential 
non-invasive diagnostic tool for DO in patients with OAB symptoms. 
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Conclusions 
Ultrasonographic parameters, such as BWT, DWT and UEBW, have been 
examined in patients with storage disorders as surrogates for DO in patients 
with OAB. Only few studies could present potential diagnostic cut-offs for 
DO. TVUS seems to be a better approach to measure BWT. However, 
standardization of methodology is still needed. 
 
Laboratory biomarkers, such as NGF, show substantial correlation with 
DO/OAB, but are still lacking a plausible specificity for DO. NIRS detects the 
hemodynamic changes caused by involuntary detrusor contractions in real 
time, but its liability to motion artifacts still limits its clinical applicability. So 
far, all these techniques still have limitations and cannot be applied reliably 
in routine clinical practice. None of these methods can quantify other 
important parameters of bladder storage function than DO. Filling 
cystometry remains the current gold standard tool in the diagnosis of 
bladder storage disorders. 
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Abstract 
 
Introduction 
Near-infrared spectroscopy (NIRS) is an optical technology able to detect 
the hemodynamic changes in biologic tissues. Our objective was to 
determine the feasibility of applying NIRS in the non-invasive diagnosis of 
detrusor overactivity (DO). 
Patients and Methods 
A comparative analysis was performed on 39 involuntary detrusor 
contractions (IDC) from 23 filling cystometries with simultaneous non-
invasive NIRS of the bladder in 14 patients with DO. Motion artifacts were 
checked for via surface EMG of the abdominal muscles. 
Results 
Thirty-nine IDC were obtained. The median amplitude of rise in detrusor 
pressure at DO was 48 cm H2O (range: 5-219). The median filling volume at 
DO was 148 ml (range: 9-531). NIRS curves demonstrated apparently 
significant deviations from baseline in 35 of 39 DO episodes (90%). All 
onsets of NIRS deviations occurred within the time period of IDC with a 
mean delay of 3 s (range: 0-9). 
Conclusions 
NIRS can be a potential tool for the non-invasive diagnosis of DO. 
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Introduction 
Overactive bladder (OAB) syndrome is highly prevalent in Western 
countries. It affects 16.6% of adults >40 years of age in Europe[1]. Filling 
cystometry is the current standard urodynamic test employed in the 
diagnosis of detrusor overactivity (DO) in patients with OAB symptoms[2]. 
However, it is invasive and may cause patient discomfort and urinary tract 
infection[3]. 
 
Near-infrared spectroscopy (NIRS) is an optical technology. It enables the 
non-invasive monitoring of hemodynamic changes in biological tissues via 
measurement of the relevant changes in the concentration of tissue 
chromophores. The chromophores are naturally occurring compounds such 
as oxy-hemoglobin (O2Hb) and deoxy-hemoglobin (HHb). These two NIRS 
parameters measure the oxygen supply and consumption of the tissue, 
respectively. The sum of both parameters (Hbsum) represents the total blood 
perfusion of the tissue under monitoring[4]. 
 
The micturition cycle is associated with substantial variations in the blood 
flow to the urinary bladder; bladder filling causes an increase in the blood 
perfusion to the bladder wall. Blood flow decreases at the maximum 
capacity, and then shows a rebound increase after emptying[5]. Anderson et 
al.[6] reported an increase in bladder wall blood perfusion during evoked 
bladder contractions. Azadzoi et al.[7] reported a marked decrease in 
bladder wall perfusion during both spontaneous and evoked bladder 
contractions in animals. NIRS was applied in classification of men with LUTS 
due to bladder outlet obstruction (BOO) according to their voiding patterns. 
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The authors reported NIRS as a good predictor of BOO with 88% specificity 
and 94% ‘precision’[8]. 
Our hypothesis was that involuntary detrusor contractions (IDC) during 
filling of the bladder have specific hemodynamic effects that can be 
detected by an imaging technology like NIRS. Our objective was to evaluate 
the feasibility of the non-invasive transcutaneous NIRS of the bladder to 
detect these hemodynamic effects during filling cystometry. 
 
Patients and Methods 
Patients 
Fourteen patients with DO were included in this exploratory study. Patients 
with gross hematuria and scars from previous bladder surgeries were 
excluded. The study was approved by the local ethical committee. 
 
Procedure 
A dipstick urinalysis was done to exclude UTI and hematuria. Filling 
cystometry (Solar™; Medical Measurement Systems, Enschede, The 
Netherlands) started with the insertion of a double lumen gas-filled urethral 
catheter of 6 Ch for intravesical pressure monitoring. Abdominal pressure 
was monitored using a rectal balloon. Water was infused10-50 ml/min at 
room temperature. 
Simultaneous with filling cystometry, trans-cutaneous non-invasive 
monitoring of the bladder region with NIRS was performed (URO-NIRS™; 
Urodynamix Technologies Ltd, Vancouver, BC, Canada). An emitter and a 
photo-receiver diode were connected to a rubbery self-adhesive patch. The 
NIRS optodes were placed directly on the abdomen, 2 cm above the pubic 
symphysis across the midline[9]. Patients were asked to limit their 
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movements and to avoid straining or urine withholding, especially at the 
moment of urgency due to DO. During the session, surface EMG monitoring 
of the abdominal wall muscles was performed to detect any motion 
artifacts. Data from NIRS were imported in a specially designed 
urodynamics database for automatic synchronization.  
 
Statistical Methods 
Comparative analysis of cystometry curves and their relevant NIRS curves 
was performed by two experienced urodynamicists. The urodynamicists 
marked pressure changes in cystometry curves indicative of DO according 
to the International Continence Society guidelines. Then they looked at the 
relevant NIRS curves (HHb, O2Hb and Hbsum) to detect significant visible 
deviations from baseline concomitant with the IDC. A Mann-Whitney U test 
was applied to measure the differences between groups. 
 
Results 
Urodynamic cystometry registrations from 14 patients with DO were 
included in the study. The mean age was 65 years (range: 38-79). The mean 
BMI was 27 kg/m2 (range: 21–33). All patients underwent one or more 
filling cystometries with simultaneous non-invasive trans-cutaneous NIRS of 
the bladder. 
Twenty-three filling sessions with a total of 39 IDC were obtained. Each IDC 
was considered as an individual case for final analysis. The median bladder 
filling volume at the start of IDC was 148 ml (range: 9-531). The median 
maximum amplitude of rise in detrusor pressure curves from baseline to 
peak at IDC was 48 cm H2O (range: 5-219). The absolute deviation from 
baseline in NIRS curves was apparently significant in 35 of 39 (90%) HHb 
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the bladder. 
Twenty-three filling sessions with a total of 39 IDC were obtained. Each IDC 
was considered as an individual case for final analysis. The median bladder 
filling volume at the start of IDC was 148 ml (range: 9-531). The median 
maximum amplitude of rise in detrusor pressure curves from baseline to 
peak at IDC was 48 cm H2O (range: 5-219). The absolute deviation from 
baseline in NIRS curves was apparently significant in 35 of 39 (90%) HHb 
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curves. The same was true for 34 of 39 (87%) O2Hb curves and for 35 of 39 
(90%) Hbsum curves. All onsets of NIRS deviations occurred within the time 
period of IDC, with a mean delay of 3 s (range: 0-9). Examples are shown in 
figures 1-3. 
 
Fig. 1. An example of DO episode with no abdominal activity. An episode of DO as detected 
by cystometry (upper graph) and NIRS (lower graph). The lower graph shows an initial 
upward slope of Hbsum, O2Hb, and HHb curves concomitant with the start of DO (point A) 
until the peak of DO (point B), followed by sustained downward slope in all NIRS curves till 
the end of DO episode. Notice the stability of abdominal pressure (Pabd) curve. 
Pves = intravesical pressure; EMGabd = EMG monitoring of the abdominal wall muscles; Pdet = 
detrusor pressure. 
 
For analysis, true positive cases were identified as the cases where at least 
two thirds of the NIRS curves were positive at IDC. The false negative cases 
were identified as the cases where at least two thirds of the NIRS curves 
were negative at IDC. Table 1 shows the results of a comparison of BMI of 
the patients, amplitude of rise in detrusor pressure at the peak of IDC, and 
the bladder filling volume at the start of IDC between both groups. 
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Fig. 2. An example of DO with potential artifact. Two consecutive DO episodes as detected by 
cystometry (upper graph) and NIRS (lower graph). Abdominal pressure (Pabd) curve shows smooth 
straining pattern as the patient was straining during the 2 episodes. The lower graph shows an upward 
slope of all NIRS curves concomitant with the start of DO (points A and C) until the peak of DO (points B 
and D), followed by a sustained but slower and less remarkable downward slope in NIRS curves until the 
end of DO episode. The second episode was followed by voiding. The Pabd curve shows straining pattern 
concomitant with DO (encircled in red). Pves = intravesical pressure; EMGabd = EMG monitoring of the 
abdominal wall muscles; Pdet = detrusor pressure. 
 
Twenty-five of the 35 IDC with significant deviations in NIRS curves 
occurred at filling volumes less than 200 ml (range: 9-531). 
Abdominal pressure curves and/or the surface EMG monitoring of the 
abdominal wall muscles curves detected straining patterns and/or motion 
artifacts in 11 of the 35 IDC with concomitant deviation in NIRS. None of the 
4 IDC with no concomitant deviation in NIRS curves had any straining 
patterns and/or motion artifact. NIRS curves demonstrated significant 
deviations from baseline in 34 occasions. These deviations were 
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straining pattern as the patient was straining during the 2 episodes. The lower graph shows an upward 
slope of all NIRS curves concomitant with the start of DO (points A and C) until the peak of DO (points B 
and D), followed by a sustained but slower and less remarkable downward slope in NIRS curves until the 
end of DO episode. The second episode was followed by voiding. The Pabd curve shows straining pattern 
concomitant with DO (encircled in red). Pves = intravesical pressure; EMGabd = EMG monitoring of the 
abdominal wall muscles; Pdet = detrusor pressure. 
 
Twenty-five of the 35 IDC with significant deviations in NIRS curves 
occurred at filling volumes less than 200 ml (range: 9-531). 
Abdominal pressure curves and/or the surface EMG monitoring of the 
abdominal wall muscles curves detected straining patterns and/or motion 
artifacts in 11 of the 35 IDC with concomitant deviation in NIRS. None of the 
4 IDC with no concomitant deviation in NIRS curves had any straining 
patterns and/or motion artifact. NIRS curves demonstrated significant 
deviations from baseline in 34 occasions. These deviations were 
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concomitant with abrupt movements or cough while detrusor pressure 
curves were stable (false-positive deviations). 
 
Table 1. Comparison of the relevant demographics and cystometric parameters between the detrusor 
overactivity  (DO) episodes with and without significant deviations in near-infrared spectroscopy (NIRS) 
curves. 
 
Cases (n = 14 patients; n = 39 DO episodes  
Mann-
Whitney U 
test (95% CI) 
p value 
true positives 
(n=10 patients; n=35 
graphs) 
false negatives 
(n=4 patients; n=4 
graphs) 
Mean BMI 26 ± 4 (20-33) 28±2 (27-31) 0.68 
Median filling  
volume at DO, ml 
150 (9-531) 
 
146 (29-174) 
 
 0.25 
Median amplitude of 
contraction at DO, cm H2O 
50 (5-219) 15 (5-51) 0.08 
 
Discussion 
Doppler flow studies revealed substantial hemodynamic changes in the 
bladder wall during the micturition cycle[5]. We studied the feasibility of 
applying the non-invasive optical technology, NIRS, for detection of the 
hemodynamic effect of IDC in patients with OAB syndrome. The assumption 
is that NIRS detects the changes in oxygen supply and oxygen consumption 
of the bladder wall during the IDC. 
In order to be able to use NIRS for this detection process, some potential 
obstacles that could hinder valid NIRS detection should be looked at. 
The first obstacle is that the bladder can be anatomically out of reach of the 
NIRS imaging scale due to the abdominal wall being too thick in some 
patients. The second obstacle is that NIRS of the bladder is performed early 
during filling cystometry while the bladder is still empty. The third obstacle 
is the expected movement of the bladder wall on changing from the flaccid 
to the contracting form, which might affect the NIRS measurements. 
Another potential obstacle is low IDC amplitude. 
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The last obstacle is the susceptibility of NIRS technology to motion 
artifacts[10]. NIRS curves demonstrated apparent significant deviation from 
baseline concomitant with the start of IDC in 35 of 39 (90%). Interestingly, 
all deviations occurred within the time period of the IDC. This shows the 
high ability of NIRS to detect the hemodynamic effect of IDC. 
Four out of 39 IDC had no concomitant change from baseline in NIRS 
curves. We looked for the anatomical factors that might cause the bladder 
to lie out of reach of the NIRS imaging scale, such as morbid obesity or small 
bladder filling volumes. All four IDC without significant deviations in NIRS 
curves occurred at a filling volume <200 ml. However, 25 of 35 IDC with 
significant deviations in NIRS curves occurred at filling volumes <200 ml. 
This means that NIRS is able to monitor the bladder at relatively lower 
volumes than expected. The mean BMI was not significantly higher in 
patients who had IDC with no concomitant deviations in NIRS curves, as 
compared to those who had IDC with positive concomitant deviations in 
NIRS curves (28 vs. 26 kg/m2 respectively; p = 0.25). 
The median maximum amplitude of a rise in detrusor pressure curves in IDC 
without significant deviations in NIRS was lower than in those with 
significant deviations (15 cm H2O vs. 50 respectively; p = 0.08). Although 
this was not statistically significant, we assume that this might be a cause of 
false negative outcomes. The reason for not being statistically significant 
might be explained by the small sample size in our pilot study and the small 
number of IDC with no concomitant NIRS deviations as compared to those 
with positive deviations (n = 4 vs. 35 episodes, respectively). More and 
bigger studies are needed to explore those factors that affect the sensitivity 
and specificity of NIRS for IDC. Further studies should explore the 
reproducibility and accuracy of NIRS in clean data set, i.e. without motion 
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artifacts. Then trials to design a clinical diagnostic setup of the technique in 
real practice are recommended. For these steps, cystometry should be the 
reference standard. 
 
In our exploratory series, NIRS could identify 90% of IDC via detection of 
their concomitant imprint on NIRS signals. The effects of IDC on NIRS signals 
might be explained by one of three possibilities. The first possibility is an 
autogenic hemodynamic phenomenon of IDC. The second possibility is a 
compressive pattern of bladder wall vessels due to the sudden contraction 
during IDC. The last possibility is an expected movement of the whole 
bladder wall with its vascular content during the IDC, leading to substantial 
change in the volume of blood crossing the imaging scale of NIRS. 
A few non-invasive techniques have been tested to replace the standard 
invasive filling cystometry for the diagnosis of IDC. These techniques 
focused on investigating some proxy parameters of IDC, such as 
sonographic measurement of bladder wall thickness[11], or measurement of 
urinary nerve growth factor[12]. However, none of these techniques can 
detect the IDC in real-time. NIRS parameters are presented as graphic 
display, this advantage enables the bladder monitoring simultaneous with 
filling cystometry. Hence, for the first time it was possible to detect the IDC 
in real-time with a new non-invasive technique, comparable to 
conventional cystometry. 
To check for the presence of motion artifacts in NIRS curves, we used the 
extra surface EMG monitoring of the abdominal wall muscles. Eleven of the 
35 IDC with concomitant deviations in NIRS curves had motion artifacts, 
either due to change in patient position during the session, or due to their 
efforts to withhold urine at moments of urgency during the IDC. Patient 
Feasibility of Non-Invasive NIRS to Diagnose Detrusor Overactivity 
 
stability and algorithms to cancel motion artifacts in NIRS[13] can be 
recommended to improve the set-up and measurements in further studies. 
 
Figure 3. An example of DO with definite motion artifacts. Abdominal pressure (Pabd)  and 
EMG monitoring of the abdominal wall muscles (EMGabd) curves show irregular abdominal 
activity pattern concomitant with DO (encircled) because the patient unexpectedly changes 
his positions by leaning forward. The NIRS part of the graph shows an abrupt, sharp, 
irregular, upward slope of all NIRS curves concomitant with the start of DO, followed by less 
remarkable sustained downward slope till the end of the DO episode. 
Pves = intravesical pressure curve; Pdet = detrusor pressure. 
 
Conclusions 
NIRS is able to detect the hemodynamic effect of DO. It can be a potential 
tool for the non-invasive diagnosis of DO. More studies are needed to 
explore the factors that influence NIRS detection of DO and to evaluate its 
applicability in clinical practice. If all practical problems are overcome, NIRS 
could be very valuable, not only in routine clinical practice, but also in 
studies exploring treatments for OAB and DO. 
 
51
Chapter 2 
 
 
artifacts. Then trials to design a clinical diagnostic setup of the technique in 
real practice are recommended. For these steps, cystometry should be the 
reference standard. 
 
In our exploratory series, NIRS could identify 90% of IDC via detection of 
their concomitant imprint on NIRS signals. The effects of IDC on NIRS signals 
might be explained by one of three possibilities. The first possibility is an 
autogenic hemodynamic phenomenon of IDC. The second possibility is a 
compressive pattern of bladder wall vessels due to the sudden contraction 
during IDC. The last possibility is an expected movement of the whole 
bladder wall with its vascular content during the IDC, leading to substantial 
change in the volume of blood crossing the imaging scale of NIRS. 
A few non-invasive techniques have been tested to replace the standard 
invasive filling cystometry for the diagnosis of IDC. These techniques 
focused on investigating some proxy parameters of IDC, such as 
sonographic measurement of bladder wall thickness[11], or measurement of 
urinary nerve growth factor[12]. However, none of these techniques can 
detect the IDC in real-time. NIRS parameters are presented as graphic 
display, this advantage enables the bladder monitoring simultaneous with 
filling cystometry. Hence, for the first time it was possible to detect the IDC 
in real-time with a new non-invasive technique, comparable to 
conventional cystometry. 
To check for the presence of motion artifacts in NIRS curves, we used the 
extra surface EMG monitoring of the abdominal wall muscles. Eleven of the 
35 IDC with concomitant deviations in NIRS curves had motion artifacts, 
either due to change in patient position during the session, or due to their 
efforts to withhold urine at moments of urgency during the IDC. Patient 
Feasibility of Non-Invasive NIRS to Diagnose Detrusor Overactivity 
 
stability and algorithms to cancel motion artifacts in NIRS[13] can be 
recommended to improve the set-up and measurements in further studies. 
 
Figure 3. An example of DO with definite motion artifacts. Abdominal pressure (Pabd)  and 
EMG monitoring of the abdominal wall muscles (EMGabd) curves show irregular abdominal 
activity pattern concomitant with DO (encircled) because the patient unexpectedly changes 
his positions by leaning forward. The NIRS part of the graph shows an abrupt, sharp, 
irregular, upward slope of all NIRS curves concomitant with the start of DO, followed by less 
remarkable sustained downward slope till the end of the DO episode. 
Pves = intravesical pressure curve; Pdet = detrusor pressure. 
 
Conclusions 
NIRS is able to detect the hemodynamic effect of DO. It can be a potential 
tool for the non-invasive diagnosis of DO. More studies are needed to 
explore the factors that influence NIRS detection of DO and to evaluate its 
applicability in clinical practice. If all practical problems are overcome, NIRS 
could be very valuable, not only in routine clinical practice, but also in 
studies exploring treatments for OAB and DO. 
 
52
Chapter 2 
 
 
References 
1. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the 
symptoms of an overactive bladder and how are they managed? A population-based 
prevalence study. BJU Int 2001;87(9):760-6. 
2. Schafer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling 
cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21(3):261-74. 
3. Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. 
Morbidity of the evaluation of the lower urinary tract with transurethral multichannel 
pressure-flow studies. J Urol 1998;159(1):191-4. 
4. Villringer A, Chance B. Non-invasive optical spectroscopy and imaging of human brain 
function. Trends Neurosci 1997;20(10):435-42. 
5. Kershen RT, Azadzoi KM, Siroky MB. Blood flow, pressure and compliance in the male 
human bladder. J Urol 2002;168(1):121-5. 
6. Andersson PO, Bloom SR, Mattiasson A, Uvelius B. Bladder vasodilatation and release of 
vasoactive intestinal polypeptide from the urinary bladder of the cat in response to 
pelvic nerve stimulation. J Urol 1987;138(3):671-3. 
7. Azadzoi KM, Pontari M, Vlachiotis J, Siroky MB. Canine bladder blood flow and 
oxygenation: changes induced by filling, contraction and outlet obstruction. J Urol 
1996;155(4):1459-65. 
8. Stothers L, Guevara R, Macnab A. Classification of male lower urinary tract symptoms 
using mathematical modelling and a regression tree algorithm of non-invasive near-
infrared spectroscopy parameters. Eur Urol 2010;57(2):327-32. 
9. Macnab AJ, Stothers L. Development of a near-infrared spectroscopy instrument for 
applications in urology. Can J Urol 2008;15(5):4233-40. 
10. Huppert TJ, Diamond SG, Franceschini MA, Boas DA. HomER: a review of time-series 
analysis methods for near-infrared spectroscopy of the brain. Appl Opt 
2009;48(10):D280-D298. 
11. Khullar V, Cardozo LD, Salvatore S, Hill S. Ultrasound: a noninvasive screening test for 
detrusor instability. Br J Obstet Gynaecol 1996;103(9):904-8. 
12. Kuo HC, Liu HT, Chancellor MB. Urinary nerve growth factor is a better biomarker than 
detrusor wall thickness for the assessment of overactive bladder with incontinence. 
Neurourol Urodyn 2010;29(3):482-7. 
13. Izzetoglu M, Chitrapu P, Bunce S, Onaral B. Motion artifact cancellation in NIR 
spectroscopy using discrete Kalman filtering. Biomed Eng Online 2010;9:16.
 
 
 
 
 
 
 
 
CHAPTER 3 
Near-Infrared Spectroscopy: a Novel, 
Noninvasive Diagnostic Method for Detrusor 
Overactivity in Patients with Overactive 
Bladder Symptoms – a Preliminary and 
Experimental Study. 
 
 
Fawzy F. Farag 1,2  MD 
Frank M. Martens 1  MD 
Kathleen W. D’Hauwers 1 MD 
Wout F. Feitz 1   MD, PhD 
John P. Heesakkers 1  MD, PhD 
1Department of Urology, Radboud University Nijmegen Medical Centre, 
Nijmegen, The Netherlands 
2Department of Urology, Sohag University, Sohag, Egypt 
 
Published in European Urology. 2011 May; 59(5):757-62 
 
 
 
53
Chapter 2 
 
 
References 
1. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the 
symptoms of an overactive bladder and how are they managed? A population-based 
prevalence study. BJU Int 2001;87(9):760-6. 
2. Schafer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling 
cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21(3):261-74. 
3. Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. 
Morbidity of the evaluation of the lower urinary tract with transurethral multichannel 
pressure-flow studies. J Urol 1998;159(1):191-4. 
4. Villringer A, Chance B. Non-invasive optical spectroscopy and imaging of human brain 
function. Trends Neurosci 1997;20(10):435-42. 
5. Kershen RT, Azadzoi KM, Siroky MB. Blood flow, pressure and compliance in the male 
human bladder. J Urol 2002;168(1):121-5. 
6. Andersson PO, Bloom SR, Mattiasson A, Uvelius B. Bladder vasodilatation and release of 
vasoactive intestinal polypeptide from the urinary bladder of the cat in response to 
pelvic nerve stimulation. J Urol 1987;138(3):671-3. 
7. Azadzoi KM, Pontari M, Vlachiotis J, Siroky MB. Canine bladder blood flow and 
oxygenation: changes induced by filling, contraction and outlet obstruction. J Urol 
1996;155(4):1459-65. 
8. Stothers L, Guevara R, Macnab A. Classification of male lower urinary tract symptoms 
using mathematical modelling and a regression tree algorithm of non-invasive near-
infrared spectroscopy parameters. Eur Urol 2010;57(2):327-32. 
9. Macnab AJ, Stothers L. Development of a near-infrared spectroscopy instrument for 
applications in urology. Can J Urol 2008;15(5):4233-40. 
10. Huppert TJ, Diamond SG, Franceschini MA, Boas DA. HomER: a review of time-series 
analysis methods for near-infrared spectroscopy of the brain. Appl Opt 
2009;48(10):D280-D298. 
11. Khullar V, Cardozo LD, Salvatore S, Hill S. Ultrasound: a noninvasive screening test for 
detrusor instability. Br J Obstet Gynaecol 1996;103(9):904-8. 
12. Kuo HC, Liu HT, Chancellor MB. Urinary nerve growth factor is a better biomarker than 
detrusor wall thickness for the assessment of overactive bladder with incontinence. 
Neurourol Urodyn 2010;29(3):482-7. 
13. Izzetoglu M, Chitrapu P, Bunce S, Onaral B. Motion artifact cancellation in NIR 
spectroscopy using discrete Kalman filtering. Biomed Eng Online 2010;9:16.
 
 
 
 
 
 
 
 
CHAPTER 3 
Near-Infrared Spectroscopy: a Novel, 
Noninvasive Diagnostic Method for Detrusor 
Overactivity in Patients with Overactive 
Bladder Symptoms – a Preliminary and 
Experimental Study. 
 
 
Fawzy F. Farag 1,2  MD 
Frank M. Martens 1  MD 
Kathleen W. D’Hauwers 1 MD 
Wout F. Feitz 1   MD, PhD 
John P. Heesakkers 1  MD, PhD 
1Department of Urology, Radboud University Nijmegen Medical Centre, 
Nijmegen, The Netherlands 
2Department of Urology, Sohag University, Sohag, Egypt 
 
Published in European Urology. 2011 May; 59(5):757-62 
 
 
 
54
Chapter 3 
 
 
Abstract 
Background 
Near-infrared spectroscopy (NIRS) is an optical technology. It detects the 
hemodynamic changes in tissues via non-invasive measurement of changes 
in the concentration of tissue chromophores, such as oxyhemoglobin 
(O2Hb) and deoxyhemoglobin (HHb). Involuntary bladder contractions may 
cause changes detectable by NIRS. 
Objective 
To address the accuracy and reproducibility of NIRS to detect the 
hemodynamic effects of detrusor overactivity (DO). 
Design, setting, and participants 
A prospective cohort study was carried out on 41 patients with overactive 
bladder symptoms. 
Measurements 
Forty-one patients underwent one or more filling cystometries with 
simultaneous NIRS of the bladder. The separated graphs representing both 
tests were presented to three urodynamicists on two occasions, 3 weeks 
apart. The graphs showed curves with and without DO episodes with the 
bladder sensations marked. Thirteen of 47 graphs (28%) with DO and 16 of 
58 graphs (28%) without DO were excluded due to motion artifacts. The 
urodynamicists marked pressure changes suggestive of DO in the 
cystometry curves. For NIRS curves they marked definite deviations from 
baseline. The sensitivity and specificity of NIRS for DO were determined. 
The inter- and intraobserver agreements were determined. 
Results and limitations 
Valid data from 33 of 41 patients (80%) were included in the analysis. The 
interobserver agreement to trace the effect of DO on NIRS curves was 
‘substantial’ (kf > 0.6). The sensitivity of the Hbsum (O2Hb + HHb) curves for 
DO was 62-97% with a specificity of 62-79% (area under the curve [AUC]: 
0.80-0.82; p < 0.001). O2Hb curves had 79-85% sensitivity and 82-91% 
specificity for DO (AUC: 0.80-0.85; p<0.001). The sensitivity and specificity 
of the HHb curves for DO were 71-82% & 77-82%, respectively (AUC: 0.73-
0.84; p < 0.001). These values represent the performance of NIRS in the 
data sample that is not contaminated with motion artifacts; they are not 
representative of a general clinical setting. 
Conclusions 
NIRS is a potential non-invasive and reproducible, diagnostic method to 
detect DO. 
NIRS: a Novel Diagnostic Method for DO in Patients with OAB Symptoms 
 
Introduction 
Overactive bladder (OAB) syndrome is highly prevalent in Western 
culture[1]. It negatively affects the patient’s quality of life[2]. Filling 
cystometry is the standard urodynamic test to detect detrusor overactivity 
(DO)[3]; however, it is invasive and may cause patient’s discomfort and 
urinary tract infections (UTI)[4]. Therefore, a non-invasive diagnostic tool 
that can replace conventional cystometry is recommendable, especially for 
patients who undergo regular urodynamic evaluation. 
 
Doppler ultrasound studies have revealed significant variations in the blood 
flow of the bladder wall during the voiding cycle[5,6] and bladder 
contractions in animal models[7]. DO is assumed to cause substantial 
variations in oxygen supply and consumption of the bladder wall during 
involuntary muscle contraction. 
Near-infrared spectroscopy (NIRS) as an imaging technology can monitor 
the hemodynamic changes during bladder filling and voiding. Light in the 
near-infrared area is capable of penetrating the skin to the underlying 
tissues and is absorbed by naturally occurring chromophores, such as 
oxyhemoglobin (O2Hb) and deoxyhemoglobin (HHb). NIRS enables 
detection of oxygen-dependant hemodynamic changes in biologic tissues 
by measurement of the relevant changes in the concentration of tissue 
chromophores relative to baseline. Total hemoglobin (Hbsum) is an indicator 
of total blood perfusion that can be derived from the sum of O2Hb and 
HHb[8]. 
 
Urologic applications of NIRS cover various urologic disorders[9]. NIRS was 
previously reported to be an independent predictor of bladder outlet 
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obstruction (BOO) with a good correlation between NIRS and pressure flow 
parameters[10]. 
Previously, we showed that transcutaneous NIRS of the bladder is feasible 
to detect DO episodes as the involuntary detrusor contractions have 
characteristic imprints on NIRS signals[11]. The objective of this study was to 
determine the accuracy and reproducibility of NIRS during cystometry in 
detecting DO episodes. Therefore, the sensitivity and specificity of NIRS 
changes compared to cystometry were investigated after exclusion of NIRS 
data contaminated with motion artifacts. Moreover, the inter- and 
intraobserver agreements of DO diagnosis in NIRS curves were determined. 
 
Patients and methods  
Patients 
The study group consisted of 41 consecutive adult patients referred to the 
Radboud University Nijmegen Medical Centre, The Netherlands for 
urodynamics between 20 August and 28 December 2009. Inclusion criteria 
were men or women ≥18 years old with urgency with or without 
incontinence, frequency and nocturia. Exclusion criteria were abdominal 
scars, hematuria and a history of mixed incontinence. One patient was 
diabetic and one was treated for hypertension. Antimuscarinics were 
stopped ≥3 days before urodynamics. This study was approved by the local 
ethics committee. 
 
Procedure 
Patients completed a 24-hour voiding diary. Patients with clinical benign 
prostatic hyperplasia (BPH) and voiding symptoms suggestive of BOO 
completed an International Prostate Symptom Score (IPSS) questionnaire. 
NIRS: a Novel Diagnostic Method for DO in Patients with OAB Symptoms 
 
Urinalysis was performed to exclude UTI and hematuria. All patients 
underwent cystometry (Solar™, Medical Measurement Systems, Enschede, 
The Netherlands). A gas-filled urethral catheter (6 Fr/Ch) was inserted to 
monitor intravesical pressure (Pves), while abdominal pressure (Pabd) was 
monitored using a rectal balloon. Water was infused at room temperature 
with filling rates of 10-50 ml/min as requested by the patient’s physician. 
The same rate was used when several cystometries were performed in the 
same patient. 
Transcutaneous, non-invasive bladder monitoring with NIRS (URO-NIRS, 
Urodynamix Technologies Ltd, Vancouver, Canada) was performed 
simultaneously with cystometry. An emitter and a sensor were connected 
to a rubbery self adhesive patch, 4 cm apart. The patch was placed on the 
abdomen 2 cm above the pubic symphysis across the midline[12]. 
Baseline NIRS reading for 30 s was followed by testing the effect of cough 
and Valsalva maneuver on NIRS signals. Patient movements, straining and 
urine withholding were restricted. Surface electromyogram (EMG) 
monitoring of the abdominal wall muscles (EMGabd) was used to rule out 
motion artifacts. Bladder sensations and events were recorded. 
 
The cystometries were diagnosed by a urodynamicist according to the 
International Continence Society guidelines to identify patients with and 
without DO. NIRS data were imported and automatically synchronized in 
the urodynamics database. Graphs contaminated with motion artifacts 
were excluded (figure 1). For rating purposes, the cystometry graphs and 
NIRS graphs were separated and coded. Graphs with DO were used as cases 
(figure 2) and graphs without DO as controls. 
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obstruction (BOO) with a good correlation between NIRS and pressure flow 
parameters[10]. 
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Fig. 1 – The method followed in deriving graphs representing cases of detrusor overactivity (DO) 
and controls. 
         OAB = overactive bladder. 
 
Inter- and intraobserver variability 
The cystometry graphs consisted of three curves representing Pves, Pabd, 
and Pdet. NIRS graphs consisted of three curves representing HHb, O2Hb 
and Hbsum. Flowmetry and EMGabd curves were added to the cystometry 
and the NIRS graphs. 
Rating was done by three experienced urodynamicists on two occasions 3 
weeks apart. The cystometry graphs and the NIRS graphs were presented 
separately and randomly to the raters. The raters did not know which NIRS 
graph belonged to which cystometry graph. The urodynamicsts had to look 
for pressure changes suggestive of DO for the cystometry graphs and 
definite deviations from baseline in each NIRS curve (O2Hb, HHb and Hbsum). 
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Fig. 2 – Detrusor overactivity (DO) as detected by cystometry and near-infrared spectroscopy 
(NIRS).Part of the cystometry (upper part) with simultaneous NIRS bladder monitoring 
(lower part) of a 69-yr-old male patient who presented with OAB symptoms showing the 
hemodynamic effects of DO represented by relative NIRS changes. An initial upward slope of 
oxyhemoglobin (O2Hb) and deoxyhemoglobin (HHb) curves, and of the curve representing 
the sum of both (Hbsum) is seen concomitant with the start of DO as evidenced by sudden 
increase in detrusor pressure (Pdet) curve with urine leakage. This initial hyperemia was 
followed by sustained downward slope in all NIRS curves until the end of DO episode. 
Pves = intravesical pressure; Pabd = intraabdominal pressure; Qura = flow rate; EMGabd = 
abdominal electromyogram; vin = volume of fluid infused in the bladder. 
 
Statistical method 
The intra- and interobserver agreements were analyzed using Cohen’s 
Kappa (kc) and Fleiss’ Kappa (kf) statistics
[13]. Kappa values were interpreted 
based on the convention by Landis and Koch: <0, no agreement; 0-0.20, 
slight agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate 
agreement; 0.61-0.80, substantial agreement; and 0.81-1.0, almost perfect 
agreement[14]. Receiver operating characteristic curves were used to 
59
Chapter 3 
 
 
 
Fig. 1 – The method followed in deriving graphs representing cases of detrusor overactivity (DO) 
and controls. 
         OAB = overactive bladder. 
 
Inter- and intraobserver variability 
The cystometry graphs consisted of three curves representing Pves, Pabd, 
and Pdet. NIRS graphs consisted of three curves representing HHb, O2Hb 
and Hbsum. Flowmetry and EMGabd curves were added to the cystometry 
and the NIRS graphs. 
Rating was done by three experienced urodynamicists on two occasions 3 
weeks apart. The cystometry graphs and the NIRS graphs were presented 
separately and randomly to the raters. The raters did not know which NIRS 
graph belonged to which cystometry graph. The urodynamicsts had to look 
for pressure changes suggestive of DO for the cystometry graphs and 
definite deviations from baseline in each NIRS curve (O2Hb, HHb and Hbsum). 
NIRS: a Novel Diagnostic Method for DO in Patients with OAB Symptoms 
 
 
Fig. 2 – Detrusor overactivity (DO) as detected by cystometry and near-infrared spectroscopy 
(NIRS).Part of the cystometry (upper part) with simultaneous NIRS bladder monitoring 
(lower part) of a 69-yr-old male patient who presented with OAB symptoms showing the 
hemodynamic effects of DO represented by relative NIRS changes. An initial upward slope of 
oxyhemoglobin (O2Hb) and deoxyhemoglobin (HHb) curves, and of the curve representing 
the sum of both (Hbsum) is seen concomitant with the start of DO as evidenced by sudden 
increase in detrusor pressure (Pdet) curve with urine leakage. This initial hyperemia was 
followed by sustained downward slope in all NIRS curves until the end of DO episode. 
Pves = intravesical pressure; Pabd = intraabdominal pressure; Qura = flow rate; EMGabd = 
abdominal electromyogram; vin = volume of fluid infused in the bladder. 
 
Statistical method 
The intra- and interobserver agreements were analyzed using Cohen’s 
Kappa (kc) and Fleiss’ Kappa (kf) statistics
[13]. Kappa values were interpreted 
based on the convention by Landis and Koch: <0, no agreement; 0-0.20, 
slight agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate 
agreement; 0.61-0.80, substantial agreement; and 0.81-1.0, almost perfect 
agreement[14]. Receiver operating characteristic curves were used to 
60
Chapter 3 
 
 
determine the diagnostic value of NIRS in predicting DO. The Mann Whitney 
U test was used for differences between groups. 
 
Results 
This study included 34 men and 7 women (mean age: 62 ± 14 year) with 
overactive bladder (OAB) symptoms. The mean body mass index was 26 
kg/m2 (range: 20–33). Seventeen patients had neurogenic disorders, 21 
men BPH and 3 idiopathic OAB. The mean frequency was 12 ± 3 voids per 
day (range: 6–17).The mean IPSS was 17 (range: 5–33) for patients with 
BPH. Fifty-two cystometry sessions with simultaneous NIRS were performed. The 
cystometries identified 23 patients with DO who underwent 34 cystometry 
sessions. Forty-seven DO episodes were identified. To get the optimal NIRS graphs, 
only 34 of 47 DO graphs were selected for the final analysis based on the stability 
of Pabd and EMGabd curves. Each DO episode was considered as an individual case. 
The median bladder filling at the start of DO episodes was 137 ml (range: 12-492 
ml). The median Pdet change at DO was 42 cm H2O (range: 6-215 cm H2O). 
Cystometry identified 18 patients (one cystometry each) without DO. Their 
data were used for control purposes. Each control cystometry session was 
divided into equal parts, which included sensation marks. A total of 58 
control graphs were obtained of which 16 (28%) were excluded based on 
the stability of Pabd and EMGabd. Thirty-four of the remaining 42 graphs were 
randomly selected as individual control cases using SPSS (SPSS Inc, Chicago, 
IL, USA). 
Table 1 shows the results of the two rating sessions. The overall diagnostic 
agreement for the three observers was 92% for cystometry graphs (kf = 
0.84). For the NIRS, the observers agreed on 81% of the HHb curves (kf 
0.63), 84% of the O2Hb curves (kf = 0.69) and 81% of the Hbsum curves (kf = 
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0.61). The AUC value ranges for the diagnostic performance of NIRS for the 
three observers were 0.73-0.84 for HHb, 0.80-0.85 for O2Hb and 0.80-0.82 
for Hbsum (p < 0.001). The intraobserver agreement for cystometry was kc = 
0.85-0.97 and for NIRS, kc = 0.53-0.79 for HHb, 0.65-0.76 forO2Hb and 0.67-
0.75 for Hbsum. The sensitivity of NIRS for DO, as an average of the three 
observers, was 92% for Hbsum, 82% for O2Hb and 77% for HHb. 
The specificity was 86% for O2Hb, 80% for HHb and 72% for Hbsum. However, 
it should be mentioned that these high values do not represent the actual 
sensitivity and specificity in a general clinical setting, but only in an optimal 
study sample (72%) not contaminated with motion artifacts. The 
performance of NIRS would have been lower if analysis of the whole group, 
including motion artifacts, was done. 
Table 1– Results of the two rating sessions* 
Patients, n = 34 
 
 
Session I Session II 
Cy. 
% 
HHb 
% 
O2Hb
% 
 
Hbsum 
 % 
Cy. 
 % 
HHb 
 % 
 
O2Hb 
% 
Hbsum 
% 
Observer 1 
Cases 100 82 85 97 
10
0 
82 88 97 
Controls 9 18 18 38 9 23 21 53 
Observer 2 
Cases 100 71 79 88 97 68 65 73 
Controls 21 23 9 26 9 26 9 38 
Observer 3 
Cases 100 79 82 91 97 62 62 65 
Controls 0 18 15 21 0 18 18 21 
Cy  = Cystometry; HHb = deoxyhemoglobin; O2Hb = oxyhemoglobin; Hbsum = total 
hemoglobin 
* The ratio of the graphs rated with the answer ‘yes’ to the total number of detrusor 
overactivity graphs in the upper row (true positives) and the ratio  of the graphs rated with 
the answer ‘yes’ to the total number of control graphs in the upper row (false positives) are 
shown for each observer. The columns in the table represent the results of rating the 
cystometry and the individual near-infrared spectroscopy curves, respectively, during the 
two rating sessions. 
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Table 2 – A comparison of some relevant demographic and urodynamic parameters between 
the true-positive and false-negative cases based on near-infrared spectroscopy diagnosis. 
 
Cases, n = 17, 34 DO episodes 
p 
value* True positives 
n = 14 patients, 
29 graphs 
False negatives 
n = 3 patients, 
5 graphs 
Mean BMI ± SD (range) 
25.8 ± 3 kg/m2 
(20.5-31) 
25.4 ± 4 kg/m2 (20.8-
28.4) 
0.63 
Median filling volume at 
DO, ml (range) 
131 (12-492) 149 (59-171) 0.51 
Median peak pressure at 
DO, cm H2O (range) 
47 (11-215) 20 (6-24) 0.004 
DO = Detrusor Overactivity; BMI = Body Mass Index; SD = standard deviation. * Mann Whitney U test. 
 
To rate false-positive and false-negative DO diagnosis in NIRS graphs, only 
graphs with at least two curves marked with a deviation were counted as 
positive. Although 16 of 58 control graphs (28%) were excluded for motion 
artifacts, the NIRS graphs were rated falsely positive in 6 of 34 (18%) 
controls. The NIRS curves showed no deviation in 5 of 34 (15%) DO 
episodes. The median change in Pdet at DO was significantly lower in these 
false-negative cases as compared to the true-positive cases (20 vs. 47 cm 
H2O; p < 0.005) (table 2). Twenty of 29 true-positive cases had DO at a filling 
volume <100 ml, while 1 in 5 false-negative cases had DO at a volume <100 
ml. No adverse events related to NIRS occurred. 
 
Discussion 
This is the first clinical study that tests the application of NIRS during the 
filling phase of the voiding cycle. Our objective was to determine the 
accuracy and reproducibility of NIRS in detecting DO episodes during 
cystometry. 
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Cystometry detects the mechanical effect of DO. NIRS is used to measure 
the changes in concentration of bladder wall chromophores relative to 
baseline in response to bladder events. The assumption is that changes in 
activity and consequent oxygen consumption cause chromophore changes. 
This real-time feature of NIRS is unique in comparison to other non-invasive 
diagnostic techniques that are examined for DO[15,16]. 
 
There are three possible reasons that can explain the characteristic imprint 
of DO on NIRS signals. The first possibility is an auto-regulatory 
hemodynamic mechanism in the bladder. The second possibility is the 
mechanical compressive effect of DO on the bladder wall vasculature. The 
third possibility is the effect of bladder wall movements during DO, leading 
to momentary changes in blood volume lying within the NIRS imaging scale. 
High inter- and intraobserver agreements are mandatory for assessment of 
the clinical applicability of any new diagnostic test. Agreement among the 
urodynamicists was ‘almost perfect’ for cystometry, while it was 
‘substantial’ for NIRS (Kf = 0.84, 0.61, 0.69, and 0.63 for cystometry, Hbsum, 
O2Hb, and HHb curves, respectively). This might be explained by the 
familiarity of the urodynamicists with the classic setup of the conventional 
cystometry. 
 
NIRS curves had a good diagnostic performance as predictors of DO, giving 
a range of AUC values of 0.80–0.85 for O2Hb curves, 0.73–0.84 for HHb 
curves and 0.80–0.82 for Hbsum curves, as calculated for the three 
observers. NIRS was highly sensitive to detect DO episodes: 92% for Hbsum, 
82% for O2Hb and 78% for HHb. Hbsum, curve being the sum of O2Hb and 
HHb, can explain its higher sensitivity for DO. 
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NIRS is susceptible to motion artifacts[17]. In order to have NIRS applied 
reliably, artifacts should be avoided. Figure 3 shows the imprint of cough 
and Valsalva’s maneuver on NIRS. Therefore, 28% of the graphs were 
 
 
Figure 3– Effect of cough and Valsalva’s maneuver on near-infrared spectroscopy (NIRS) 
curves and abdominal electromyogram (EMGabd) when tested at the beginning of the filling 
session. Cough causes sharp rise in all NIRS curves and EMGabd (between the two vertical red 
lines). Valsalva’s maneuver leads to a slower and more sustained rise in NIRS curves 
(between the two vertical black lines). The NIRS changes started earlier than the actual rise 
in abdominal pressure because the patient leaned forward prior to straining. The blue arrow 
points to re-zero NIRS to normalize all NIRS parameters before filling starts. 
Pves = intravesical pressure; Pabd = intra-abdominal pressure; Qura = flow rate; O2Hb = 
oxyhemoglobin; HHb = deoxyhemoglobin; Hbsum = O2Hb + HHb. 
 
excluded from analysis. The overall specificity of NIRS parameters for DO 
was 86% for O2Hb, 80% for HHb and 72% for Hbsum. There were six false-
positive cases out of the 34 control graphs. This implies that observers still 
see some deviations in NIRS curves in absence of DO. One explanation 
could be a DO episode that was not detected by cystometry. Radley et al. 
found that conventional cystometry classified only 32 of 106 women with 
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OAB symptoms as having DO, while ambulatory urodynamics classified 70 
women as having DO[18]. Another explanation could be the wash-out effect 
of accumulated vasodilator substances as part of the regulatory 
mechanisms to maintain blood perfusion to the bladder wall during 
filling[19]. A third possibility would be a misinterpretation of the physiologic, 
systemic, hemodynamic fluctuations of respiratory signals or cardiac 
pulsations[17]. This is unlikely because normally these fluctuations are 
regular, rhythmic and of low amplitude. 
 
NIRS failed to identify 5 of 34 cases with DO as compared to urodynamics. 
Explanations could be a bladder contraction with low amplitude or the 
bladder lying out of reach of the NIRS imaging scale due to a small bladder 
volume or a thick abdominal wall. Twenty of 29 true-positives had DO at 
filling volumes <100 ml, while only 1 in 5 false-negative cases had DO at 
<100 ml. Only the difference in Pdet was significant between the false-
negative and true-positive cases. Therefore, a bladder contraction with a 
low Pdet seems to be the main reason for the false negativity. 
 
Our study has some limitations. More men were included than women, 
while generally OAB symptoms are more prevalent in women. This can be 
explained by the high inclusion number of men with BPH. We excluded 28% 
of the graphs due to motion artifacts. It was mandatory in our methodology 
to have non-contaminated data in order to evaluate the scientific value of 
NIRS in the diagnosis of DO. We believe that the sensitivity and specificity 
were high in our series because they were tested only within a selected 
data sample. However, the situation should be different when the clinical 
applicability of NIRS will be addressed. Recently, algorithms were 
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NIRS in the diagnosis of DO. We believe that the sensitivity and specificity 
were high in our series because they were tested only within a selected 
data sample. However, the situation should be different when the clinical 
applicability of NIRS will be addressed. Recently, algorithms were 
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developed for cancellation of motion artifacts[21]. This could be applied to 
improve future study set-ups. 
No laboratory screening was done to exclude systemic vasculopathies. 
 
Conclusions 
In the current study, we showed that NIRS is non-invasive and reproducible 
with high sensitivity for detecting DO. Its value for clinical trials evaluating 
treatments for DO remains to be determined. NIRS curves correlate well 
with DO episodes detected by conventional urodynamics. NIRS seems to 
detect the hemodynamic changes caused by detrusor contractions. This 
implies that NIRS can be used to study the regulatory mechanisms of blood 
perfusion to the bladder during filling as well as the hemodynamic 
phenomenon accompanying DO. NIRS is a potential non-invasive diagnostic 
tool for DO in patients with OAB symptoms. 
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Abstract 
Introduction 
Pressure flow study (PFS) is the current standard test in the diagnosis of 
voiding disorders. It is invasive and potentially morbid. Attempts are 
currently ongoing to develop noninvasive techniques to replace PFS. 
Methods 
Pub Med and Web of Science searches of the published data on noninvasive 
diagnostic techniques for bladder outlet obstruction (BOO) in patients with 
lower urinary tract symptoms (LUTS) were carried out. The 
pathophysiological and clinical relevance in addition to the diagnostic 
accuracy of these techniques were scrutinized. 
Results 
Noninvasive measurement of isovolumetric pressure was able to address 
the detrusor contractility, but the extent of contribution of abdominal 
pressure during voiding is still lacking in this method. Non-urodynamic 
parameters, derived from ultrasonographic methods, such as bladder wall 
thickness (BWT), detrusor wall thickness (DWT), intravesical prostatic 
protrusion (IVPP) and ultrasonographic estimated bladder weight (UEBW), 
have good evidence on an ultra-structural basis and show good correlation 
to BOO. Standardization of methodologies followed in measuring these 
parameters will determine their applicability in clinical practice. Other 
techniques, such as Doppler ultrasound uroflowmetry, perineal noise 
recording and Doppler resistivity index of the bladder wall, are gaining 
evidence. More extensive studies are needed to determine the 
reproducibility of these techniques. 
Attempts to combine some of the above-mentioned parameters could 
improve their statistical performance. However, more clinical value can be 
obtained by combining parameters sharing common clinical and 
pathophysiological criteria. 
Conclusions 
Measurement of the isovolumetric pressure and ultrasonographic derived 
surrogates of BOO are the most promising for the future of noninvasive 
diagnosis of BOO. NIRS is unique for its ability to detect the hemodynamic 
effect of detrusor contraction during voiding in real time. However, its 
clinical value still needs to be evaluated. None of these techniques has been 
proven to effectively replace the standard PFS in the diagnosis of voiding 
disorders. 
 
 
Non-Invasive Techniques in the Diagnosis of Voiding Disorders 
Introduction 
Lower urinary tract symptoms (LUTS) are highly prevalent in male 
population; 62% of men above the age of 40 years old experienced LUTS at 
least once in their life, 29% of these symptoms were reported during 
voiding[1]. Voiding LUTS are defined according to the -International 
Continence Society (ICS) guidelines as hesitancy, slow intermittent stream, 
straining and terminal dribble. Pressure flow study (PFS) is the current 
standard urodynamic test for the diagnosis of bladder outlet obstruction 
(BOO) in patients with voiding LUTS. This test is unique in its ability to 
estimate the detrusor muscle voiding pressure that plays a pivotal role not 
only in the diagnosis, but also in surgical decision making in patients with 
BOO due to BPH. However, the PFS test is invasive, expensive and time 
consuming. It can also cause discomfort, urinary tract infection (UTI) and 
hematuria[2]. 
 
This review overlooks the existing non-invasive diagnostic tools and 
appreciates their usefulness as a replacement for conventional 
urodynamics in the evaluation of lower urinary tract dysfunctions during 
the voiding phase of the micturition cycle. 
For every technique, the index study was presented and then followed by 
the more recent studies. We focused on the rational implied to address the 
pathophysiological and clinical relevance of the non-urodynamic 
parameters derived from these studies. 
 
1. Uroflowmetry 
Observation of urine flow provides objective evidence of normality of 
voiding. Flowmeters are designed on the basis of either a rotation disk or 
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weight transducer mechanisms. Flowmetry includes observation of flow 
pattern and rate. A normal voiding pattern is a smooth bell shaped curve, 
while an obstructed void shows a more flattened trace with intermittency. 
A constrictive urethral obstruction may show a flattened plateau flow 
pattern. Flow rate, defined as the volume of urine voided through the 
urethra per time unit, includes many variables. The most frequently used 
variable is the maximum flow rate (Qmax). A Qmax below 10 ml/s might 
indicate BOO[3]. Abrams et al.[4] recommended flowmetry to be done 
routinely in patients undergoing prostatectomy due to BPH because it could 
be a predictor of good surgical outcome. However, there are many 
limitations to rely on flowmetry as a single tool in the diagnosis of BOO. An 
important disadvantage of flowmetry is that it cannot distinguish between 
BOO and poor detrusor contractility[3,5]. In a multicentre study[6] 1271 men 
between 45 - 88 years old presented with LUTS and BPH, Qmax weakly 
correlated with patients‘ symptoms (r = -0.19; р < 0.001).  A Qmax cut-off 
value of 10 ml/s had a sensitivity, specificity and positive predictive value 
(PPV) of 47%,70% and 70%, respectively for BOO. Qmax show clinically 
important variations when flowmetry measurements are repeated in the 
same visit. In a study that included 147 men with LUTS, uroflowmetry was 
assessed in two visits, twice in each visit, two weeks apart. In the first visit, 
the intra-individual difference in Qmax was 2.1 ml/s between the first and 
second voids (р = 0.71). While in the second visit it was 5.18 ml/s (р = 0.35) 
making single flowmetry measurement questionable, especially when 
surgical intervention is expected[7]. Therefore, trials were performed to get 
multiple measurements of flowmetry from one patient. In a study by 
Reynard[8] 165 men with LUTS were asked to void 4 times in a flowmeter to 
assess the incremental value of consequent voids. The post-void residual 
Non-Invasive Techniques in the Diagnosis of Voiding Disorders 
urine (PVR) was also measured.  Then, the patients underwent PFS to be 
classified as obstructed or unobstructed. Four threshold Qmax values were 
suggested as indicators of BOO: <8, <10, <12 and <15 ml/s for void one. 
Then to the highest value of Qmax on voids one and two, voids one to three, 
and voids one to four. The authors reported significant increase in 
maximum values of Qmax on consequent voids (≥3 ml/s; р = 0.017). 
Specificity and PPV of Qmax for BOO at various thresholds improved on 
consecutive voids. On the other hand, sensitivity of Qmax for BOO showed a 
steady decrease. Apart from the above-mentioned weaknesses of 
uroflowmetry to detect BOO, it has to be mentioned that automated 
maximum flow rate readings are liable for artifacts and may be 
misleading[3]. 
Up till now, uroflowmetry can be used as a single screening test to identify 
patients with LUTS who really need further PFS to establish the diagnosis of 
BOO, but still cannot replace PFS in such diagnosis. 
 
2.       Ultrasonographic methods 
2.1. Bladder wall thickness 
Voiding against high resistance of the bladder outlet complex is suspected 
to be a leading cause of increase in the bladder wall thickness (BWT)[9]. 
Elbadawi et al. studied the ultra-structural morphologic changes in bladder 
wall specimens obtained from patients with BOO. The changes were mainly 
increase in the smooth muscles bulk with or without interstitial collagen 
deposition[10]. Accordingly, it was assumed that measurement of the 
increase in the mean BWT can be used as a diagnostic test for BOO. 
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The normal range of BWT was investigated in 410 healthy children (1 day-
18 years) and 10 adults (19-42 years). The mean BWT was 2.13 ± 0.59 mm. 
The authors found no significant difference between male and female 
children (2.19 mm vs. 2.08 mm respectively; р = 0.07)[11]. On the other 
hand, the mean BWT in healthy adults demonstrated a significant 
difference between women and men (3.0 mm vs. 3.33 mm; р < 0.003)[12]. 
 
BWT decreases with increase in bladder filling[11]. To solve this problem, 
trials were done to standardize it with regard to different bladder filling 
volumes. Hence, the bladder wall thickness index (BWTI) was developed[13]. 
BWT was measured at four sites: floor, dome and the two lateral bladder 
walls. Longitudinal and transverse inner bladder diameters were also 
measured. The outcome of the averaged BWT at all points divided by the 
averaged bladder inner diameters provides the BWTI. The authors 
suggested a cut-off of 0.13 with 100% sensitivity, 90% specificity and 94% 
PPV for obstruction (p = 0.0004)  
 
Others measured the BWT at fixed filling volumes. Manieri et al.[14] 
measured the BWT at 150 ml bladder filling in 174 patients. They found that 
a cut-off value of 5 mm holds a specificity of 92% but with a low sensitivity 
of 54% for BOO, while BWT strongly correlated with urodynamics 
parameters in favor of obstruction (r = 0.6; р ≤ 0.0001). 
 
Hakenberg et al. reported a BWT of 3.67 ± 0.11 mm in a group of men 
above the age of 60 years with LUTS and BPH with a significant difference 
from the other two healthy groups of their study (3.33 ± 0.08 mm for 
healthy men and 3.05 ± 0.06 mm for healthy women; р < 0.002)[12]. 
Non-Invasive Techniques in the Diagnosis of Voiding Disorders 
It is a matter of opinion whether the increase in BWT is a pathognomonic of 
BOO or not. Frequent involuntary contractions of detrusor muscle against 
the closed urethral sphincter complex are assumed to cause detrusor 
muscle hypertrophy and an increase in the BWT[9,15]. BWT was increased 
due to collagen and fibrous elements deposition due to the aging process. 
There was no significant difference in BWT between the unobstructed men 
of 60 years and those with BOO (3.57 ± 0.2 mm vs. 3.67 ± 0.11 mm, 
respectively)[12]. Blatt et al.[16] found no significant difference in the BWT 
patients with normal urodynamic investigations and those who were 
proven to have BOO or DO. They proved neither a significant gender 
difference, nor a statistical correlation between age and increase in BWT. 
 
2.2. Detrusor wall thickness  
Detrusor wall thickness (DWT) can be defined sonographically as the 
hypoechoic area between two hyper hypoechoic lines; the outer line 
represents the bladder adventitia and the inner line represents the bladder 
mucosa and submucosa[11,17]. The detrusor muscle is supposed to be the 
actual part of the bladder wall that shows increase in volume due to 
hypertrophy. Hypertrophy can be a result of contraction against high 
resistance due to either BOO[18] or detrusor overactivity (DO)[9]. Therefore, 
studies were performed to measure the mean DWT as an indicator of BOO 
in men with LUTS. 
 
DWT decreases gradually with bladder filling up to 250 ml beyond which 
the DWT becomes stable with no further significant decrease. It 
demonstrates a significant difference between men and women (1.4 mm 
vs. 1.2 mm respectively; p < 0.001)[19]. This can be explained by the higher 
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Non-Invasive Techniques in the Diagnosis of Voiding Disorders 
It is a matter of opinion whether the increase in BWT is a pathognomonic of 
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resistance met by the urine flow on passing the male prostatic urethra. 
Oelke et al.[18] suggested 2 mm as cut-off DWT for the diagnosis of BOO 
with 95.5% PPV. While Kessler et al.[20] reported 2.9 mm cut-off DWT to 
have a PPV of 100%, but with low sensitivity (43%). 
 
Some of these studies showed good diagnostic accuracy in terms of 
likelihood ratio (LR) to detect BOO[21]. However, different devices were 
used, such as linear or convex scanning probes with different frequencies, 
depths of wave penetration, and zooming powers. This is probably the 
reason of inconsistence in results of their studies. All these factors make it 
difficult to compare all studies in a standardized analytic way, and strike a 
big query about reliability of measurement of BWT and/or DWT as a single 
diagnostic tool for BOO[22]. 
All these studies assume that the BWT is symmetrical all over the bladder. 
This may be inconsistent with the ultra-structural description of the bladder 
wall in men with BOO, which revealed a patchy distribution of the increased 
BWT[23]. 
This tool was proven to be a good predictor of BOO, but still cannot 
discriminate between different causes of infravesical obstruction such as 
BPH, bladder neck contracture, urethral stricture, or detrusor-sphincter 
dyssynergia. Moreover, it cannot differentiate between BOO or the 
frequently accompanying DO as the actual etiological reason for the 
increased DWT and/or BWT. 
 
The procedure of measurement is simple, but still carries a potential bias of 
subjective error, especially with inexperienced observers. BWT and DWT 
were measured at different sides of the bladder wall, but not much 
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attention was paid to the indentation effect of the nearby structures, such 
as bowel at the dome or pelvic organs at the bladder base. These factors 
may affect the accuracy and reproducibility of the measurement procedure. 
BWT and DWT decrease with increase in bladder filling. To overcome this 
problem, measurements were taken at fixed bladder volume, which hinders 
the clinical utility of this tool. The suggested BWTI needs to be applied in 
larger studies in children and also needs to be tested on adult population 
before it can be a broadly accepted solution of this problem in clinical 
practice. 
 
2.3. Ultrasonic estimated bladder weight 
One of the ultrasonic methods investigated as a non-invasive tool in the 
diagnosis of functional lower urinary tract disorders in both filling and 
voiding phases is ultrasonic estimation of bladder weight (UEBW). Kojima et 
al.[17] studied 10 bladder autopsies taken from 10 men between 25-92 years 
old. Bladders were filled with saline at fixed filling volumes and BWT was 
measured using ultrasound. The inner and outer bladder dimensions were 
also measured. The authors assumed the bladder to be as a sphere; the 
inner calculated bladder volume was subtracted from the outer total 
bladder volume. The outcome was multiplied by the specific gravity which 
equals approximately 1. Bladders were emptied and the actual weights 
were directly measured. Cross sections of the bladder wall were obtained 
and compared to ultrasonic measurements: the authors found no 
difference between the sonographic and the actual BWT. UEBW 
significantly correlated with the actual bladder weight (r = 0.970; р < 
0.0001). However, it was smaller than the actual weight with a mean error 
of 12.5%. 
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One year later, Kojima et al.[24] applied this new tool as a diagnostic 
noninvasive method for BOO in 65 men with LUTS. Patients were classified 
as obstructed or unobstructed based on the conventional PFS diagnosis. 
UEBW was significantly higher in the obstructed group than in the 
unobstructed group (46.2 ± 13 g vs. 29.3 ± 9 g respectively; р < 0.0001). It 
correlated significantly with obstructive urodynamic parameters. The 
authors suggested UEBW to be a useful clinical tool in the diagnosis of BOO, 
especially for follow-up of patients who are subjected to medical 
treatment. 
 
UEBW was suggested as a useful tool for follow-up in patients with BOO 
due to BPH after prostatectomy. UEBW significantly decreased from 52.9 ± 
22.6 g to be 31.6 ± 15.8 g (р < 0.0001) in a series of 33 patients after 12 
weeks follow-up post prostatectomy[25]. When investigated as a predictor 
for acute urinary retention in patients with LUTS, UEBW had a sensitivity 
and specificity of 74% and 71%, respectively using a cut-off value of 40 g[26]. 
UEBW offers a good solution for the bladder filling volume dependence 
problem, which may hinder the clinical utility of ultrasonic measurement of 
BWT and DWT. However, assuming the urinary bladder to be spherical in 
shape does not seem to match reality. 
 
2.4. Ultrasonic estimated intravesical prostatic protrusion 
The enlarged prostatic lobes can protrude through the urinary bladder neck 
causing mechanical obstruction during micturition[27]. The intravesical 
prostatic protrusion (IVPP) is defined sonographically as the distance 
between the top of the protruded prostate inside the bladder neck down to 
the end of the prostate base at bladder circumference. It was measured by 
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trans-abdominal ultrasound (TAUS) in a study that included 200 men with 
LUTS[28]. IVPP was classified into three grades according to the degree of 
protrusion: grade I <5mm, grade II = 5-10 mm and grade III >10 mm. 
Patients were classified as obstructed or not using ‘BOOI’. The IVPP grade 
had higher PPV for BOO than other parameters like Qmax or PVR (94% vs. 
74% and 93% respectively). Grade III IVPP was associated with higher ‘BOOI’ 
than the lower grades (p < 0.001). The authors think that IVPP can be added 
to other established variables that are investigated routinely in a set of 
diagnosis of BOO. 
 
Almost similar results were reported by studies done later. Lim et al.[29] 
studied 114 men with LUTS and BPH. They found IVPP to have the best 
correlation with BOO diagnosis defined by the ’BOOI’ Remarkably, it was 
the only independent variable that was able to predict BOO (p < 0.02). Reis 
et al.[30] suggested an IVPP cut-off value of 5 mm for the diagnosis of BOO 
with sensitivity and specificity of 95% and 50%, respectively. 
 
Like BWT and DWT, IVPP was proven to decrease with increasing bladder 
volume[31]. It means that IVPP should be measured at a certain filling 
volume, which may hinder the clinical utility of this tool. Also, it is useful 
only to exclude BPH as a single cause of BOO, which offers an anatomical 
but not functional diagnosis. If it is applied as a single diagnostic tool in 
patients suffering from BOO with BPH the functional status of the detrusor 
muscle will still be lacking. This fact lowers the diagnostic value of this tool, 
especially when a surgical intervention is an option in these patients. Most 
of the studies done to investigate IVPP did not include data about BWT 
and/or DWT. If these data were included, the diagnostic value of these 
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studies would have been increased because of their expected relevant 
pathophysiology. 
 
2.5. Ultrasonic measurement of post-void residual urine  
PVR is defined as the amount of urine that remains in the bladder after 
completion of the act of micturition. It increases in patients with BOO[32]. A 
cut-off value of 100 ml was suggested as an indicator of poor voiding with a 
possibility of BOO[33]. However, for a long time, it has been a matter of 
opinion whether it is a reliable indicator for BOO or not. PVR was found to 
decrease in patients after surgical relief of their obstruction[34]. 
 
A large number of patients with clinically proven BOO have no significant 
PVR. Abrams et al.[35] found that in those patients with high PVR detrusor 
pressure at the end of the voiding the cycle is lower than expected. This 
implies that detrusor muscle contraction stops before completion of 
micturition. Therefore, it has been assumed that PVR increases as a direct 
result of bladder muscle decompensation due to long term BOO. PVR is 
thought not to be increased as a direct mechanical effect of urethral 
outflow obstruction, but it might reflect detrusor muscle underactivity 
rather than a true BOO. Kranse et al.[36] reported a weak correlation 
between BOO and PVR. They concluded that PVR still cannot be used as a 
single reliable diagnostic test for the diagnosis of BOO. Griffiths et al.[37] 
found that PVR increases with aging, even in the absence of obstruction. 
PVR shows large variations when measured in different day times in the 
same subject, with the largest amount being obtained in the early morning 
measurements. This means that PVR is influenced by the hormonal status 
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and physical activities of the patient. If this could be controlled, PVR might 
be a reliable and reproducible clinical diagnostic tool for BOO[38]. 
 
Evaluation of PVR using ultrasonography is an easy and nice replacer for the 
conventional catheterization method, especially in relatively high risk 
patients, e.g. in patients with neurogenic bladder disorders and those with 
renal transplants. A large study included 324 men between 48-75 years 
old[39], where bladder diameters were obtained by sector ultrasound. After 
approximation to a geometric figure, the authors applied 11 formulas 
available in the literature at that time. The authors found the formula 
suggested by Org et al.[40] to have the greatest accuracy: bladder volume = 
transverse depth X sagittal height X 12.56. However, no single formula 
proved to be the best for quantitative assessment of PVR. The authors 
concluded that ultrasound can only replace the catheter when qualitative 
measurements are more important than quantitative ones, especially in 
risky patients. 
 
All recent studies worked only on enhancing accuracy of ultrasonic 
estimation of PVR, but the major problem is still there: PVR cannot 
differentiate between BOO and detrusor underactivity. It is not reliable as a 
single diagnostic test of BOO, but can still be a useful tool in evaluating the 
treatment efficacy of various therapeutic modalities of BOO due to BPH.  
 
2.6. Doppler ultrasound urinary flow velocity 
Non-invasive Doppler ultrasound uroflowmetry (DUF) was introduced by 
Ozawa et al.[41] in 2 stages. The first stage was experimentally designed to 
test the sensitivity of DUF to detect flow velocity of fluids passed through 
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an artificial urethral tube. This was based on a hypothesis that micro 
bubbles resulting from pressure fluctuation during fluid flow can cause the 
‘Doppler effect’, which is a basic requirement to get a measurable Doppler 
flow. 
 
In the second clinical stage, they developed a prototype robotic controlled 
Doppler probe holder applied to the perineum in two groups of patients. 
One of them was a control group, while the other group included patients 
with BOO. Combined measurements of DUF velocity (V) and flow rate (Q) 
were done using specially designed equipment for this purpose. The 
authors suggested a new variable, which is the functional cross sectional 
area of the urethra (A) to be a new reliable urodynamic parameter able to 
diagnose BOO. It is calculated from the equation: A (cm2) = Q (ml/s) ÷V 
(cm/s). This parameter ’A’ was significantly lower in the obstructed group 
than in the control group (0.31 ± 0.16 cm2 vs. 0.73 ± 0.23 cm2 respectively; p 
< 0.006)[41]. 
Two radiologically located anatomical sites were selected to measure the 
maximum DUFV. The first site is the distal prostatic urethra just above the 
external urethral sphincter where flow velocity one (V1) is measured. The 
second site is the membranous urethra where flow velocity two (V2) is 
measured. The result of dividing V1 by V2 is called the velocity ratio (VR). 
’V’ had a good correlation with ‘BOOI‘ (r = 0.73; p = 0.001). All patients who 
had a ’VR‘ higher than 1.6 were classified as obstructed, while those with 
’VR‘ lower than 1.1 were classified as unobstructed or equivocal, as 
compared to the conventional PFS diagnosis, having the ’AG‘ number 
respectively above or below 40[42]. 
 
Non-Invasive Techniques in the Diagnosis of Voiding Disorders 
DUFV measurement is non-invasive and offers both functional and 
anatomical diagnosis of BOO. However, it is still lacking data about detrusor 
contractility and is not a valid option in patients who cannot void. 
Moreover, it needs special equipment and software. More studies need to 
be done to evaluate its clinical applicability in the diagnosis of BOO. 
 
2.7. Doppler ultrasonographic measurement of detrusor resistive 
index (RI) 
Lin and Saito[43-44] showed in animal studies that the blood flow to the 
urinary bladder decreases in response to BOO. Based on this finding, trials 
to assess the arterial blood flow to the urinary bladder in patients with BOO 
were done. Naya et al.[45] applied color Doppler ultrasonography to 
evaluate the arterial blood flow to the bladder wall in 35 patients with 
increased UEBW. They determined the arterial resistive index (RI) as an 
indicator of blood flow changes: RI = Vmax – Vmin / Vmax, where Vmax and Vmin 
are the maximum and minimum blood flow velocity respectively expressed 
in cm/s. 
 
In patients with an increased UEBW measured at a fixed bladder volume of 
100 ml, ’RI’ was able to distinguish BOO from neurogenic bladder wall 
hypertrophy as two major causes of abnormal increase in UEBW with 84% 
sensitivity, 76% specificity and 80% diagnostic accuracy for obstruction. 
Belenky et al.[46] reported 86% diagnostic accuracy of ’RI’ for BOO when 
measured in three different sites in the urinary bladder. The authors found 
no significant difference in Doppler readings with either empty or full 
bladders. 
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Applying the same technique using a transrectal approach to investigate the 
prostate gland in patients with clinical BOO and BPH, Kojima et al.[47] 
reported 85% sensitivity of prostate arterial ‘RI’ for BOO detection, but with 
low specificity of 46%. 
 
These studies depend mainly on investigating the arterial hemodynamic 
changes in bladder wall or prostate gland that theoretically may develop in 
the course of the infravesical obstruction. This can be affected by some 
pathological conditions other than compensatory ischemic hypertrophy of 
the bladder wall, such as diabetic vasculopathy or atherosclerosis. None of 
these studies showed whether these factors were concerned or not, which 
makes the specificity of these methods questionable. 
 
3. Perineal Noise Recording 
Results of clinical vascular experiments done in the early seventies of the 
last century showed that carotid arterial stenosis of a patient with 
atherosclerosis has a characteristic turbulent flow distal to the site of 
obstruction. Investigators developed a so-called ’phono-angiogram‘ to 
detect this phenomenon[48]. Trials were expanded to urology in order to 
apply this audio technology to investigate urethral obstruction. An in-vitro 
study[49] was done to evaluate the phonographic characteristics of a silicon 
tube model of the male urethra through which a fluid passed under 
different grades of obstruction. The authors found that the mechanical 
vibrations induced by turbulent fluid in an obstructed urethral model could 
be measured using a microphone applied to the outer surface of the tube. 
The frequency spectrum of the vibration signals showed dependence on 
many factors; one of these factors was the degree of obstruction. In a 
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clinical study that included 16 healthy volunteers[50], a microphone was 
pressed against the perineum just behind the scrotum and the acoustic 
signals during voiding were recorded. The authors reported significant, 
repeatable, intervolunteer differences in acoustic signal frequency with 
smaller intra-volunteer differences. 
 
This method seems to be a potential non-invasive method for the diagnosis 
of BOO. But first it needs to be tested in patients with LUTS and clinical BPH 
in order to evaluate its clinical applicability compared to the standard PFS. 
 
4. Non-invasive measurement of isovolumetric bladder pressure 
Assuming that there is a continuous fluid column between the bladder 
cavity and the urethra during voiding, McRae et al.[51] proposed that the 
isovolumetric intravesical pressure can be measured indirectly by applying 
external compression with certain pressure, controlled by a manometer 
around the penile urethra. 
 
Penile cuff method 
Different methods were used applying the same principle; one of these 
methods was the penile cuff method. This method implied occluding the 
urine stream through the penile urethra by inflating a 2 cm wide penile cuff 
up to 250 cm H2O. The patient was asked to start voiding once he felt urine 
passage down the urethra. Theoretically this means that pressure inside the 
distended part of the urethra proximal to occlusion is equal to the 
intravesical pressure. The high pressure inside the cuff was released slowly 
(8 cm H2O/s) to allow voiding. Once a flow rate reading of 1 ml/s was 
reached, rapid deflation of the cuff was done. The cuff pressure at the first 
85
Chapter 4 
 
 
Applying the same technique using a transrectal approach to investigate the 
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flow was suggested to be theoretically equal to the intravesical pressure. 
However, it was found to be higher than the actual intravesical bladder 
pressure measured by conventional PFS with a mean difference of 37±16 
cm H2O. A formula: [R = Piso/Qi² (cm H2O/cc
2/s2)] was postulated to score 
obstruction in ascending grades from 1 to 3 points. This formula represents 
the energy transfer ratio between the maximum isovolumetric detrusor 
pressure (Piso) and the maximum urethral carrying squared capacity (Qi²). It 
was calculated in patients before and after they received a definitive 
treatment[52]. ’R’ was remarkably improved in a patients’ group that 
underwent surgical correction of their BOO. The average improvement was 
62% for bladder neck incision procedures and 79% for transurethral 
prostatectomy (TURP) procedures. This improvement was less noticeable in 
patients who received conservative treatment. 
These findings were obtained from a small number of 26 patients implying 
that statistical conclusions should be dealt with caution. 
 
The penile cuff inflation method was tried to increase the accuracy of the 
isovolumetric bladder pressure measurement. A cohort of 35 patients was 
included in a clinical study[53] in which an automatically inflatable penile cuff 
was applied around the penile urethra. Once voiding started gradual 
increase in pressure at a rate of 10 cm H2O per second was done until 
voiding stopped. Intra-urethral pressure was found to be affected 
significantly by the penile size (p = 0.002) and the material of the cuff (p = 
0.001). The authors recommended the use of cuffs with a width of 40 to 50 
mm and soft pliable materials to get optimal results. 
A larger study was performed on 151 men with LUTS[54] who underwent 
non-invasive measurement of isovolumetric bladder pressure using the 
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penile cuff inflation test with simultaneous conventional PFS. The cuff 
derived mean intra-urethral pressure was higher than the actual mean 
intravesical pressure derived from PFS by 16 cm H2O. This can be explained 
by the lower position of the penile cuff than the actual intra-pelvic position 
of the bladder. Interestingly, the patients completed a questionnaire where 
80% of them preferred the use of penile cuff test instead of the 
conventional PFS. 
 
A nomogram was developed by plotting the isovolumetric bladder pressure 
values obtained from the penile cuff test against the Qmax values obtained 
from conventional uroflowmetry done in the same patients in a clinical 
study that included 144 patients with LUTS[55]. At Qmax <10 ml/s it was 
possible to classify these patients into obstructed, unobstructed and 
equivocal groups with sensitivity, specificity, PPV, and NPV of 59%, 89%, 
77% and 77%, respectively for obstruction. The nomogram could identify 
good symptomatic outcome with 50% improvement of the IPSS four 
months after surgery in a study performed on 208 patients planned for 
TURP[56] with predictive values of 87% and 56% in respectively obstructed 
and unobstructed patient groups. It was remarkable that only 2% of the 
patients reported a self-limited urethral bleeding and pain as adverse 
events. 
 
Condom catheter method 
An external, self adhesive, condom catheter has been introduced for the 
first time by Ron van Mastrigt et al. for the non-invasive measurement of 
the isovolumetric pressure[57,58]. The rationale behind this the technique 
was that intravesical pressure could be measured in the periphery (urethra) 
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non-invasively, rather than inside the bladder through an invasive catheter, 
having a continuous column of fluid between the inside of the bladder and 
the urethra. 
 
Forty-six patients with LUTS underwent invasive pressure flow study with 
simultaneous measurement of isovolumetric pressure using the condom 
catheter technique. The condom catheter used in this technique consisted 
of 4 basic components: a condom that fits to the penis, a tube that drains in 
a flowmeter, a valve and a pressure transducer. During voiding, the urine 
outflow is interrupted by closing the tube with the valve. The pressure 
transducer measures the pressure inside the condom at that moment and 
displays a flow rate on a computer screen. 
In 26 successful measurements, the agreement between the pressure 
inside the bladder (invasive) and outside the bladder (condom) was better 
in the patients with no obstruction than in the group of obstructed patients. 
The pressure inside and outside the bladder was significantly different 
between both groups. The pressure difference between the pressure inside 
and outside the bladder showed significant correlation with the urethral 
resistance factor (URA)[58]. 
 
A nomogram was further constructed based on condom pressure values 
plotted versus flow rate values. About 92% of patients were successfully 
reclassified as having BOO or not compared to a conventional pressure flow 
study[59]. 
The applicability and reproducibility of the non-invasive condom catheter 
method was addressed in 730 volunteer men who were able to void 
continuously with a Qmax of at least 5.4 ml/s to ensure accurate reflection of 
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the bladder pressure[60]. A modified condom type catheter was used. The 
condom had a stiff shaft to withstand high pressures and it was connected 
to 3 tubes that could be controlled separately by pneumatic valves. The 
tubes had connections to a dome that is screwed on a pressure transducer 
and provided with three different metal outflow resistances. Once the 
patient starts voiding, the outflow resistance was gradually increased 
through controlling different tubes until the flow was completely 
interrupted; theoretically, at this point, condom pressure reflected the 
isovolumetric pressure inside the bladder. 
 
A total of 659 were eligible for inclusion in the condom measurements; 618 
patients had at least one successful measurement and were therefore 
included in the final analysis. The mean maximum pressure measured by 
the condom type catheter was 101±34 cm H2O. A total of 555 patients 
underwent two successful measurements in the same session on the same 
day. In 80% of them, the mean difference between the two pressure values 
recorded by condom catheter was -1 cm H2O, significantly different from 0 
(p<0.001). About 10% of the patients reported a short term, tolerable 
unpleasant sensation on the glans penis during the test and 7% reported 
self limiting terminal hematuria. 
 
Indirect measurement of isovolumetric bladder pressure is an easy 
technique with an acceptable low morbidity. The rational of this method 
sounds logic, because it implies measurement of a urodynamically 
important and widely acceptable parameter. This is lacking in all other non-
invasive urodynamic methods. Therefore, this technique has similarities 
with the conventional PFS and can be potentially informative in case of 
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detrusor under activity. However, it cannot prove or exclude the effect of 
changes in the abdominal pressure on the vesical pressure. 
 
5.  Quantitative near-infrared Spectroscopy 
Near-infrared spectroscopy (NIRS) is an optical technology. Light in the 
near-infrared spectrum can penetrate the skin to underlying tissues to be 
absorbed by naturally occurring chromophores. Examples of these 
chromophores are oxy-hemoglobin (O2Hb) and deoxy-hemoglobin (HHb). 
O2Hb and HHb absorb light photons in the near-infrared spectrum at 
different wavelengths. Therefore, measurement of changes in their 
concentrations in biologic tissues at a certain moment relative to baseline 
can give an idea about the relevant oxygen dependant hemodynamic 
changes in these tissues at that moment[61,62]. Recently, the feasibility of 
urinary bladder monitoring with NIRS has been proven by Macnab et al.[63].  
 
Stothers et al.[64] evaluated 64 men with LUTS using conventional PFS with 
simultaneous NIRS of the bladder. Patients were classified into obstructed 
and unobstructed groups based on ’Abrams-Griffiths nomograms’. A 
classification and regression tree (CART) model was applied to determine 
the independent ability of NIRS data to reclassify patients as compared to 
the standard PFS. The authors reported a good discriminatory ability of 
NIRS data related to obstruction with 100% sensitivity and 88% specificity 
for BOO. 
The chronicity, degree of obstruction, systemic vasculopathies and the 
potential effect of BWT should be considered when NIRS is applied as a 
single tool of investigation in voiding dysfunctions[65]. 
Non-Invasive Techniques in the Diagnosis of Voiding Disorders 
The techniques developed for the non-invasive diagnosis of BOO in men 
with voiding LUTS were based on two approaches. The first approach was 
indirect measurement of the isovolumetric bladder pressure during voiding, 
which is a crucial urodynamic parameter. This technique demonstrated 
good accuracy as compared to the conventional PFS. Accordingly, PFS are 
not any more unique in their ability to identify intravesical pressure. 
However, more attention should be paid to the abdominal pressure 
contribution and its impact on the results in this technique. The second 
approach was measurement of theoretically relevant, non-urodynamic 
parameters to BOO such as BWT, DWT and UEWB. These sonographically 
derived parameters showed good correlation to BOO, but are still lacking 
standardization of methodologies followed in their measurements. Cut-off 
values of these parameters need to be developed for patients in various 
ages and genders in order to be reproducible in clinical practice. DUF, 
perineal sound, NIRS, and Doppler RI show growing evidence, but their 
reproducibility still needs to be tested in larger patient study groups to 
determine their clinical utility. 
We think that if NIRS, DUFV or IVPP techniques are combined with other 
non-invasive parameters such as IPSS, Qmax, prostatic volume, PVR, BWT, 
DWT and UEBW more effective and clinically expressive diagnostic 
performance of these parameters will be obtained. 
Flowmetry and ultrasonographic assessment of PVR cannot distinguish BOO 
from detrusor undercontractility but can still be applied for initial 
evaluation and follow-up of patients with LUTS. NIRS detects the 
hemodynamic changes caused by detrusor contractions. More basic and 
clinical studies are needed to evaluate the value of this technology in the 
non-invasive diagnosis of BOO. 
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Abstract 
 
Introduction 
To investigate the accuracy of uroflowmetry with disposable QSingle 
compared to measurements with home-based digital device and compared 
to a single clinical measurement. 
 
Patients and Methods 
60 men with LUTS were included in a prospective, open-label, multicentre 
study. Uroflowmetry measurements were done using three 
devices/methods: single clinic-based method, followed by up to 12 
measurements using the disposable home-based QSingle, and up to 12 
measurements using a home-based digital device. Subjective data on ease 
of use of QSingle and preference of patients were investigated and objective 
measures of Qmax and voided volume from the three devices were 
compared. 
 
Results 
Mean Qmax values of 12, 13 and 16 ml/s were achieved with QSingle device, 
standard clinic method, and digital device, respectively. Mean Qmax 
obtained with QSingle device did not differ from the one obtained with clinic 
method. A significantly higher mean Qmax was recorded for the digital 
device. Mean voided volumes recorded with each device differed 
marginally. Handling capabilities of the QSingle device were considered good 
by all subjects. 
 
Conclusions 
The accuracy of Qmax and voided volume mean measurements with QSingle 
was comparable to one standard clinic recording. QSingle offers a viable 
alternative to reduce the number of clinic visits and can be used by other 
care givers. 
 
 
Disposable Home Urinary Flowmeter as a Diagnostic Tool in Males with LUTS 
 
Introduction 
Clinical uroflowmetry has been recommended to be performed before 
surgical intervention for male patients with lower urinary tract symptoms 
(LUTS) suggestive of bladder outlet obstruction (BOO) in order to exclude 
patients unlikely to benefit from the surgery[1]. It can also be of great value 
in the evaluation of treatment outcomes in these patients. However, clinic-
based uroflowmetry has some flaws: the setting is artificial and often it is 
difficult to void at the desired moment. Moreover, a single measurement of 
the voided Qmax is a poor representative for the ‘best value’ to objectively 
characterize patients’ voiding parameters since there is a high variability of 
Qmax
[2]. On the other hand, performing multiple uroflowmetries necessitates 
multiple visits to the hospital with increased costs. 
 
Therefore, there is a need for representative and accurate way of recording 
uroflowmetry parameters that is more patient friendly. This study 
investigated whether repeated measurements using a single use 
uroflowmetry device, QSingle, would result in a repeatable and accurate 
measurement of uroflowmetry parameters compared to a single clinic-
based measurement. 
 
Patients and Methods 
Participants: 
Sixty-eight male subjects with LUTS suggestive of BOO were screened for 
the study. Subjects were ineligible if they were practicing clean intermittent 
self-catheterization (CIC), had an ongoing symptomatic urinary tract 
infection (UTI), suffered from neurogenic bladder, had started treatment 
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with BPH medication within the last 2 months, or had presented with signs 
of severe urinary flow obstruction.  
Study Design: 
This was a prospective, open-label, multicentre investigation. All subjects 
underwent serial measurements of their maximum urinary flow rate (Qmax) 
and voided volumes in three different settings: the first by doing a single 
measurement using the standard clinical uroflowmeter (Qclinic) (supplied by 
Dantec, Medtronic or Urocap). This was followed by performing up to 12 
measurements using QSingle (AstraTech AB, Sweden) home-based 
uroflowmeter (QSingle). Finally, up to 12 measurements were done using 
Urospec™ (Medispec), a home-based digital uroflowmeter (Qdigital). The 
order of the two types of home-flow measurements was determined at 
random. Measurements obtained by the digital device were used as the 
reference standard in our study. 
 
 
Figure 1. QSingle device 
 
 
Disposable Home Urinary Flowmeter as a Diagnostic Tool in Males with LUTS 
 
Home-flowmetry Devices: 
QSingle (AstraTech AB, Sweden) is a single-use disposable device to measure 
Qmax and total voided volume. The device (figure 1) has been developed to 
offer a simple uroflowmetry measurement at home. The product displays 
the results in a stepwise manner and the results are transferred to a 
removable scratch card. On the device there are indicators showing 
stepwise increments in Qmax from 0 to 17 ml/s. It also contains a reservoir 
with a printed scale to house the voided volume in interval steps ranging 
from 50 to 600 ml. Urospec™ digital uroflowmeter (Medispec) is a battery 
operated unit that provides measurement of Qmax, voided volume, weight, 
voiding time and voiding frequency. Data are stored in an internal memory. 
The Urospec™ flowmeter was the reference to which the other devices 
were compared.  
 
   Figure. 2. Instructions for the patient showing steps to use the QSingle device. 
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and voided volumes in three different settings: the first by doing a single 
measurement using the standard clinical uroflowmeter (Qclinic) (supplied by 
Dantec, Medtronic or Urocap). This was followed by performing up to 12 
measurements using QSingle (AstraTech AB, Sweden) home-based 
uroflowmeter (QSingle). Finally, up to 12 measurements were done using 
Urospec™ (Medispec), a home-based digital uroflowmeter (Qdigital). The 
order of the two types of home-flow measurements was determined at 
random. Measurements obtained by the digital device were used as the 
reference standard in our study. 
 
 
Figure 1. QSingle device 
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The Urospec™ flowmeter was the reference to which the other devices 
were compared.  
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Investigative studies: 
All subjects were instructed to record up to 12 consecutive representative 
urinary voids using the QSingle and then using Qdigital device at home. 
Instructions for patients on how to use the QSingle are illustrated in figure 2. 
After the home recording sessions, patients returned the Qdigital device 
together with a voiding diary from QSingle. Patient also completed a 
questionnaire about their experiences with the various devices. The 
questionnaire included a number of questions related to the perception of 
use and handling of the respective measuring devices. For the new QSingle 
device, a number of questions related to handling capabilities were 
included. 
 
Ethics:  
The study was performed in accordance with the Declaration of Helsinki 
and it was consistent with ISO 14155 and ICH/Good Clinical Practice and 
applicable regulatory requirements. The study was approved by the Ethics 
Committee/Institutional Review Board in each participating centre.  
 
Statistical Analysis: 
The primary objective was to determine the diagnostic accuracy of the Qmax 
obtained from at least 3 to a maximum of 12 measurements using the QSingle 
device compared to the accuracy of the Qmax obtained from the single 
measurement using  Qclinic. Three measurements with the QSingle device were 
taken because this was considered an adequate number to be reliable. The 
outcome was related to the mean Qmax obtained from the 12 
measurements performed using the Qdigital. 
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Secondary study objectives were to evaluate results for different subgroups 
of subjects. The study was analyzed applying the principles Intention-to-
treat (ITT) and per-protocol (PP). The ITT-analysis was considered the 
primary analysis set. Subjects fulfilling the eligibility criteria and presenting 
with evaluable data were included in the PP analysis set.  
The size of the trial was calculated based on estimations from technical 
specifications from each device and data from the literature of mean Qmax 
to be expected in this study population[3]. The study was designed with an 
80% power to detect a difference in flow of >2 ml/s at a significance level of 
5%. The aim was to include 75 subjects. Based on an interim analysis, a 
total of 60 subjects were deemed sufficient for statistical comparison. 
 
From the individual data collected, differences in mean values of voided 
volumes and Qmax were calculated for each subject and tested using the 
Wilcoxon signed-rank test. Similarly, individual differences were calculated 
between measurements from the three devices. 
Each Qmax collected was put into eight categories in accordance with the 
scale available on the QSingle (table 1). Individual paired mean Qmax values for 
each subject and method/device were categorized according to the scale. 
No covariates were judged to influence the outcome of the variables. 
Recorded urinary flows below the requested amount of 100 ml were 
excluded from analysis[4]. 
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Table 1. Categories for comparisons of individual mean Qmax for each device/method 
 
Category label Qmax interval for each category label 
0 0 
5 0 < Qmax < 6 
7 6 < Qmax < 8 
9 8 < Qmax < 10 
11 10 < Qmax < 12 
13 12 < Qmax < 14 
15 14 < Qmax < 16 
17 16 < Qmax <  
 
Results 
Sixty-eight men with LUTS suggestive of BOO were screened for the study; 
of these a total of 60 subjects with a mean IPSS of 17.4 (range 2-38), a mean 
age of 66 years (range 43-84) and a mean period with LUTS of 5.8 years 
 (range 0-38) were recruited. As there were some missing data in various 
registrations for 8 patients, study data were also analyzed according to the 
principles of a PP analysis to check the robustness of the ITT analysis. This 
analysis did not show any important differences and is therefore omitted 
from presentation. 
 
One more patient was excluded due to data loss. The results of the three 
different methods obtained from a total of 59 subjects using Qclinic, QSingle, 
and Qdigital are shown in table 2 and figure 3. The mean urinary volumes 
recorded with each device were 250, 238 and 224 ml for Qclinic, QSingle, and 
Qdigital, respectively. This was not statistically different. Mean Qmax-values of 
12, 13 and 16 ml/s were recorded with QSingle, Qclinic, and Qdigital, respectively. 
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For QSingle, the mean Qmax from the first three consecutive measurements 
was very similar to the data from the total of 12measurements. For Qdigital, a 
significantly higher mean Qmax was recorded. 
 
 
Qsingle vs. Qclinic 
Computed individual mean values from each subject’s measurements of 
Qmax values and voided volumes were used to compare the Qclinic and the 
QSingle device. Qmax recorded by Qclinic was not significantly higher than Qmax 
recorded by the QSingle device (table 3). The same was true for the mean 
voided volumes per void. 
 
Table 2. Flow measurements with the Qclinic, QSingle, and the Qdigital devices 
 
 n Mean SD Min Max 
Qclinic
a, b      
    Qmax ml/s 59 13 7 5 39 
    Voided volume, ml 59 250 130 30 566 
QSingle
c      
    Qmax, ml/s, all 57 12 4 4 17
d 
    Qmax, ml/s, first 3 assessments 57 12 4 3 17d 
    Voided volume, ml, all 57 238 94 79 508 
    Voided volume, ml, first 3 
assessments 
57 234 104 67 533 
Qdigital
e      
    Qmax, ml/s 52 16 8 6 47 
    Voided volume, ml 52 224 76 85 457 
a Equipments from Dantec Dynamics Ltd, Medtronic Inc. or Laborie Medical Technologies 
Inc. b Three subjects had 2 Qclinic measurements. 
c Data from 57 subjects (2 subjects reported 
9 measurements). d Maximum value of registration, flows exceeding 17 ml/s are also 
registered as 17 ml/s. e No data from 8 subjects (3 subjects reported 9-11 measurements) 
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 Figure 3. Qmax for measurements 1-12 with QSingle and Qdigital device. The Qclinic average 
 flow of 13.3 ml/s is marked as a reference line. 
 
Qdigital vs. Qclinic and Qdigital vs. QSingle 
Individual mean voided volumes and Qmax were also used for calculation of 
the differences between Qdigital and Qclinic and for the differences between 
Qdigital and QSingle devices, respectively. The lowest mean voided volume was 
obtained with Qdigital and the highest value with Qclinic. No statistically 
significant differences were obtained regarding voided volumes. The Qmax 
with the Qdigital device was 3 ml higher than with the Qclinic (p = 0.0001) and 4 
ml higher than with the QSingle device (p< 0.0001). 
Comparisons of paired Qmax values 
Individual categorized paired Qmax values are presented in tables 3, 5 and 7. 
Twenty-three subjects had a higher QSingle-Qmax, whereas 23 subjects had a 
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higher Qclinic-Qmax (p = 1.0). Qdigital-Qmax was higher in 26 subjects; 8 subjects 
had a higher Qclinic-Qmax (p = 0.0029). 
 
Table 3. Paired categorized mean Qmax flow rates (ml/s) for the Qclinic and the QSingle 
device. 
Device 
used 
QSingle mean of 3 measurements 
0-5 5-7 7-9 9-11 11-13 13-15 15-17 17- Total 
Q
cl
in
ic
 
0-5          0 
5-7       1   1 
7-9  2 2 3  1   8 
9-11  1 3 2   2 1 9 
11-13  1 2 1 2 2   8 
13-15  1  1 2   4 2 10 
15-17     4 1 1 7 13 
17-      3 1 3 7 
Total 0 5 7 7 8 8 8 13 56 
Number of subjects (n) in each interval. Green boxes denote equivalence. 
 
Table 4. Paired categorized mean Qmax flow rates (ml/s) as ≤10.0, 10.1-15.0 and ≥ 
15.0 for the Qclinic and the QSingle device. 
Device 
used 
QSingle mean of 3 measurements 
0 - 10 10 - 15 15 - Total 
Q
cl
in
ic
 
0 - 10 14 4 1 19 
10 - 15 5 11 8 24 
15 - 0 7 6 13 
Total 19 22 15 56 
Number of subjects (n) in each flow interval. Green boxes denote equivalence. 
 
Finally, 33 subjects had a higher Qdigital-Qmax compared to 5 subjects with a 
higher QSingle-Qmax (p < 0.0001). Paired Qmax values were re-categorized 
based on the Qclinic data into three groups <10, 11-15 and >15ml/s to 
analyze how many patients switched these categories based on the home-
based flowmetry data (tables 4, 6, 8). Interestingly, 81% of the subjects 
preferred to measure their urinary flow at home. The handling capabilities 
of the QSingle device were well appreciated by all subjects. 
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Table 5. Paired categorized mean Qmax flow rates (ml/s) for the Qclinic and the Qdigital 
device. 
Device 
used 
Qdigital 
0-5 5-7 7-9 9-11 11-13 13-15 15-17 17- Total 
Q
cl
in
ic
 
0-5          0 
5-7         1 1 
7-9   1 1 3 2 1  8 
9-11    2 3  2 1 8 
11-13   1 2 2  3  8 
13-15      2  5 7 
15-17      2 6 4 12 
17-       3 4 7 
Total 0 0 2 5 8 6 15 15 51 
Number of subjects (n) in each flow interval. Green boxes denote equivalence. 
 
Table 6. Paired categorized mean Qmax flow rates (ml/s) as ≤10.0, 10.1-15.0 and ≥ 
15.0for the Qclinic and the Qdigital device. 
Device 
used 
Qdigital 
0 - 10 10 - 15 15 - Total 
Q
cl
in
ic
 
0-10 6 9 3 18 
10-15 3 6 11 20 
15 - 0 4 9 13 
Total 9 19 23 51 
Number of subjects (n) in each flow interval. Green boxes denote equivalence. 
 
Table 7. Paired categorized mean Qmax flow rates (ml/s) for the QSingle and the Qdigital 
device. 
Device used 
Qdigital 
0-5 5-7 7-9 9-11 11-13 13-15 15-17 17- 
Tota
l 
Q
Si
ng
le
 
0-5          0 
5-7    2   2   4 
7-9     4 3    7 
9-11    1 3 2 1  7 
11-13     1 1 3 1 6 
13-15      1 5 2 8 
15-17      1 3 4 8 
17-     1  3 8 12 
Total 0 0 2 5 8 7 15 15 52 
Number of subjects (n) in each flow interval. Green boxes denote equivalence. 
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Table 8. Paired categorized mean Qmax flow rates (ml/s) as ≤10.0, 10.1-15.0 and ≥ 
15.0 for the QSingle and the Qdigital device. 
Device used 
Qdigital 
0 - 10 10 - 15 15 - Total 
Q
Si
ng
le
 
0-10 9 8 1 18 
10-15 0 10 10 20 
15 - 0 2 12 14 
Total 9 20 23 52 
Number of subjects (n) in each flow interval. Green boxes denote equivalence. 
 
Discussion 
‘The bladder is an unreliable witness’[5]. This widely accepted dogma led to 
the development of a range of alternative investigations to supplement the 
patient’s subjective assessment of LUTS. Pressure flow study (PFS) is the 
current standard urodynamic test for the diagnosis of male LUTS. However, 
it is invasive and can cause patient discomfort. Uroflowmetry is a non-
invasive test and it has been widely used as a screening tool for men 
presenting with LUTS. Uroflowmetry is superior to reliance on symptoms 
alone[6-9]. It is valuable to quantify impaired urinary flow and can be used 
for follow-up after treatment[9], which can reduce the number of 
unnecessary, invasive pressure flow study.  
 
The combination of uroflowmetry with post void residual measurement can 
be of value in male LUTS assessment as expressed in various European 
guidelines[10-12]. However, it was recommended by the National Institute for 
Health and Clinical Excellence (NICE) only as secondary assessment tool in 
these patients as they did not sufficiently increase the accuracy of BOO 
diagnosis and therefore could not be considered as cost-effective primary 
diagnostics[13]. 
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A recognized problem with clinical uroflowmetry is that it may not be 
representative of what is normal for the individual; the circumstances in 
which the clinical uroflowmetry are measured are not totally physiological 
as patients have to present to the clinic holding their urine, and often they 
have to visit the toilet earlier than planned for uroflowmetry. Moreover, 
not every health care professional interested in voiding has a uroflowmeter 
and ultrasound equipment. Many general practitioners and neurologists 
seeing patients with voiding complaints would like to have an impression 
about patients’ voiding capabilities[14,15]. Symptoms, voiding diaries, 
uroflowmetry and postvoid residual in combination could provide a 
potential prediction of obstruction in many cases, which may reduce the 
further need for invasive testing. This implies that a good alternative device 
for clinical uroflowmetry could be valuable for many healthcare 
professionals. 
Home-based uroflowmetry could be such an alternative; various types of 
home-based uroflowmetry devices are available[16,17]. However, most of 
them are not disposable and are therefore costly[17,18]. QSingle was developed 
based on an idea by Pel et al.[19]; the flowmeter consists of a funnel 
connected to a collecting tube. Urine coming into the funnel is collected 
and exits through one or more ports. The higher the flow rate; the more 
exit ports emit the urine.  
 
This study aimed to evaluate the applicability and accuracy of home-based 
uroflowmetry measurement using a single-use flowmetry device compared 
to the standard method of clinic-based uroflowmetry. The average of the 
first three home-based uroflowmetry measurements was almost identical 
to all available measurements (table 2). Thus, three uroflowmetry 
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measurements using QSingle seem to give a representative estimate of a 
patient’s urinary flow comparable to clinic-based uroflowmetry. 
The Qmax and voided volumes obtained with QSingle were slightly lower than 
the ones obtained from one clinic-based flow measurement; this implies 
that QSingle is a reliable device with the potential to replace clinic-based 
flows, and that the QSingle does not under- or overestimate the voiding 
capabilities of patients. 
 
A limitation of our study was that we used only one clinical flow as a 
reference although we know that only one flow is not as representative as 
the mean of several flow measurements. However, we used this design 
because we know that in clinical practice decisions are often made on the 
basis of a single clinic-based measurement. Another limitation was that 
QSingle can only measure Qmax up to 17 ml/s. Moreover, a substantial 
proportion of patients did not suffer from severe LUTS. 
The subjects in this study preferred home-based uroflowmetry over clinic-
based uroflowmetry; similar observations have been made in previous 
studies[16,20]. Home-based uroflowmetry using the QSingle device seems to 
offer a simple, convenient alternative to clinical-based uroflowmetry. 
 
Data from this study suggest that the QSingle device can be used in a 
urological practice as a reliable home-based method where patients can do 
measurements in their own environment with the potential to reduce the 
number of clinic visits. 
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measurements using QSingle seem to give a representative estimate of a 
patient’s urinary flow comparable to clinic-based uroflowmetry. 
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Conclusions 
Measurements with the QSingle device compared to the standard clinic-based 
method resulted in similar voided volumes and Qmax-values. The disposable 
single-use device was considered easy to manage and was preferred by the 
majority of subjects. The QSingle device may be useful as an inexpensive tool 
for monitoring LUTS in a non-urological healthcare setting. 
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Abstract 
Introduction 
To determine the difference in response of near-infrared spectroscopy 
(NIRS) of the bladder during voiding between men with and without 
bladder outlet obstruction (BOO) and also to determine the diagnostic 
value of NIRS in men with lower urinary tract symptoms (LUTS). 
Methods 
A prospective case series study included men with LUTS. Patients 
completed an International Prostate Symptom Score (IPSS) questionnaire 
and prostate volumes were measured sonographically. Patients underwent 
pressure flow study (PFS) with simultaneous NIRS of the bladder. 
Amplitudes of deoxy-hemoglobin (HHb), oxy-hemoglobin (O2Hb) and total 
hemoglobin (Hbsum) were calculated at Qmax, relative to baseline. Patients 
were urodynamically classified as obstructed or unobstructed. A recursive 
partition analysis (RPA) was performed to reclassify patients using NIRS 
amplitudes, followed by combined data of NIRS amplitudes, prostate 
volume, IPSS and Qmax to determine the best predictor(s) of BOO. 
Results 
Thirty-six patients were included. PFS classified 28 patients as obstructed 
and 8 as unobstructed. The median HHb and Hbsum amplitudes were 
significantly higher in the obstructed group. RPA of NIRS relative amplitudes 
correctly reclassified 89% of patients [AUC: 0.91]. RPA of the combined 
IPSS, prostate volume, PVR and Qmax correctly reclassified 72% of patients 
[AUC: 0.84]. When NIRS amplitudes were added to this combination, RPA 
revealed a significantly (P<0.001) higher rate of correct reclassification in 
89% of patients with 89.3% sensitivity and 88% specificity for obstruction 
[AUC: 0.96]. 
Conclusions 
NIRS data can be of diagnostic value for BOO in men with LUTS either alone, 
or in combination with other non-invasive parameters. 
 
 
 
 
NIRS in Men with LUTS 
Introduction 
Benign prostatic hyperplasia (BPH) is a common disease in elderly men. BPH 
can be a leading cause of bladder outlet obstruction (BOO) and lower 
urinary tract symptoms (LUTS). Twenty-five percent of men above 60 years 
require surgical treatment for BOO[1]. BOO is characterized by an increase in 
detrusor pressure with a decreased urinary flow rate during voiding[2]. A 
pressure flow study (PFS) is the current standard diagnostic test for BOO[3]. 
However, this test is invasive with potential morbidity. Therefore, it is 
worthwhile to develop a non-invasive diagnostic technique for BOO. 
 
Doppler ultrasonographic studies and radioisotope labeled microsphere 
techniques have revealed significant hemodynamic changes in the urinary 
bladder during the micturition cycle. Near-infrared spectroscopy (NIRS) is a 
function imaging technology. It enables non-invasive evaluation of oxygen 
dependent hemodynamic changes in biological tissues by measurement of 
the relevant changes in the concentration of tissue hemoglobin. Oxy-
hemoglobin (O2Hb) and deoxy-hemoglobin (HHb) represent both oxygen 
supply and consumption of the tissue. The sum of O2Hb and HHb (Hbsum) 
represents the total blood perfusion of the tissue under monitoring[4-6]. 
Macnab et al. applied qualitative NIRS patterns combined with maximum 
flow rate (Qmax) and post-void residue (PVR) in classification of men with 
LUTS[7]. Stothers et al.[8] evaluated 64 men with LUTS using conventional 
PFS with simultaneous NIRS of the bladder during voiding. Authors reported 
a good discriminatory ability of NIRS data related to obstruction with 100% 
sensitivity and 88% specificity for BOO. 
In the current study, a quantitative approach of NIRS parameters was used. 
Our objective was to determine the difference in the response of NIRS data 
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from the bladder during voiding between men with and without BOO. A 
secondary objective was to determine the diagnostic value of NIRS in men 
with LUTS suggestive of BOO, either alone, or in combination with other 
non-invasive diagnostic parameters of prostate volume, International 
Prostate Symptom Score (IPSS) and Qmax. 
 
Patients and Methods 
Participants were adult men referred to the Radboud University Nijmegen 
Medical Centre for urodynamic evaluation of their LUTS. Exclusion criteria 
were hematuria, a scar of previous pelvic surgery and a history of radical 
prostatectomy. The protocol for this study has been approved by the local 
Ethics Committee of the Radboud University Nijmegen Medical Centre 
(2009/188) and conforms to the provisions of the Declaration of Helsinki. 
Patients received no medication for their urologic disorders prior to the 
date of investigation. Patients completed the IPSS questionnaire. 
Transrectal ultrasound was performed to measure the prostate volume. 
Dipstick urinalysis was performed to exclude hematuria and urinary tract 
infection. 
All patients underwent PFS (Solar, Medical Measurement Systems, 
Enschede, The Netherlands). A gas filled urethral catheter (6 Fr/Ch) and a 
rectal catheter were inserted to monitor vesical pressure (Pves) and 
abdominal pressure (Pabd), respectively. Water was infused at room 
temperature at a rate of 50 ml/min until maximum capacity was reached. 
Then, the patients were asked to void in the flowmeter in sitting or standing 
position according to their preference. Simultaneous trans-cutaneous NIRS 
of the bladder was performed during the PFS (URO-NIRS™, Urodynamix 
NIRS in Men with LUTS 
Technologies Ltd, Vancouver, BC, Canada). NIRS optodes were placed on 
the abdomen 2 cm above the pubic symphysis across the midline[9]. Patients 
were asked to remain still in standing or sitting position to have baseline 
readings of the NIRS curves. Then, permission to void was given and 
patients were asked to avoid straining. Simultaneous PFS and NIRS data 
acquisition was performed with a sampling frequency of 10 Hz. 
 
Data pre-processing and analysis 
Data processing was performed by using MATLAB software (MATLAB 
R2009a, version 7.8.0.374, The Mathworks Inc, Natick, Massachusetts, 
USA). NIRS data was filtered using a second order Butterworth low-pass 
filter with a cut-off frequency of 0.2 Hz. 
Two points were marked on the detrusor pressure (Pdet) curve during 
voiding activity (figure 1); point ‘A’, at the beginning of detrusor muscle 
contraction and point ‘B’ at Pdet.Qmax. Baseline readings of HHb, O2Hb and 
Hbsum curves were obtained by averaging 30 seconds of data before point 
‘A’. Relative amplitudes of NIRS curves were calculated by subtracting the 
averaged 30 seconds baseline of every curve from the point ‘B’ of the same 
curve. 
 
Patients were urodynamically classified as obstructed or unobstructed using 
‘Detrusor/flow plot’ according to Griffiths[10]. Diagnosis of obstruction was 
made when the group-specific resistance factor (URA) was >28. To obtain 
an 80% probability of detecting a difference of 3 µmol/l in NIRS amplitudes 
between the obstructed and the unobstructed groups, a 2-tailed alpha level 
was set at α = 0.05 and a standard deviation of 3; the sample size needed 
was found to be 33 patients. 
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Median (range) demographic, urodynamic and NIRS parameters were 
calculated. A Mann Whitney U-test was applied to test the differences 
between groups. Differences with p-values less than 0.05 were considered 
statistically significant. 
 
Figure 1. An example of voiding session without potential motion artifacts. Pressure flow 
study with simultaneous near-infrared spectroscopy (NIRS) of a man with LUTS bladder 
outlet obstruction. Thirty seconds of baseline were averaged between points ‘X’ and ‘A’ for 
all NIRS parameters. The amplitudes of change in deoxy-hemoglobin (HHb), oxy-hemoglobin 
(O2Hb), and total hemoglobin (Hbsum) were calculated as out the result of subtracting the 
averaged 30 s baseline form the values at point ‘B’ for each NIRS parameter. 
Pves = vesical pressure, Pabd = abdominal pressure, Pdet = detrusor pressure, Qura = urinary 
flow rate. FS = first sensation, SD = strong desire, MCC = maximum cystometric capacity. 
 
Statistics 
Recursive partition analysis (RPA)[11] was then performed to test the ability 
of NIRS relative amplitudes to predict obstruction. RPA is a non-parametric 
NIRS in Men with LUTS 
method that recursively partitions data for relating independent variable(s) 
(NIRS and other non-invasive parameters) to a dependent variable 
(urodynamic diagnosis) creating a tree of partitions. It finds a set of cuts of 
the independent variable(s) that best predict the dependent variable by 
searching all possible cuts until the desired fit is reached. RPA was 
performed to test the ability of the combined data of prostate volume, IPSS 
and Qmax to predict obstruction. Finally, RPA of the combined data of NIRS 
amplitudes, Qmax, IPSS and prostate volume was performed to explore the 
clinical usefulness of quantitative NIRS when combined with these 
parameters in the diagnosis of BOO in men with LUTS. 
The sensitivity and specificity in predicting obstruction together with the 
area under the receiver-operating curve (AUC) were calculated. An AUC of 1 
indicates a perfect test in predicting obstruction. The percentage of correct 
classifications obtained with the three different RPA were compared using 
the student t-test for proportions based on their SDs calculated as √ (p*(1-
p)/N) where p is the proportion and N the sample size. 
Statistical analysis was done with MATLAB (The Mathworks Inc, Natick, 
Massachusetts, USA) and JMP® 7.0.2 (SAS Institute, Cary, NC). 
 
Results 
Thirty-six men with LUTS were included in this study. The mean age was 
67±9.3 y (range: 42-86), the mean BMI was 26.6±3.2 kg/m2 (range: 21-34), 
the mean IPSS was 17±7 (range: 5-33), and the mean prostate volume was 
52.6±33.2 cm3 (range: 21-160). Twenty-eight patients (77%) had 
urodynamic obstruction, while eight patients (23%) were unobstructed. The 
median relative amplitudes of HHb were significantly higher in the 
obstructed group (P = 0.45). Table 1 shows a comparison of NIRS, 
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Figure 1. An example of voiding session without potential motion artifacts. Pressure flow 
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flow rate. FS = first sensation, SD = strong desire, MCC = maximum cystometric capacity. 
 
Statistics 
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urodynamic obstruction, while eight patients (23%) were unobstructed. The 
median relative amplitudes of HHb were significantly higher in the 
obstructed group (P = 0.45). Table 1 shows a comparison of NIRS, 
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urodynamic and other relevant parameters between obstructed and 
unobstructed groups. Figure 2 shows results of box-plot NIRS amplitudes of 
HHb, O2Hb and Hbsum based on presence or absence of obstruction. 
 
Table 1. Comparison of demographic, urodynamic and near-infrared spectroscopy (NIRS) 
parameters between the obstructed and unobstructed groups.  
BMI =body mass index, IPSS = international prostate symptom score, PSA = prostate specific 
antigen, Qmax = maximum flow rate, PVR = postvoid residual urine, HHb = deoxy-hemoglobin, 
O2Hb = oxy-hemoglobin, Hbsum = total hemoglobin (Hbsum = HHb + O2Hb), Pdet.Qmax = detrusor 
pressure at maximum flow rate. * P-value < 0.05 is significant (Mann Whitney U test). 
 
Statistics 
(median) 
 
Obstructed 
n = 28 
Unobstructed 
n = 8 
P-value* 
Age 
(yr) 
68 (52-86) 68.5 (42-76) 0.99 
BMI 
(Kg/m2) 
26.5 (20-32) 26.6 (24-34) 0.69 
IPSS 19 (7-28) 12 (5-33) 0.23 
Prostate volume 
 
42 (23-160) 32 (21-50) 0.15 
Voided 
volumes 
172 (16-600) 201 (97-424) 0.69 
Qmax 
(ml/s) 
 
5 (2-12) 7 (2-9) 0.69 
Pdet.Qmax 
(cmH2o) 
69 (37-175) 39 (26-47) 0.005* 
PVR 
(ml) 
169 (0-682) 103 (0-350) 0.69 
HHb 
(µmol/l) 
1.8 (-4.0-6.2) -4.5 (-5.6-2.1) 0.045* 
O2Hb 
(µmol/l) 
1.1 (-5.8-7.5) 0.32 (-1.5-4.8) 0.09 
Hbsum 
(µmol/l) 
2.6 (-9.0-9.5) 0.33 (-4.8-2.6) 0.23 
NIRS in Men with LUTS 
Four of 36 patients had overt abdominal activity during voiding. Although 
this trend implies increased oxygen consumption or muscle fatigue during 
voiding in these patients, we tried to minimize any potential artifact in 
NIRS. Therefore, analysis was repeated after exclusion of these 4 patients. 
The median relative amplitude of HHb was still higher in the obstructed 
group (1.0 µmol/l, n= 25) than in the unobstructed group (-1.0 µmol/l, n = 
7) but without statistical significance (P = 0.12) 
 
 
Figure 2. Scatter-Plot amplitudes of deoxy-hemoglobin (HHb), oxy-hemoglobin (O2Hb), and 
total hemoglobin (Hbsum) based on presence or absence of obstruction according to standard 
urodynamic diagnosis. Despite the overlapping, NIRS parameters were significantly higher in 
obstructed patients compared to unobstructed patients. 
 
RPA of NIRS relative amplitudes revealed that NIRS correctly classified 
patients as obstructed or unobstructed in 32 of 36 patients (88%) with 96% 
sensitivity and 62% specificity, 90% PPV and 62% NPV for BOO [AUC: 0.92]. 
RPA of the combined Qmax, IPSS, PVR and prostate volume correctly 
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classified 26 of 36 patients (72%) with 71% sensitivity and 75% specificity, 
91% PPV, and 75% NPV for BOO [AUC: 0.84]. When NIRS amplitudes were 
added to this combination, RPA showed correct classification in 32 of 36 
patients (88%) with 89.3% sensitivity and 87.5% specificity, 96.3% PPV, and 
87.5% NPV for BOO [AUC: 0.96] This increase of percentage correct 
classifications was statistically significant (P<0.001). Figure 3 shows the 
classification responses of this non-invasive combination; the computed 
probability of having the diagnosis ‘obstructed’ was 100% using the cut-off 
Hbsum >= 2.6 µmol/l in 15 of 36 patients. For patients with Hbsum amplitudes 
< 2.6 µmol/l the prostate volume was checked; a cut-off value >= 71 grams 
had a 100% probability to be obstructed in 5 of 36 patients. For patients 
with prostate volume < 71 grams, the IPSS was checked; an IPSS < 15 had a 
0% probability of being obstructed in 5 of 36 patients. For patients with IPSS 
>= 15, the Qmax was checked; the Qmax cut-off value < 8 ml/s had a 100% 
probability of being obstructed in 5 of 36 patients while a Qmax >= 8 ml/s 
had a 62% probability of being obstructed in 3 of 36 patients. 
 
Discussion 
Qualitative NIRS has been applied in monitoring of bladder hemodynamic 
during voiding phase[7-9] and filling phase[12] of the micturition cycle. In the 
current study, relative changes in the concentration of hemoglobin in the 
bladder wall were quantified during the initial phase of detrusor muscle 
contraction until the point of Qmax. We believe it is the most active phase of 
voiding cycle with substantial hemodynamic changes are expected due to 
central and/or peripheral regulatory mechanisms of blood flow and the 
mechanical effect of contraction on the bladder wall vasculature (myogenic 
NIRS in Men with LUTS 
effect). NIRS measures changes in hemoglobin concentration and oxygen 
consumption in biological tissues mainly from the venous blood 
compartment[13-15]. Hemodynamic studies of skeletal muscles revealed that 
forceful contraction results in compression of the muscle vasculature with 
expulsion of the blood into the extra-muscular venous compartment 
‘muscle pump’ effect[16]. The same would be true for detrusor muscle 
contraction during voiding. Therefore, a higher venous outflow would be 
expected in the obstructed group due to the more powerful contraction of 
the bladder exerted to overcome the high outlet resistance. 
The median amplitude of change in HHb was significantly higher in the 
obstructed group. This overall trend may reflect a pathophysiologic 
phenomenon of increased oxygen extraction during more powerful 
detrusor muscle contraction with progressive muscle fatigue. 
In spite of this overall trend of NIRS data to be higher in the obstructed 
group, there was some overlap between the obstructed and unobstructed 
groups as shown in figure 2. While Azadzoi et al.[18] observed a decrease in 
blood flow to the bladder wall during spontaneous and evoked contractions 
in animal studies. Kershen et al.[19] showed that the urinary blood flow is 
increased with increase in bladder pressure and volume, while Kroyer et 
al.[20] reported inconsistent variations in mucosal and muscular blood flow 
of the bladder with increased bladder pressure in dogs. In their experiment, 
the blood flow of the bladder was increased in one dog, decreased in 
another dog and showed no change in a third dog. Doppler ultrasound 
studies have shown a high arterial resistive index in patients with BOO[21-
23]. These studies attributed their findings to ischemic changes in the 
bladder wall due to BOO. We think that time factor and chronicity of BOO 
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needed to develop this proposed ischemia should be taken into account, 
meaning that it may not occur in patients with recent history of LUTS/BOO. 
 
Figure 3. Classification responses of recursive partition analysis of the combined non-
invasive parameters of near-infrared spectroscopy (NIRS), prostate volume, maximum flow 
rate (Qmax), and International Prostate Symptom Score (IPSS). -log10(p-value); Prob = 
probability of having the diagnosis either obstructed or unobstructed. Total number of 
patients is 36. Number of true positives is 25 of 28, number of false positives is 1 of 8, 
number of true negatives is 7 of 8, and number of false negatives is 3 of 28. The sensitivity 
and specificity for obstruction is 89.3% and 88%, respectively [AUC: 0.96] 
NIRS in Men with LUTS 
Our findings may explain the inconsistency in NIRS patterns reported by 
Chung et al.[24]; the authors applied a non-invasive diagnostic algorithm of 
Qmax, PVR and qualitative NIRS patterns during voiding in men with LUTS. 
This algorithm came with low diagnostic value for BOO [AUC: 0.48] and 
interestingly 35% of patients with BOO had a downward, 15% a flat and 
50% an upward NIRS pattern. While 57% of patients with no BOO had a 
downward, 14% a flat and 29% of these patients had an upward NIRS 
pattern. 
An exploratory analysis was further performed to explore potential 
usefulness of NIRS in clinical practice. Results of RPA using the relative 
amplitudes of NIRS revealed their ability to correctly classify 88% of 
patients. While correct classification using prostate volume, IPSS, PVR and 
Qmax was only in 72% of patients. This indicates that NIRS data would be of 
value in the diagnosis of BOO independently. When NIRS data were 
combined with other parameters, like prostate volume, IPSS PVR, and Qmax, 
it significantly improved their diagnostic performance to predict BOO. A 
classification model was developed combining all these parameters, the 
software found no suitable cut in a PVR parameter that matches the 
desired fit, and therefore, PVR was automatically excluded in this model. 
This model successfully classified 89% of patients with 89.3% sensitivity and 
87.5% specificity, 96.3% PPV and 87.5% NPV for BOO [AUC: 0.96]. 
In previous work by Stothers et al.[8], the authors developed a classification 
and regression tree model using relative changes in the concentration of 
HHb and O2Hb from start to end points of urinary outflow with high 
sensitivity (100%) and specificity (89%) of NIRS to BOO. The mathematical 
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model applied in this study is fully described by Guevara et al.[25], which 
seems to be relatively difficult to comprehend and to use. 
 
NIRS is susceptible to motion artifacts[26]. Abdominal straining can lead to 
exaggerated NIRS response[27]. Four patients were excluded due to overt 
abdominal activity during voiding. The median relative amplitude of HHb 
was still higher in the obstructed group but with no statistical significance, 
which implies a potential increase in oxygen consumption or detrusor 
muscle fatigue during voiding, and therefore such data can still be of value 
even though spikes due to motion artifacts occur in the Pabd curve. For 
optimal application of NIRS in clinical practice, we recommend a strict 
instruction to the patients to avoid using abdominal straining during the 
measurements. We also would suggest extra monitoring of abdominal 
muscles during measurements using accelerometry. Finally, algorithms to 
cancel motion artifacts in NIRS for monitoring of brain activity are currently 
available[28,29]. It will be of great value to develop such algorithms for NIRS in 
Urology. 
 
A limitation in our study would be the difficulty to select the time window 
within which  NIRS changes were quantified in future studies using NIRS 
alone. A solution would be to apply point ‘A’ as the point of first deviation 
from a stable baseline before the onset of urinary flow. Another limitation 
would be the relatively small sample size to run a RPA. The resulted 
algorithm needs to be validated in larger studies. 
 
 
 
NIRS in Men with LUTS 
Conclusions 
When applying NIRS in men with LUTS during voiding, there is an overall 
trend of the relative median amplitude of HHb to be higher in men with 
BOO. This seems to be of physiologic origin due to increased the amount of 
oxygen consumed during voiding. NIRS data can be of diagnostic value in 
men with LUTS. An algorithm is being developed in our series that would 
provide hemodynamic, anatomical and functional evaluation of the lower 
urinary tract. Moreover, it esteems the impact of BOO on the patient. 
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Abstract 
Purpose 
Pressure flow studies and filling cystometry are currently the standard 
diagnostic urodynamic tests for lower urinary tract symptoms. A non-
invasive ultrasound based method for 2-dimensional monitoring of 
deformation (or strain) in the detrusor muscle may provide insight into 
detrusor muscle structural and dynamic properties related to pressure in 
physiological and disease conditions. 
Materials and Methods 
In a male patient population with lower urinary tract symptoms, strain in 
the detrusor muscle (perpendicular to the bladder wall) was estimated 
based on 2-dimensional radio frequency ultrasound imaging. The estimated 
strain was correlated to detrusor pressure and urinary flow rate using 
Spearman’s correlation coefficient. 
Results 
Twenty men (mean + SD age 66+6 years) with lower urinary tract symptoms 
were included in the study. Ultrasound data acquisition was successful in 13 
patients. In 7 patients data acquisition failed due to out-of-plane motion of 
the bladder wall during voiding or as a result of patient movement during 
acquisition. The estimated strain correlated positively with detrusor 
pressure in the 5 patients with an isovolumetric detrusor contraction 
(Spearman’s 0.70–0.99, p <0.05). Of 8 patients with urinary voiding during 
detrusor muscle contraction this correlation was significantly positive in 5 
patients (Spearman’s 0.52–0.81, p <0.05). 
Conclusions 
In 13 of 20 patients with lower urinary tract symptoms we demonstrated 
that strain in the detrusor muscle can be estimated using ultrasound 
imaging. The estimated strain correlated positively with the detrusor 
pressure. Optimal results were obtained in the pre-voiding phase, 
suggesting that ultrasound strain imaging can possibly be used to monitor 
detrusor muscle activity in real time. 
 
 
 
Noninvasive 2D Monitoring of Strain in the Detrusor Muscle in Patients with LUTS  
 
The bladder is a hollow smooth muscular structure. The function of the 
bladder is to store urine at a low pressure and, when the subject finds it 
appropriate, expel the urine until complete emptying is achieved. This 
requires coordination between detrusor muscle contraction and urethral 
outlet complex relaxation[1]. Disturbances in this coordination lead to 
voiding dysfunction such as bladder outlet obstruction. BOO is 
characterized by an increase in detrusor pressure with a decreased urinary 
flow rate during voiding[2]. Of men older than 60 years 25% require surgical 
treatment for BOO[³]. A pressure flow study is the current standard 
diagnostic urodynamic test for BOO. It studies the relation between bladder 
contractility and the resulting urine flow output[4]. To perform a PFS, 
transurethral and rectal pressure measurement catheters are necessary to 
quantify pdet. The latter represents the component of the intravesical 
pressure (pves) that results from contraction of the detrusor muscle in the 
bladder wall. Pdet is calculated by subtracting the abdominal pressure 
(measured with the rectal catheter) from pves (measured with the 
transurethral catheter)[2,5]. The urinary flow rate is measured using an 
external flowmeter. The invasive nature of PFS can lead to potential 
morbidities, such as urinary tract infections, discomfort and pain. 
Therefore, it is desirable to develop a non-invasive diagnostic technique to 
quantify detrusor muscle contractility. Such a non-invasive method could 
make diagnostic procedures more patient friendly. With ultrasound imaging 
it is possible to estimate deformation in biological tissues[6]. This 
deformation can be passive (as a result of applying an external 
compression) or active (in the case of a muscle contraction). This technique 
has been applied in dynamic monitoring of local skeletal muscle strain 
during contraction[7]. In the current study ultrasound technology was 
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applied to measure deformation of the detrusor muscle (strain) during and 
before the voiding phase. The hypothesis for the study was that for an 
increase in detrusor pressure the detrusor muscle needs to contract and 
that these contractions result in a change in muscle thickness. Monitoring 
this deformation may provide a clue to understanding the mechanisms of 
pves production in relation to detrusor muscle structural and dynamic 
properties in physiological and disease conditions.  
 
Patients and Methods 
Patient Population 
A total of 20 male patients with LUTS, referred to the Radboud University 
Nijmegen Medical Centre, Nijmegen, The Netherlands, for urodynamic 
investigations were included in the study. The research was performed in 
accordance with the Declaration of Helsinki of the World Medical 
Association[8] and was approved by the local ethical committee. Inclusion 
criteria were men older than 45 years with LUTS. Exclusion criteria were 
men with neurogenic voiding dysfunction, urinary tract infection, 
hematuria, previous radical prostatectomy or TURP. All 20 patients signed 
an informed consent. 
 
Data Acquisition 
All 20 patients underwent standard PFS (MMS Medical Measurement 
Systems, Enschede, The Netherlands). The prostate volume was measured 
using transrectal ultrasound and PVR was measured using a transurethral 
catheter. During voiding, RF ultrasound data were acquired using a SONOS® 
7500 ultrasound system equipped with a linear array transducer, 11-3L, fc 
7.5 MHz. At the end of the PF and just before the patient was given the 
Noninvasive 2D Monitoring of Strain in the Detrusor Muscle in Patients with LUTS  
 
command to void, the transducer was placed transversal above the pubic 
bone. Before placement a sufficient amount of ultrasound gel was applied 
on the skin and the transducer was placed gently in a stable manner to 
prevent unnecessary pressure application and potential affection of the 
bladder function. At each ultrasound recording the detrusor was identified 
as a delineated structure[9]. The urinary flow and pdet were recorded 
simultaneously using standard urodynamic equipment (figure 1). At the 
onset of an increase in pdet, approximately 20 seconds of ultrasound data 
were acquired prospectively at a frame rate of 2 Hz (2 patients) and 5 Hz 
(18 patients), and stored for offline analysis. The ultrasound data that 
corresponded to the increase in pdet toward the opening pressure were 
selected for further analysis. 
 
Data Analysis 
In each recording a ROI was selected that encompassed the detrusor 
muscle. To make sure that data analysis is performed on the same part of 
the detrusor muscle during the voiding cycle, the location of the ROI was 
corrected for axial and lateral movement of the bladder wall during 
acquisition using a tracking algorithm[10]. The deformation was estimated 
using a coarse-to-fine normalized cross correlation based strain 
algorithm[11]. A short explanation of this technique is presented in figure 2. 
The first (coarse) iteration was based on the envelope of the raw RF signals. 
The envelope was calculated by demodulation of the RF signals, i.e. the 
absolute value of the Hilbert transform of the RF signals. The following 
iterations (fine) were based on the raw RF signals. After each iteration, the 
estimated displacements were median filtered to reduce the accumulation 
of noise in the final displacement estimate. To improve the final 
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displacement estimate, local aligning and temporal stretching were 
applied[12]. Subsequently the axial strain was derived from the 
displacements using 2D least squares strain estimators[13]. In the resulting 
2D elastogram we calculated the mean and SD. The strain between the 
sequential ultrasound frames was then accumulated with respect to the 
first acquired frame, i.e. a previous muscle status. From each cumulative 
strain curve we identified εmax and from the urodynamic measurements we 
measured pdet at the maximum strain and pdet at the first acquired 
ultrasound frame. From these 2 values we calculated the change in 
detrusor pressure at maximum strain (Δpdet@εmax) with respect to the first 
acquired ultrasound frame (figure 1). The estimated axial strain in the 
detrusor muscle was correlated to pdet and Qura using Spearman’s 
correlation coefficient.  
 
Results 
Twenty patients with LUTS were included in the study. The demographic 
and urodynamic data and post-measurement treatment modality are 
shown in table 1. Urodynamic/clinical diagnosis and treatment modality for 
individual patients are shown in table 2. In 7 patients the acquisition of 
ultrasound data failed due to out-of-plane motion of the bladder wall 
during voiding or as a result of patient movement during acquisition.  
In 5 patients ultrasound data were acquired during an isovolumetric 
contraction (i.e. an increase in detrusor pressure without urinary flow) in 
the prevoiding phase. All 5 patients with isovolumetric contraction voided 
after the ultrasound data acquisition. In all 5 patients the axial strain 
showed a significantly positive correlation with pdet (Spearman’s coefficient 
0.70–0.99, p <0.05). An example of strain in the detrusor during an 
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isovolumetric contraction is shown in figure 3. In 8 patients ultrasound data 
were acquired during a part of the voiding phase in which there was an 
increase in detrusor pressure and urinary flow. In 5 of these 8 patients we 
found a significant positive correlation between the cumulative axial strain 
in the detrusor muscle and pdet (Spearman’s coefficient 0.52–0.81, p <0.05). 
One patient displayed a significant negative correlation and 2 patients 
showed a non-significant correlation. Also in 6 of these 8 patients we found 
a significant positive correlation between the axial strain and urinary flow 
(Spearman’s coefficient 0.32–0.90, p <0.05). In 1 patient this correlation 
was non-significant and in 1 there was a significant negative correlation 
(same patient as for pdet). A typical example of strain in the detrusor muscle 
during voiding is shown in figure 4. From the 13 patients with a successful 
ultrasound acquisition the maximum strain (εmax) is plotted versus the 
change in detrusor pressure at the maximum strain (Δpdet@εmax) as 
presented in figure 5. The isovolumic and the non-isovolumic cases are 
indicated by open and closed circles, respectively. 
 
Discussion 
In this study we presented preliminary data on strain in the detrusor muscle 
estimated from ultrasound imaging and postulated as an indication of 
detrusor contractility. In the 5 patients without urinary flow (isovolumetric 
contraction), as shown in figure 3, strain in the detrusor muscle was 
observed to increase with an increase in pdet. This measurement indicates 
that the thickening of the detrusor muscle is possibly related to the 
contraction of the muscle. Also, in these patients the correlation coefficient 
was higher than in the patients who showed an increase in urinary flow rate 
simultaneous with a detrusor pressure increase. 
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Table 1. Demographic and urodynamic data 
 Mean Median SD Min Max 
Age 66.9 66.0 6.5 54 82 
Body mass index (kg/m2) 25.5 25.1 4.3 16.0 34.7 
Prostate volume (cc) 83 63 66 19 296 
International prostate symptom score 17 17 8 1 31 
Detrusor opening pressure (cm H2O) 83 73 35 41 153 
Pdet at max flow rate (cm H2O) 76 67 30 40 129 
Free flow voided volume (ml) 175 137 209 0 935 
Free flow max flow rate (ml/sec) 7.70 7.50 5.0 0 17 
Free flow PVR (ml) 125 97 134 2 501 
PFS voided volume (ml) 206 208 175 0 652 
PFS max flow rate (ml/sec) 5.7 5.5 4.1 0 14 
PFS PVR (cc) 169 57 198 3 604 
  
 
A second plausible explanation for the thickening of the detrusor muscle 
could be the change of volume in the bladder as a result of voiding. A 
positive correlation with the urinary flow rate was observed in those 
patients in whom the correlation with the detrusor pressure was positive. 
An example, in which an increase in detrusor pressure is accompanied by an 
increase in urinary flow rate, is shown in figure 4. In these cases the 
correlation coefficient was lower than in the isovolumic cases. The findings 
in the (non)-isovolumic cases indicate that contraction of the detrusor 
muscle and change in bladder volume contribute to the measured strain in 
the detrusor muscle. It appears that the change in bladder volume also 
affects the measured strain and, thus, that the estimated detrusor muscle 
deformation is related to the combination of active muscle contraction and 
to volume change caused by voiding. This may reveal the importance of 
exploring the contribution of isovolumetric intravesical pressure in changing 
the detrusor strain and the effect of volume change on the amount and 
pattern of detrusor strain. Further (in vitro) investigation may provide more 
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information to understand the links among volume change, muscle 
contraction and the measured strain.  
 
Table 2. Urodynamic diagnosis and treatment modality in individual patients 
Pt No BOO Treatment 
1 Pos TURP 
2  Pos  TURP 
3 Neg Watchful waiting 
4 Pos Alpha blocker 
5 Pos On list for green light laser 
6 Neg Watchful waiting 
7 Pos TURP 
8 Neg  Alpha blocker 
9 Pos Green light laser prostatectomy 
10 Pos On list for green light laser 
11 Pos Clean intermittent self-catheterization 
12 Pos Open prostatectomy 
13 Pos Green light laser prostatectomy 
14 Pos Alpha blocker 
15 Pos On list for TURP or green light laser prostatectomy 
16 Pos Transurethral microwave therapy 
17 Pos Green light laser prostatectomy 
18 Pos Green light laser prostatectomy 
19 Neg Alpha blocker 
20 Pos On list for green light laser 
 
Theoretically, the best correlation between strain and pressure will be 
present during the pre-voiding phase. The reasoning is that during the pre-
voiding phase the detrusor muscle contracts, which results in an increase in 
intravesical pressure without volume change. In the patient with a 
significant negative correlation between detrusor strain and detrusor 
pressure, we measured a peak flow rate of 10 ml per second with a small 
increase in detrusor pressure (Δpdet 10 cm H2O) during the period of data 
141
Chapter 7 
 
 
 
Table 1. Demographic and urodynamic data 
 Mean Median SD Min Max 
Age 66.9 66.0 6.5 54 82 
Body mass index (kg/m2) 25.5 25.1 4.3 16.0 34.7 
Prostate volume (cc) 83 63 66 19 296 
International prostate symptom score 17 17 8 1 31 
Detrusor opening pressure (cm H2O) 83 73 35 41 153 
Pdet at max flow rate (cm H2O) 76 67 30 40 129 
Free flow voided volume (ml) 175 137 209 0 935 
Free flow max flow rate (ml/sec) 7.70 7.50 5.0 0 17 
Free flow PVR (ml) 125 97 134 2 501 
PFS voided volume (ml) 206 208 175 0 652 
PFS max flow rate (ml/sec) 5.7 5.5 4.1 0 14 
PFS PVR (cc) 169 57 198 3 604 
  
 
A second plausible explanation for the thickening of the detrusor muscle 
could be the change of volume in the bladder as a result of voiding. A 
positive correlation with the urinary flow rate was observed in those 
patients in whom the correlation with the detrusor pressure was positive. 
An example, in which an increase in detrusor pressure is accompanied by an 
increase in urinary flow rate, is shown in figure 4. In these cases the 
correlation coefficient was lower than in the isovolumic cases. The findings 
in the (non)-isovolumic cases indicate that contraction of the detrusor 
muscle and change in bladder volume contribute to the measured strain in 
the detrusor muscle. It appears that the change in bladder volume also 
affects the measured strain and, thus, that the estimated detrusor muscle 
deformation is related to the combination of active muscle contraction and 
to volume change caused by voiding. This may reveal the importance of 
exploring the contribution of isovolumetric intravesical pressure in changing 
the detrusor strain and the effect of volume change on the amount and 
pattern of detrusor strain. Further (in vitro) investigation may provide more 
Noninvasive 2D Monitoring of Strain in the Detrusor Muscle in Patients with LUTS  
 
information to understand the links among volume change, muscle 
contraction and the measured strain.  
 
Table 2. Urodynamic diagnosis and treatment modality in individual patients 
Pt No BOO Treatment 
1 Pos TURP 
2  Pos  TURP 
3 Neg Watchful waiting 
4 Pos Alpha blocker 
5 Pos On list for green light laser 
6 Neg Watchful waiting 
7 Pos TURP 
8 Neg  Alpha blocker 
9 Pos Green light laser prostatectomy 
10 Pos On list for green light laser 
11 Pos Clean intermittent self-catheterization 
12 Pos Open prostatectomy 
13 Pos Green light laser prostatectomy 
14 Pos Alpha blocker 
15 Pos On list for TURP or green light laser prostatectomy 
16 Pos Transurethral microwave therapy 
17 Pos Green light laser prostatectomy 
18 Pos Green light laser prostatectomy 
19 Neg Alpha blocker 
20 Pos On list for green light laser 
 
Theoretically, the best correlation between strain and pressure will be 
present during the pre-voiding phase. The reasoning is that during the pre-
voiding phase the detrusor muscle contracts, which results in an increase in 
intravesical pressure without volume change. In the patient with a 
significant negative correlation between detrusor strain and detrusor 
pressure, we measured a peak flow rate of 10 ml per second with a small 
increase in detrusor pressure (Δpdet 10 cm H2O) during the period of data 
142
Chapter 7 
 
 
acquisition. Such a change in volume could result in movement of the 
bladder wall, resulting in decorrelation of the RF signals and in an 
erroneous negative correlation. Previous to the urinary flow we did observe 
an increase in detrusor strain (εmax 8.8%) with a non varying pdet of 70 cm 
H2O since the start of the data acquisition. However, as soon as voiding 
started the estimated strain collapsed. This is probably the result of out-of-
plane motion of the bladder wall during data acquisition. To our knowledge, 
this is the first study to monitor detrusor muscle activity before and during 
voiding using ultrasonography. The strain in the detrusor muscle showed a 
positive trend with detrusor pressure in the 13 successful ultrasound 
acquisitions. The presented values of strain were cumulated with respect to 
the first acquired ultrasound image. Therefore, an increase in axial strain 
indicates thickening of the detrusor muscle with respect to a baseline 
muscle status, whereas a decrease indicates compression of the detrusor 
muscle. 
 
In 7 patients tracking of the bladder wall failed. The most common cause of 
this failure was out-of plane motion of the bladder wall during voiding or as 
a result of patient movement during acquisition. A possible solution for this 
out-plane-motion problem could be the extension of the data acquisition 
from 2 to 3 dimensions. Another cause was the challenge for the urologist 
to get the bladder wall adequately and in time in the imaging plane of the 
transducer. There was only a limited time window to place the transducer 
and find the bladder wall before the patient started to void. With the 
progression of the study the success rate of the ultrasound acquisitions 
increased. Another parameter to consider is the frame rate of data 
acquisition. The frame rate was set at 5 Hz in 18 patients and at 2 Hz in 2 
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patients. The latter frame rate increased the length of data acquisition but 
also decreased the correlation of ultrasound signals between sequential 
frames. The reduced frame rate also reduced the refresh rate of the image 
on the ultrasound system. This reduced refresh rate posed an extra 
challenge for the urologist to find and to keep the bladder wall in the 
imaging plane of the transducer. Therefore, a frame rate of 5 Hz was 
preferred. The selection of the frame rate to be used resulted from a trade-
off between the applicability of the technique for the urologist and the time 
window (in seconds) that could be acquired. The cause of this trade-off is 
the limited system data memory that limits the number of RF ultrasound 
frames that could be acquired. An increase in this data memory could, for 
example, extend the number of acquirable frames. 
 
At the current stage of this study we are working on extending the time 
window from a limited 5 seconds to 30 to 50 seconds, which will be of great 
value to obtain an optimal understanding of the dynamics of voiding by 
studying detrusor strain in a complete voiding cycle. Thus, ultrasound strain 
imaging could possibly be used as an indication of muscle contraction in the 
diagnosis of BOO. Most previous studies to develop non-invasive diagnostic 
techniques for BOO in patients with LUTS examined static parameters such 
as ultrasonographic measurement of detrusor wall thickness[14] or bladder 
weight[15]. Other trials investigated dynamic parameters during voiding such 
as perineal noise recording[16,17] and color Doppler urinary flow velocity[18] 
or near-infrared spectroscopy[19]. However these studies were lacking the 
information about detrusor contractility. This is important to avoid 
undiagnosed detrusor hypocontractility, especially if surgical interference is 
to be considered[20]. For a long time this made conventional PFS the gold 
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standard diagnostic technique for BOO in patients with LUTS. Ultrasonic 
monitoring of detrusor muscle contractility presents the first direct non-
invasive approach to quantify detrusor contractility before voiding. This 
approach can be of great usefulness in the assessment of detrusor muscle 
structural and dynamic properties in relation to its function in health and 
disease conditions. This assessment can then be performed without the 
necessity of an invasive PFS with the potential morbidities of discomfort, 
pain and urinary tract infection.  
 
Conclusions 
In 13 of 20 patients with LUTS we showed that strain in the detrusor can be 
estimated using ultrasound imaging. The estimated strain correlated 
positively with the detrusor pressure in the pre-voiding phase. This suggests 
that ultrasound strain imaging can possibly be used to monitor detrusor 
muscle activity in real time.  
 
 
Noninvasive 2D Monitoring of Strain in the Detrusor Muscle in Patients with LUTS  
 
 
Figure 1. Analysis of urodynamic signals and ultrasound imaging. At onset of voiding 
(increase in pdet) ultrasound data acquisition started. From ultrasound data cumulative axial 
strain was derived in selected ROI and maximum axial strain (εmax) was identified. Detrusor 
pressure at maximum strain (εmax) and detrusor pressure at start of acquisition (ε0) were 
identified in urodynamic signals, and used to calculate change in detrusor pressure at 
maximum strain. 
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Figure 2. Estimation of time delay _ from RF ultrasound line before and after deformation. 
From B-mode images (A) RF line is selected (B). Region of approximately 1 mm around is 
selected in pre-deformation line and of approximately 2 mm is selected in post deformation 
line (C). Then 2 regions are cross-correlated between RF line before and after deformation 
(D). One cross- correlation function is calculated from envelope of RF signal (broken line) and 
one from RF line (solid line). Through maximum of cross-correlation function and points left 
and right of maximum, parabolic function is fitted to achieve sub pixel accuracy in estimation 
of time delay. Time delay multiplied by speed of sound in tissue results in displacement 
estimate of selected region. 
 
 
 
Figure 3. Example of axial strain in detrusor muscle in patient with isovolumetric contraction 
of detrusor muscle. Axial strain increases with increase in detrusor pressure without any 
change in bladder volume. 
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Figure 4. Example of axial strain in detrusor muscle in patient with increase in Qura 
simultaneous with increase in detrusor pressure. Axial strain increases with increase in 
detrusor pressure accompanied by change in bladder volume. 
 
 
Figure 5. Detrusor pressure change between start of ultrasound data acquisition and point of 
maximum strain as function of maximum strain. Open circles represent patients with 
isovolumetric contraction and closed circles represent those with non-isovolumetric 
contraction. 
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SUMMARY 
AND FUTURE DIRECTIONS 
 
 
Summary 
 
Filling cystometry is currently the standard diagnostic test for detrusor 
overactivity (DO) in patients with overactive bladder symptoms (OAB). 
Pressure flow study (PFS) is the standard test for the diagnosis of bladder 
outlet obstruction (BOO) in patients with voiding lower urinary tract 
symptoms (LUTS). However, these tests are invasive and can cause 
potential morbidities, such as urinary tract infections, discomfort and pain. 
Therefore, in this thesis we described new non-invasive techniques for 
mentoring of bladder activity in patients with functional lower urinary tract 
disorders in both filling and voiding phases. 
 
In chapters 1 and 4 reviewing the literature of the clinical studies that have 
been performed to develop non-invasive diagnostic tools for storage phase 
disorders revealed that the ultrasonographic parameters, such as bladder 
wall thickness (BWT), detrusor wall thickness (DWT) and ultrasound 
estimated bladder weight (UEBW) have been examined as surrogates for 
DO in patients with OAB syndrome. Only few studies could present 
potential diagnostic cut-offs for DO. However, these studies showed that 
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the methodology is not always consistent and not very standardized. 
Studies that investigated laboratory biomarkers such as nerve growth factor 
showed substantial correlation with DO and/or OAB, but with low 
specificity for DO as it can be increased in response to BOO, interstitial 
cystitis and prostatitis. In conclusion, the above-mentioned techniques 
cannot be applied reliably in routine clinical practice yet. 
 
Clinical studies that have been done to develop non-invasive diagnostic 
tools for voiding phase disorders, namely BOO, in men with voiding LUTS 
followed two approaches: The first approach was indirect measurement of 
the isovolumetric bladder pressure during voiding, which showed good 
accuracy as compared to the conventional PFS. We think that estimation of 
the abdominal pressure contribution and its impact on the results will add 
more value to this technique. The second approach was ultrasonographic 
measurement of non-urodynamic parameters, such as BWT, DWT and 
UEWB, these parameters showed good correlation to BOO with some cut-
offs for BOO diagnosis were developed and recently, guidelines have been 
proposed to standardize these measurements. 
 
Other techniques of Doppler ultrasound urinary flow velocity 
measurement, perineal sound recording, near-infrared spectroscopy (NIRS), 
and Doppler resistive index of bladder wall arteries all show growing 
evidence, but their reproducibility still needs to be tested in larger patients 
study groups. Studies that combined various non-urodynamic parameters 
improved their diagnostic performance statistically. However, these 
parameters were diverse regarding the pathophysiological and clinical 
concerns. NIRS detects the hemodynamic changes caused by detrusor 
 
contractions. However, more basic and clinical studies are needed to 
evaluate the independent value of this technology in the non-invasive 
diagnosis of BOO. 
 
NIRS is an optical technology. NIRS of biological tissues enables non-
invasive evaluation of oxygen dependent hemodynamic changes in these 
tissues via measurement of the relevant changes in the concentration of 
hemoglobin. Oxy-hemoglobin (O2Hb) and deoxy-hemoglobin (HHb) 
represent the oxygen supply and consumption of the tissue under 
monitoring, respectively. The sum of O2Hb and HHb is Hbsum, it represents 
the total blood perfusion of this tissue. 
 
In chapter 2 we explored the feasibility of NIRS to detect the hemodynamic 
effect of DO during filling cystometry. Our theory was that NIRS can detect 
the changes in oxygen supply and oxygen consumption of the bladder wall 
during DO. NIRS curves demonstrated apparently significant deviation from 
baseline concomitant with the start of DO in 35 of 39 occasions; all 
deviations occurred within the time period of the IDC. The median detrusor 
pressure at maximum flow rate in DO episodes without significant 
deviations in NIRS was lower than in those with significant deviations. NIRS 
could identify 90% of DO episodes via detection of their concomitant 
imprint on NIRS signals. 
 
We proposed three possible explanations for the effects of DO on NIRS 
imprint. The first possibility is an autogenic hemodynamic phenomenon of 
DO. The second possibility is a compressive pattern of bladder wall vessels 
due to the sudden contraction during DO. The last possibility is an expected 
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tools for voiding phase disorders, namely BOO, in men with voiding LUTS 
followed two approaches: The first approach was indirect measurement of 
the isovolumetric bladder pressure during voiding, which showed good 
accuracy as compared to the conventional PFS. We think that estimation of 
the abdominal pressure contribution and its impact on the results will add 
more value to this technique. The second approach was ultrasonographic 
measurement of non-urodynamic parameters, such as BWT, DWT and 
UEWB, these parameters showed good correlation to BOO with some cut-
offs for BOO diagnosis were developed and recently, guidelines have been 
proposed to standardize these measurements. 
 
Other techniques of Doppler ultrasound urinary flow velocity 
measurement, perineal sound recording, near-infrared spectroscopy (NIRS), 
and Doppler resistive index of bladder wall arteries all show growing 
evidence, but their reproducibility still needs to be tested in larger patients 
study groups. Studies that combined various non-urodynamic parameters 
improved their diagnostic performance statistically. However, these 
parameters were diverse regarding the pathophysiological and clinical 
concerns. NIRS detects the hemodynamic changes caused by detrusor 
 
contractions. However, more basic and clinical studies are needed to 
evaluate the independent value of this technology in the non-invasive 
diagnosis of BOO. 
 
NIRS is an optical technology. NIRS of biological tissues enables non-
invasive evaluation of oxygen dependent hemodynamic changes in these 
tissues via measurement of the relevant changes in the concentration of 
hemoglobin. Oxy-hemoglobin (O2Hb) and deoxy-hemoglobin (HHb) 
represent the oxygen supply and consumption of the tissue under 
monitoring, respectively. The sum of O2Hb and HHb is Hbsum, it represents 
the total blood perfusion of this tissue. 
 
In chapter 2 we explored the feasibility of NIRS to detect the hemodynamic 
effect of DO during filling cystometry. Our theory was that NIRS can detect 
the changes in oxygen supply and oxygen consumption of the bladder wall 
during DO. NIRS curves demonstrated apparently significant deviation from 
baseline concomitant with the start of DO in 35 of 39 occasions; all 
deviations occurred within the time period of the IDC. The median detrusor 
pressure at maximum flow rate in DO episodes without significant 
deviations in NIRS was lower than in those with significant deviations. NIRS 
could identify 90% of DO episodes via detection of their concomitant 
imprint on NIRS signals. 
 
We proposed three possible explanations for the effects of DO on NIRS 
imprint. The first possibility is an autogenic hemodynamic phenomenon of 
DO. The second possibility is a compressive pattern of bladder wall vessels 
due to the sudden contraction during DO. The last possibility is an expected 
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movement of the whole bladder wall with its vascular content during the 
DO, leading to substantial change in the volume of blood crossing the 
imaging scale of NIRS. 
 
To check for the presence of motion artifacts in NIRS curves, we used the 
extra surface EMG monitoring of the abdominal wall muscles. Eleven of the 
35 DO with concomitant deviations in NIRS curves had motion artifacts, 
either due to change in patient position during the session or due to their 
trials to withhold urine at moments of urgency during the DO. 
 
It could be argued that the urodynamicists, while gauging the NIRS traces, 
were aware of the pressure and flow events of the corresponding 
cystometry channels. Therefore, to have more blinded methodology, this 
point was considered on conducting the larger study described in chapter 3. 
 
In chapter 3 we determined the reproducibility and accuracy of NIRS in the 
diagnosis of DO in a larger group of patients with OAB syndrome. Three 
urodynamicists were asked to identify deviations in NIRS at the time of DO. 
Agreement among the urodynamicists was ‘almost perfect’ for cystometry, 
while it was ‘substantial’ for NIRS. We think this can be explained by the 
familiarity of the urodynamicists with the classic setup of the conventional 
cystometry.  
 
NIRS was highly sensitive to detect DO episodes: 92% for Hbsum, 82% for 
O2Hb and 78% for HHb. Hbsum curve being the sum of O2Hb and HHb can 
explain its higher sensitivity for DO. NIRS curves had a good diagnostic 
performance as predictors of DO, giving a range of AUC values of 0.80–0.85 
 
for O2Hb curves, 0.73–0.84 for HHb curves and 0.80–0.82 for Hbsum curves, 
as calculated for the three observers. The overall specificity of NIRS 
parameters for DO was 86% for O2Hb, 80% for HHb, and 72% for Hbsum. The 
sensitivity and specificity were high in this study because they were tested 
in a data sample after exclusion of cases with motion artifacts. However, 
the situation should be different when the clinical applicability of NIRS will 
be addressed. 
 
The two above-mentioned exploratory studies conducted at the 
Department of Urology of the Radboud University Nijmegen Medical Centre 
revealed that NIRS curves correlate well with DO episodes detected by 
conventional urodynamics. NIRS detects the hemodynamic changes caused 
by detrusor contractions. This implies that NIRS can be used to study the 
regulatory mechanisms of blood perfusion to the bladder during filling as 
well as the hemodynamic phenomenon accompanying DO. NIRS is a 
reproducible, non-invasive potential diagnostic tool, with high sensitivity for 
DO in patients with OAB symptoms. However, its value in clinical practice 
remains to be determined. 
 
In chapter 5 the applicability and accuracy of multiple uroflowmetry 
measurements using a new disposable home-based urinary flowmeter 
(QSingle) in the diagnosis and management of men with LUTS were explored. 
The diagnostic performance of this new method was compared to 
measurements with home-based digital device and compared to single 
clinical measurement. This was a prospective, multicentre study. The mean 
Qmax obtained using QSingle device did not differ from that obtained with 
clinic method. 
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conventional urodynamics. NIRS detects the hemodynamic changes caused 
by detrusor contractions. This implies that NIRS can be used to study the 
regulatory mechanisms of blood perfusion to the bladder during filling as 
well as the hemodynamic phenomenon accompanying DO. NIRS is a 
reproducible, non-invasive potential diagnostic tool, with high sensitivity for 
DO in patients with OAB symptoms. However, its value in clinical practice 
remains to be determined. 
 
In chapter 5 the applicability and accuracy of multiple uroflowmetry 
measurements using a new disposable home-based urinary flowmeter 
(QSingle) in the diagnosis and management of men with LUTS were explored. 
The diagnostic performance of this new method was compared to 
measurements with home-based digital device and compared to single 
clinical measurement. This was a prospective, multicentre study. The mean 
Qmax obtained using QSingle device did not differ from that obtained with 
clinic method. 
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While it was significantly higher for the digital device, mean voided volumes 
recorded with each device differed marginally. Patients reported good 
handling capabilities using the QSingle device. It is concluded that applying 
this new home-based uroflowmetry can offer an easy and viable alternative 
of comparable accuracy to reduce the number of visits to the clinic in the 
follow-up and management of patients with LUTS. 
 
Chapter 6 presents results of an application of a quantitative approach of 
NIRS in monitoring of voiding activity in 36 men with LUTS suggestive of 
obstruction. An algorithm was developed that combined quantitative NIRS 
with other non-invasive parameters of ultrasonographic measurement of 
the prostate volume, International Prostate Symptom Score (IPSS), PVR and 
Qmax. Raw NIRS data were used for quantifying amplitudes of change in the 
concentration of HHb, O2Hb and Hbsum in the bladder wall during voiding 
activity in relation to changes in detrusor pressure. 
 
The hypothesis was that detrusor muscle contraction during voiding 
requires energy production with expected increase in oxygen demands and 
consumption. Results of PFS with simultaneous NIRS of the bladder during 
voiding revealed that the median amplitude of change in HHb was 
significantly higher in the obstructed group, which reflects higher oxygen 
consumption of the bladder wall during voiding. Patients were classified as 
obstructed or unobstructed based on detrusor/flow plot according to 
Griffiths. Recursive partition analysis (RPA) using amplitudes of change in 
HHb, O2Hb and Hbsum revealed the ability of NIRS to predict obstruction 
with 96% sensitivity and 62% specificity for BOO. However, 4 patients (12%) 
were misclassified. 
 
When RPA was done using other non-invasive parameters, like prostate 
volume, IPSS, PVR and Qmax, this combination revealed a misclassification of 
10 patients (28%) with 71% sensitivity for BOO. This indicates that NIRS 
showed better prediction of BOO than the other non-invasive parameters in 
our series. When NIRS parameters were combined with other non-invasive 
parameters of prostate size, IPSS, PVR and Qmax NIRS significantly (P = 
0.001) improved their low diagnostic performance to predict BOO. A 
reclassification model was developed combining all these parameters. This 
model successfully reclassified patients in our series with 89.3% sensitivity 
and 88% specificity for BOO [AUC: 0.96]. 
 
The algorithm combining NIRS, prostate volume, IPSS and Qmax is not only a 
non-invasive diagnostic method of BOO, but also provides hemodynamic, 
anatomical, and functional evaluation of the lower urinary tract. Moreover, 
it takes in consideration the impact of BOO on the patient. Therefore, our 
algorithm can be a valuable alternative to other invasive and non-invasive 
diagnostic tools for BOO. 
 
In chapter 7 we presented the results of an experiment to quantify the 
detrusor muscle strain during voiding using the 2D ultrasonography. It is the 
first direct non-invasive approach to quantify detrusor contractility before 
voiding. This approach can be of great usefulness in assessment of detrusor 
muscle structural and dynamic properties in relation to its function in 
health and disease. Though the primary results are relatively promising as 
we could prove - in most cases - that detrusor strain significantly with the 
change in detrusor pressure, a more extended time window of 
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non-invasive diagnostic method of BOO, but also provides hemodynamic, 
anatomical, and functional evaluation of the lower urinary tract. Moreover, 
it takes in consideration the impact of BOO on the patient. Therefore, our 
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In chapter 7 we presented the results of an experiment to quantify the 
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first direct non-invasive approach to quantify detrusor contractility before 
voiding. This approach can be of great usefulness in assessment of detrusor 
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health and disease. Though the primary results are relatively promising as 
we could prove - in most cases - that detrusor strain significantly with the 
change in detrusor pressure, a more extended time window of 
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measurement that covers the whole voiding activity would be more 
informative. 
 
Currently, trials are done at our center to extend the time window from a 
limited 5 s. to be 30 to 50 s., which will be of great value to obtain optimal 
understanding of the dynamics of voiding by studying detrusor strain in a 
complete voiding cycle and to conclude the actual value of this technique in 
the diagnosis of voiding dysfunctions. Out-plane-motion problem could be 
the extension of the data acquisition from 2D to 3D.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future directions 
 
Routine diagnostic approaches for functional lower urinary tract disorders 
are: history taking from the patient, voiding diaries, Urgency Severity 
Scores, IPSS, Quality of Life questionnaires, clinical examination, cystoscopy 
and uroflowmetry. 
Conventional filling cystometry and pressure flow studies are currently the 
standard tools for voiding LUTS and OAB symptoms. These tools necessitate 
insertion of transurethral and rectal catheters. Therefore, it is invasive and 
potentially morbid and it does not seem to be possible - at least in the near 
future - to avoid using these catheters to lessen the invasiveness 
conventional of urodynamics. 
What are the key parameters in the diagnosis of voiding LUTS and/or OAB 
symptoms? If we answer this question we will be able to understand the 
rational of non-invasive urodynamics. Urodynamics estimates the pressure 
changes inside the bladder and abdomen to conclude:  detrusor muscle 
compliance, the abrupt increase in detrusor pressure during DO and 
pressure exerted by detrusor pressure to void against bladder outlet 
resistance. 
 
Over the last few decades, efforts have been directed towards 
development of various urodynamic and non-urodynamic approaches to 
estimate directly or –most of the time - indirectly functional and anatomical 
changes in detrusor muscle all over the voiding cycles. An example of 
urodynamic non-invasive approaches is the measurement of isovolumetric 
vesical pressure using penile cuff method. Non-urodynamic approaches can 
be classified as imaging approaches like ultrasonic measurement of BWT, 
157
 
 
 
 
measurement that covers the whole voiding activity would be more 
informative. 
 
Currently, trials are done at our center to extend the time window from a 
limited 5 s. to be 30 to 50 s., which will be of great value to obtain optimal 
understanding of the dynamics of voiding by studying detrusor strain in a 
complete voiding cycle and to conclude the actual value of this technique in 
the diagnosis of voiding dysfunctions. Out-plane-motion problem could be 
the extension of the data acquisition from 2D to 3D.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future directions 
 
Routine diagnostic approaches for functional lower urinary tract disorders 
are: history taking from the patient, voiding diaries, Urgency Severity 
Scores, IPSS, Quality of Life questionnaires, clinical examination, cystoscopy 
and uroflowmetry. 
Conventional filling cystometry and pressure flow studies are currently the 
standard tools for voiding LUTS and OAB symptoms. These tools necessitate 
insertion of transurethral and rectal catheters. Therefore, it is invasive and 
potentially morbid and it does not seem to be possible - at least in the near 
future - to avoid using these catheters to lessen the invasiveness 
conventional of urodynamics. 
What are the key parameters in the diagnosis of voiding LUTS and/or OAB 
symptoms? If we answer this question we will be able to understand the 
rational of non-invasive urodynamics. Urodynamics estimates the pressure 
changes inside the bladder and abdomen to conclude:  detrusor muscle 
compliance, the abrupt increase in detrusor pressure during DO and 
pressure exerted by detrusor pressure to void against bladder outlet 
resistance. 
 
Over the last few decades, efforts have been directed towards 
development of various urodynamic and non-urodynamic approaches to 
estimate directly or –most of the time - indirectly functional and anatomical 
changes in detrusor muscle all over the voiding cycles. An example of 
urodynamic non-invasive approaches is the measurement of isovolumetric 
vesical pressure using penile cuff method. Non-urodynamic approaches can 
be classified as imaging approaches like ultrasonic measurement of BWT, 
158
 
 
 
 
DWT and UEBW, and laboratory approaches like estimation of urinary NGF 
and other neurotrophins. 
In this thesis, we presented two novel imaging approaches to monitor 
storage and voiding phase events, applying two different technologies: NIRS 
of the bladder in patients with voiding LUTS and patients with OAB 
symptoms, and 2D ultrasonography in monitoring of voiding activity in men 
with LUTS. Our thesis presented also for an interesting home-based urinary 
flowmeter as a non-invasive tool to measure urinary flow parameters. 
NIRS can detect the hemodynamic effects of bladder contractions, either 
involuntary contractions during filling, or voluntary contractions during 
voiding. Therefore, NIRS can indirectly indicate the presence of abnormal 
bladder activity during filling, namely DO. 
NIRS showed high sensitivity and specificity for DO in clean data sample 
without motion artifacts. In addition to its potential independent diagnostic 
ability for some functional lower urinary tract disorders, such as DO and 
BOO, NIRS can provide adjuvant hemodynamic evaluation of these 
disorders. This advantage can open the way for the development of new 
diagnostic and treatment strategies for these disorders based on 
hemodynamic pathophysiological aspects. NIRS was successfully combined 
with some other parameters of prostate volume, IPSS, and maximum flow 
rate in the diagnosis of BOO in men with voiding LUTS. 
2D ultrasonography and its novel application in monitoring of bladder 
activities, gave a direct access for the first time to monitor dynamic changes 
in bladder wall and specifically the detrusor muscle component. All 
previous imaging approaches were concerned with static measurement of 
BWT, DWT and UEBW, as indications for bladder hypertrophy in response 
 
to DO and/or BOO. Our results indicate a considerable correlation between 
detrusor strain measured by 2D ultrasonography and detrusor pressure. 
Therefore, we try to explore the possibility of replacing the invasive 
urodynamic measurement of detrusor pressure by 2D ultrasonographic 
estimation of detrusor strain in the near future. 
Some limitations emerged during developing our NIRS and 2D 
ultrasonography techniques: importantly, NIRS susceptibility to motion 
artifacts and the limited time window for 2D monitoring of detrusor 
activity. 
Future studies should investigate the possibility of developing algorithms to 
cancel motion artifacts in NIRS in order to introduce this promising 
technique as a non-invasive diagnostic tool for DO and/or BOO in clinical 
practice. EMG or accelerometry of the abdominal muscles could be a useful 
tool to monitor the effect of abdominal activity during NIRS measurements. 
Some more technical work is needed to extend the time window of 
measurement to cover the whole act of voiding. Out-plane-motion 
problems could be the extension of the data acquisition from 2D to 3D. 
The home-based QSingle flowmetry device showed comparable results to the 
standard clinic-based method. It is easy to manage by patients in their own 
environment with the potential to reduce the number of clinic visits.  
When the clinical setup and reproducibility of NIRS and 2D sonographic 
measurement of detrusor strain techniques described in our thesis are well 
established they will become reliable, independent, diagnostic tools - or at 
least - a useful screening tool for BOO and DO in patients with functional 
lower urinary tract disorders. 
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Various combinations of non-invasive diagnostic tools could be of high 
value in clinical setup for functional lower urinary tract disorders. 
Sonographic measurement of BWT with NIRS monitoring of the bladder 
activity could give valuable insight to the correlation between the 
hypertrophic and the vascular changes of the bladder wall due to BOO or 
DO. 
2D ultrasonographic estimation of detrusor strain can be combined with 
uroflowmetry and new nomograms could be developed plotting 2D 
detrusor strain versus flow rate values in the diagnosis of BOO. 
We are currently developing qualitative and quantitative NIRS and 2D 
sonographic parameters to predict BOO and DO. A small wireless NIRS or 
bladder-scan devices would be placed over the bladder in combination with 
a home-based flowmeter will be the future setup of a small functional 
urology unit. Moreover, smart phone and tablet devices applications can be 
designed for more public and convenient use of our novel diagnostic tools. 
There would be a possibility of having a smart toilet supplied with NIRS, 2D 
ultrasound and a flowmeter. Data collected from patients at home will be 
easily transferred to a remote-processing computer for the convenience of 
the patients.  
Future directions should also explore the possibility of recording changes in 
the intravesical pressure. It is obvious that all above-mentioned studies 
tried to approach this important parameter either in a direct or indirect 
way, for example, it could be interesting to develop a device that records 
intravesical changes similar to the one used by ophthalmologists. Presence 
of such a device can lead to jump in the field of urodynamics when NIRS 
and 2D ultrasound will be combined with a home-based flowmeter to 
replace the conventional urodynamics. 
 
sAMENVATTING 
Urodynamica omvat de gestandaardiseerde diagnostiek voor afwijkingen en 
ziektes aan het urinestelsel. Deze is invasief te noemen en kan zodoende 
pijn en ongerief bij de patiënt veroorzaken. Deze thesis beschrijft nieuwe 
innovatieve en niet-invasieve urodynamische technieken ter monitoring van 
de blaasactiviteit in patiënten met functionele afwijkingen aan het 
urinewegstelsel.  
 
Zowel hoofdstuk 1 en 4 beschrijven literatuuroverzichten van de klinische 
studies die zijn uitgevoerd voor de ontwikkeling van niet-invasieve 
diagnostische instrumenten voor functionele afwijkingen aan het 
urinewegstelsel. 
 
In hoofdstuk 2 is de haalbaarheid onderzocht van de toepassing van near-
infrared spectroscopie (NIRS) in de detectie van het hemodynamische 
effect van detrusor overactiviteit (DO) gedurende cystometrie. De theorie 
behelst dat NIRS de veranderingen in zuurstofvoorziening en 
zuurstofconsumptie in de blaaswand kan detecteren gedurende DO. 
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Hoofdstuk 3 beschrijft de reproduceerbaarheid en nauwkeurigheid van 
NIRS in de diagnose van DO in een grote groep patiënten met overactieve 
blaas (OAB) syndroom. 
 
Hoofdstuk 5 omschrijft de toepasbaarheid en nauwkeurigheid van 
meerdere uroflowmetrische metingen met een nieuwe disposable 
flowmeter in de diagnose en aansturing van mannen met lagere urine 
traject symptomen (LUTS). 
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DWT  Detrusor wall thickness 
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ICS  International Continence Society 
IDC  Involuntary detrusor contractions 
IPSS  International Prostate Symptom Score 
IVPP  Intravesical prostatic protrusion 
Kc  Cohen’s Kappa statistics 
Kf Fleiss’ Kappa statistics 
 LR  Likelihood ratio 
LUTS  Lower urinary tract symptoms 
LSQSE  Least Squares Strain Estimators 
Ml/S  Milliliter per second 
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NIRS  Near-infrared spectroscopy 
NGF  Nerve growth factor 
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OAB  Overactive bladder 
O2Hb  Oxyhemoglobin 
Pabd  Abdominal pressure 
Pdet  Detrusor pressure 
Pdet.max   Maximum amplitude of rise in detrusor pressure  
PFS  Pressure flow study 
PPV  Positive predictive value 
P  Level of significance 
Pves  Intravesical pressure 
PVR  Postvoid residual  
pg  Picogram 
Qmax  Maximum urinary flow rate  
Qura  Flow rate curve 
QUADAS   Quality assessment of diagnostic accuracy studies 
Qclinic  Clinical urowflometer 
Qdigital  Digital uroflowmeter 
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QSingle  Home-based uroflowmeter 
RI  Resistive index 
RF  Radiofrequency 
ROC  Receiver operating characteristics curve  
ROI  Region-of-interest 
SUI  Stress urinary incontinence 
TVUS   Trans vaginal ultrasound 
TAUS  Trans abdominal ultrasound 
TLUS  Trans labial ultrasound 
TRUS  Trans rectal ultrasound 
TURP  Trans urethral resection of the prostate 
UEBW  Ultrasonographic estimated bladder weight 
UTI  Urinary tract infection 
V  Velocity 
Vin  Volume of fluid infused in the bladder 
VR  Velocity ratio 
Vs  Versus 
Δpdet@εmax Detrusor pressure at maximum strain 
εmax  Maximum strain 
µmol/l  Micromol per liter 
 
